array(1) { [0]=> object(Apache_Solr_Document)#24 (3) { ["_documentBoost":protected]=> bool(false) ["_fields":protected]=> array(6) { ["content_id"]=> array(1) { [0]=> string(14) "DIRECTORY_3462" } ["content_title"]=> array(1) { [0]=> string(16) "MASSIMO ANDREONI" } ["description"]=> array(1) { [0]=> string(287410) "Inserire qui il curriculumInsert here the curriculum a:268:{i:0;a:14:{s:9:"citazione";s:289:"Infante, M., Buoso, A., Pieri, M., Lupisella, S., Nuccetelli, M., Bernardini, S., et al. (2021). Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1-16.";s:4:"data";s:10:"2021-02-18";s:2:"id";s:20:"PUBBLICAZIONE_411294";s:6:"handle";s:11:"2108/266534";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/13";s:9:"metadata4";N;s:9:"metadata5";s:139:"Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study";s:9:"metadata6";s:135:"Infante, M; Buoso, A; Pieri, M; Lupisella, S; Nuccetelli, M; Bernardini, S; Fabbri, A; Iannetta, M; Andreoni, M; Colizzi, V; Morello, M";s:9:"metadata7";s:29:"10.1080/07315724.2021.1877580";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:1;a:14:{s:9:"citazione";s:217:"Liguori, C., Pierantozzi, M., Spanetta, M., Sarmati, L., Cesta, N., Iannetta, M., et al. (2021). Depressive and anxiety symptoms in patients with SARS-CoV2 infection. BRAIN, BEHAVIOR, & IMMUNITY. HEALTH, 278, 339-340.";s:4:"data";s:4:"2021";s:2:"id";s:20:"PUBBLICAZIONE_404993";s:6:"handle";s:11:"2108/260988";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/17";s:9:"metadata4";N;s:9:"metadata5";s:68:"Depressive and anxiety symptoms in patients with SARS-CoV2 infection";s:9:"metadata6";s:177:"Liguori, C; Pierantozzi, M; Spanetta, M; Sarmati, L; Cesta, N; Iannetta, M; Ora, J; Mina, GG; Puxeddu, E; Balbi, O; Pezzuto, G; Magrini, A; Rogliani, P; Andreoni, M; Mercuri, NB";s:9:"metadata7";s:25:"10.1016/j.jad.2020.09.042";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:2;a:14:{s:9:"citazione";s:320:"Malagnino, V., Teti, E., Compagno, M., Coppola, L., Salpini, R., Svicher, V., et al. (2021). HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA After Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort. MICROORGANISMS, 9(2), 1-13.";s:4:"data";s:4:"2021";s:2:"id";s:20:"PUBBLICAZIONE_413247";s:6:"handle";s:11:"2108/268343";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/04";s:9:"metadata4";N;s:9:"metadata5";s:198:"HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA After Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort";s:9:"metadata6";s:205:"Malagnino, V; Teti, E; Compagno, M; Coppola, L; Salpini, R; Svicher, V; Basso, M; Battagin, G; Panese, S; Cristina Rossi, M; Scaggiante, R; Zago, D; Iannetta, M; Giuseppe Parisi, S; Andreoni, M; Sarmati, L";s:9:"metadata7";s:29:"10.3390/microorganisms9020396";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:3;a:14:{s:9:"citazione";s:264:"Macchi, B., Frezza, C., Marino-Merlo, F., Minutolo, A., Stefanizzi, V., Balestrieri, E., et al. (2020). Appraisal of a Simple and Effective RT-qPCR Assay for Evaluating the Reverse Transcriptase Activity in Blood Samples from HIV-1 Patients. PATHOGENS, 9(12), 1-9.";s:4:"data";s:10:"2020-12-13";s:2:"id";s:20:"PUBBLICAZIONE_407075";s:6:"handle";s:11:"2108/262815";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore BIO/19";s:9:"metadata4";N;s:9:"metadata5";s:136:"Appraisal of a Simple and Effective RT-qPCR Assay for Evaluating the Reverse Transcriptase Activity in Blood Samples from HIV-1 Patients";s:9:"metadata6";s:139:"Macchi, B; Frezza, C; Marino-Merlo, F; Minutolo, A; Stefanizzi, V; Balestrieri, E; Cerva, C; Sarmati, L; Andreoni, M; Grelli, S; Mastino, A";s:9:"metadata7";s:24:"10.3390/pathogens9121047";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:4;a:14:{s:9:"citazione";s:391:"Salpini, R., Battisti, A., Piermatteo, L., Carioti, L., Anastasiou, O.E., Gill, U.S., et al. (2020). Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection. EMERGING MICROBES & INFECTIONS, 9(1), 928-939.";s:4:"data";s:7:"2020-12";s:2:"id";s:20:"PUBBLICAZIONE_408261";s:6:"handle";s:11:"2108/263821";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/07";s:9:"metadata4";N;s:9:"metadata5";s:242:"Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection";s:9:"metadata6";s:434:"Salpini, R; Battisti, A; Piermatteo, L; Carioti, L; Anastasiou, OE; Gill, US; Di Carlo, D; Colagrossi, L; Duca, L; Bertoli, A; La Rosa, KY; Fabeni, L; Iuvara, A; Malagnino, V; Cerva, C; Lichtner, M; Mastroianni, CM; De Sanctis, GM; Paoloni, M; Marignani, M; Pasquazzi, C; Iapadre, N; Parruti, G; Vecchiet, J; Sarmati, L; Andreoni, M; Angelico, M; Grelli, S; T Kennedy, P; Verheyen, J; Aquaro, S; Silberstein, FC; Perno, CF; Svicher, V";s:9:"metadata7";s:29:"10.1080/22221751.2020.1757998";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:5;a:14:{s:9:"citazione";s:273:"Scutari, R., Piermatteo, L., Ciancio Manuelli, M., Iannetta, M., Salpini, R., Bertoli, A., et al. (2020). Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis. LIFE, 10(11), 1-9.";s:4:"data";s:10:"2020-11-23";s:2:"id";s:20:"PUBBLICAZIONE_403925";s:6:"handle";s:11:"2108/260996";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/17";s:9:"metadata4";N;s:9:"metadata5";s:147:"Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis";s:9:"metadata6";s:246:"Scutari, R; Piermatteo, L; Ciancio Manuelli, M; Iannetta, M; Salpini, R; Bertoli, A; Alteri, C; Saccomandi, P; Bellocchi, MC; Malagnino, V; Teti, E; Sforza, D; Siragusa, L; Grande, M; Sarmati, L; Svicher, V; Andreoni, M; Ceccherini-Silberstein, F";s:9:"metadata7";s:20:"10.3390/life10110302";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:6;a:14:{s:9:"citazione";s:273:"Scutari, R., Piermatteo, L., Ciancio Manuelli, M., Iannetta, M., Salpini, R., Bertoli, A., et al. (2020). Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis. LIFE, 10(11), 1-9.";s:4:"data";s:10:"2020-11-23";s:2:"id";s:20:"PUBBLICAZIONE_406875";s:6:"handle";s:11:"2108/262629";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/18";s:9:"metadata4";N;s:9:"metadata5";s:147:"Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis";s:9:"metadata6";s:246:"Scutari, R; Piermatteo, L; Ciancio Manuelli, M; Iannetta, M; Salpini, R; Bertoli, A; Alteri, C; Saccomandi, P; Bellocchi, MC; Malagnino, V; Teti, E; Sforza, D; Siragusa, L; Grande, M; Sarmati, L; Svicher, V; Andreoni, M; Ceccherini-Silberstein, F";s:9:"metadata7";s:20:"10.3390/life10110302";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:7;a:14:{s:9:"citazione";s:238:"Amati, F., Vancheri, C., Latini, A., Colona, V.L., Grelli, S., D'Apice, M.R., et al. (2020). Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patients. HELIYON, 6(10), e05143.";s:4:"data";s:7:"2020-10";s:2:"id";s:20:"PUBBLICAZIONE_397955";s:6:"handle";s:11:"2108/254596";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/03";s:9:"metadata4";N;s:9:"metadata5";s:120:"Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patients";s:9:"metadata6";s:175:"Amati, F; Vancheri, C; Latini, A; Colona, VL; Grelli, S; D'Apice, MR; Balestrieri, E; Passarelli, C; Minutolo, A; Loddo, S; Di Lorenzo, A; Rogliani, P; Andreoni, M; Novelli, G";s:9:"metadata7";s:29:"10.1016/j.heliyon.2020.e05143";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:8;a:14:{s:9:"citazione";s:279:"Iannetta, M., Cesta, N., Stingone, C., Malagnino, V., Teti, E., Vitale, P., et al. (2020). Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 45, 102442.";s:4:"data";s:7:"2020-10";s:2:"id";s:20:"PUBBLICAZIONE_400934";s:6:"handle";s:11:"2108/257266";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/26";s:9:"metadata4";N;s:9:"metadata5";s:133:"Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab";s:9:"metadata6";s:208:"Iannetta, M; Cesta, N; Stingone, C; Malagnino, V; Teti, E; Vitale, P; De Simone, G; Rossi, B; Ansaldo, L; Compagno, M; Spalliera, I; Di Lorenzo, A; Landi, D; Nicoletti, CG; Marfia, GA; Andreoni, M; Sarmati, L";s:9:"metadata7";s:27:"10.1016/j.msard.2020.102442";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:9;a:14:{s:9:"citazione";s:202:"Latini, A., Agolini, E., Novelli, A., Borgiani, P., Giannini, R., Gravina, P., et al. (2020). COVID-19 and genetic variants of protein involved in the SARS-CoV-2 entry into the host cells. GENES, 11(9).";s:4:"data";s:7:"2020-09";s:2:"id";s:20:"PUBBLICAZIONE_397591";s:6:"handle";s:11:"2108/254254";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore BIO/18";s:9:"metadata4";N;s:9:"metadata5";s:93:"COVID-19 and genetic variants of protein involved in the SARS-CoV-2 entry into the host cells";s:9:"metadata6";s:185:"Latini, A; Agolini, E; Novelli, A; Borgiani, P; Giannini, R; Gravina, P; Smarrazzo, A; Dauri, M; Andreoni, M; Rogliani, P; Bernardini, S; Helmer-Citterich, M; Biancolella, M; Novelli, G";s:9:"metadata7";s:21:"10.3390/genes11091010";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:10;a:14:{s:9:"citazione";s:227:"Rizza, S., Coppeta, L., Grelli, S., Ferrazza, G., Chiocchi, M., Vanni, G., et al. (2020). High body mass index and night shift work are associated with COVID-19 in health care workers. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION.";s:4:"data";s:10:"2020-08-27";s:2:"id";s:20:"PUBBLICAZIONE_402891";s:6:"handle";s:11:"2108/259070";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/07";s:9:"metadata4";N;s:9:"metadata5";s:93:"High body mass index and night shift work are associated with COVID-19 in health care workers";s:9:"metadata6";s:128:"Rizza, S; Coppeta, L; Grelli, S; Ferrazza, G; Chiocchi, M; Vanni, G; Bonomo, OC; Bellia, A; Andreoni, M; Magrini, A; Federici, M";s:9:"metadata7";s:26:"10.1007/s40618-020-01397-0";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:11;a:14:{s:9:"citazione";s:291:"Adorni, F., Prinelli, F., Bianchi, F., Giacomelli, A., Pagani, G., Bernacchia, D., et al. (2020). Self-reported symptoms of SARS-CoV-2 infection in a non-hospitalized population: results from the large Italian web-based EPICOVID19 cross-sectional survey. JMIR PUBLIC HEALTH AND SURVEILLANCE.";s:4:"data";s:10:"2020-07-10";s:2:"id";s:20:"PUBBLICAZIONE_397012";s:6:"handle";s:11:"2108/253702";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/17";s:9:"metadata4";N;s:9:"metadata5";s:155:"Self-reported symptoms of SARS-CoV-2 infection in a non-hospitalized population: results from the large Italian web-based EPICOVID19 cross-sectional survey";s:9:"metadata6";s:270:"Adorni, F; Prinelli, F; Bianchi, F; Giacomelli, A; Pagani, G; Bernacchia, D; Rusconi, S; Maggi, S; Trevisan, C; Noale, M; Molinaro, S; Bastiani, L; Fortunato, L; Jesuthasan, N; Sojic, A; Pettenati, C; Tavio, M; Andreoni, M; Mastroianni, C; Antonelli Incalzi, R; Galli, M";s:9:"metadata7";s:13:"10.2196/21866";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:12;a:14:{s:9:"citazione";s:213:"Liguori, C., Pierantozzi, M., Spanetta, M., Sarmati, L., Cesta, N., Iannetta, M., et al. (2020). Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. BRAIN BEHAVIOR AND IMMUNITY.";s:4:"data";s:10:"2020-05-13";s:2:"id";s:20:"PUBBLICAZIONE_392004";s:6:"handle";s:11:"2108/249226";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/17";s:9:"metadata4";N;s:9:"metadata5";s:86:"Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection";s:9:"metadata6";s:188:"Liguori, C; Pierantozzi, M; Spanetta, M; Sarmati, L; Cesta, N; Iannetta, M; Ora, J; Genga Mina, G; Puxeddu, E; Balbi, O; Pezzuto, G; Magrini, A; Rogliani, P; Andreoni, M; Biagio Mercuri, N";s:9:"metadata7";s:25:"10.1016/j.bbi.2020.05.037";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:13;a:14:{s:9:"citazione";s:293:"Salpini, R., Piermatteo, L., Battisti, A., Colagrossi, L., Aragri, M., Yu La Rosa, K., et al. (2020). A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro. VIRUSES, 12(2), 251.";s:4:"data";s:10:"2020-02-23";s:2:"id";s:20:"PUBBLICAZIONE_374369";s:6:"handle";s:11:"2108/233885";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/17";s:9:"metadata4";N;s:9:"metadata5";s:169:"A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro";s:9:"metadata6";s:353:"Salpini, R; Piermatteo, L; Battisti, A; Colagrossi, L; Aragri, M; Yu La Rosa, K; Bertoli, A; Saccomandi, P; Lichtner, M; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Iapadre, N; Cerva, C; Aquaro, S; Angelico, M; Sarmati, L; Andreoni, M; Verheyen, J; Ceccherini-Silberstein, F; Levrero, M; Perno, CF; Belloni, L; Svicher, V";s:9:"metadata7";s:17:"10.3390/v12020251";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:14;a:14:{s:9:"citazione";s:305:"Arcese, W., Cerretti, R., Sarmati, L., Cudillo, L., De Angelis, G., Mariotti, B., et al. (2020). MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION.";s:4:"data";s:10:"2020-02-14";s:2:"id";s:20:"PUBBLICAZIONE_372948";s:6:"handle";s:11:"2108/232692";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";s:77:"Haplo vs Identical Sibling; Matched pair analysis; hematological malignancies";s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:162:"MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES";s:9:"metadata6";s:325:"Arcese, W; Cerretti, R; Sarmati, L; Cudillo, L; De Angelis, G; Mariotti, B; Bruno, A; Mangione, I; Rapanotti, C; Andreani, M; De Fabritiis, P; Dentamaro, T; Cupelli, L; Mengarelli, A; Marchesi, F; Tirindelli, MC; Annibali, O; Tafuri, A; Ferrari, A; Cedrone, M; Anaclerico, B; Adorno, G; Miccichè, S; Andreoni, M; Picardi, A";s:9:"metadata7";s:26:"10.1016/j.bbmt.2020.02.005";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:15;a:14:{s:9:"citazione";s:257:"Fontana, C., Angeletti, S., Mirandola, W., Cella, E., Alessia, L., Zehender, G., et al. (2020). Whole genome sequencing of carbapenem-resistant Klebsiella pneumoniae: evolutionary analysis for outbreak investigation. FUTURE MICROBIOLOGY, 15(3), 203-212-212.";s:4:"data";s:7:"2020-02";s:2:"id";s:20:"PUBBLICAZIONE_374375";s:6:"handle";s:11:"2108/233891";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/17";s:9:"metadata4";N;s:9:"metadata5";s:119:"Whole genome sequencing of carbapenem-resistant Klebsiella pneumoniae: evolutionary analysis for outbreak investigation";s:9:"metadata6";s:178:"Fontana, C; Angeletti, S; Mirandola, W; Cella, E; Alessia, L; Zehender, G; Favaro, M; Leoni, D; Rose, DD; Gherardi, G; Florio, LD; Salemi, M; Andreoni, M; Sarmati, L; Ciccozzi, M";s:9:"metadata7";s:21:"10.2217/fmb-2019-0074";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:16;a:14:{s:9:"citazione";s:223:"Armenia, D., Di Carlo, D., Flandre, P., Bouba, Y., Borghi, V., Forbici, F., et al. (2020). HIV MDR is still a relevant issue despite its dramatic drop over the years. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 75(5), 1301-1310.";s:4:"data";s:10:"2020-01-24";s:2:"id";s:20:"PUBBLICAZIONE_384209";s:6:"handle";s:11:"2108/242573";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/07";s:9:"metadata4";N;s:9:"metadata5";s:74:"HIV MDR is still a relevant issue despite its dramatic drop over the years";s:9:"metadata6";s:356:"Armenia, D; Di Carlo, D; Flandre, P; Bouba, Y; Borghi, V; Forbici, F; Bertoli, A; Gori, C; Fabeni, L; Gennari, W; Pinnetti, C; Mondi, A; Cicalini, S; Gagliardini, R; Vergori, A; Bellagamba, R; Malagnino, V; Montella, F; Colafigli, M; Latini, A; Marocco, R; Licthner, M; Andreoni, M; Mussini, C; Ceccherini Silberstein, F; Antinori, A; Perno, CF; Santoro, M";s:9:"metadata7";s:18:"10.1093/jac/dkz554";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:17;a:14:{s:9:"citazione";s:289:"Soulie, C., Santoro, M.M., Storto, A., Abdi, B., Charpentier, C., Armenia, D., et al. (2020). Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY.";s:4:"data";s:10:"2020-01-24";s:2:"id";s:20:"PUBBLICAZIONE_374497";s:6:"handle";s:11:"2108/233895";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/17";s:9:"metadata4";N;s:9:"metadata5";s:155:"Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy";s:9:"metadata6";s:228:"Soulie, C; Santoro, MM; Storto, A; Abdi, B; Charpentier, C; Armenia, D; Jary, A; Forbici, F; Bertoli, A; Gennari, W; Andreoni, M; Mussini, C; Antinori, A; Perno, CF; Calvez, V; Ceccherini-Silberstein, F; Descamps, D; Marcelin, A";s:9:"metadata7";s:18:"10.1093/jac/dkz553";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:18;a:14:{s:9:"citazione";s:242:"Formica, V., Minieri, M., Bernardini, S., Ciotti, M., D'Agostini, C., Roselli, M., et al. (2020). Complete blood count might help to identify subjects with high probability of testing positive to SARS-CoV-2. CLINICAL MEDICINE, 20(4), 114-119.";s:4:"data";s:4:"2020";s:2:"id";s:20:"PUBBLICAZIONE_395216";s:6:"handle";s:11:"2108/251973";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore BIO/12";s:9:"metadata4";N;s:9:"metadata5";s:108:"Complete blood count might help to identify subjects with high probability of testing positive to SARS-CoV-2";s:9:"metadata6";s:153:"Formica, V; Minieri, M; Bernardini, S; Ciotti, M; D'Agostini, C; Roselli, M; Andreoni, M; Morelli, C; Parisi, G; Federici, M; Paganelli, C; Legramante, J";s:9:"metadata7";s:25:"10.7861/clinmed.2020-0373";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:19;a:14:{s:9:"citazione";s:259:"Kondili, L., Mennini, F., Andreoni, M., Babudieri, S., Gardini, I., Rossi, A., et al. (2020). Verso una politica sanitaria di screening e linkage to care per l’eliminazione dell’infezione da epatite C in Italia. LE INFEZIONI IN MEDICINA, Speciale 2, 5-28.";s:4:"data";s:4:"2020";s:2:"id";s:20:"PUBBLICAZIONE_399565";s:6:"handle";s:11:"2108/255951";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:17:"Settore SECS-P/06";s:9:"metadata4";N;s:9:"metadata5";s:120:"Verso una politica sanitaria di screening e linkage to care per l’eliminazione dell’infezione da epatite C in Italia";s:9:"metadata6";s:100:"Kondili, L; Mennini, F; Andreoni, M; Babudieri, S; Gardini, I; Rossi, A; Russo, F; Nava, F; Vella, S";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:20;a:14:{s:9:"citazione";s:278:"Marcellusi, A., Bini, C., Andreoni, M., Sarmati, L., Espin, J., P Horcajada, J., et al. (2020). Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European Countries. CLINICAL DRUG INVESTIGATION, 40(4), 305-318.";s:4:"data";s:4:"2020";s:2:"id";s:20:"PUBBLICAZIONE_373036";s:6:"handle";s:11:"2108/232751";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:17:"Settore SECS-P/05";s:9:"metadata4";N;s:9:"metadata5";s:136:"Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European Countries";s:9:"metadata6";s:139:"Marcellusi, A; Bini, C; Andreoni, M; Sarmati, L; Espin, J; P Horcajada, J; Czypionka, T; Andretta, D; Sciattella, P; Favato, G; Mennini, FS";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:21;a:14:{s:9:"citazione";s:212:"Novelli, A., Biancolella, M., Borgiani, P., Cocciadiferro, D., Colona, V.L., D'Apice, M.R., et al. (2020). Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients. HUMAN GENOMICS, 14(1), 29.";s:4:"data";s:4:"2020";s:2:"id";s:20:"PUBBLICAZIONE_400651";s:6:"handle";s:11:"2108/256999";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/03";s:9:"metadata4";N;s:9:"metadata5";s:77:"Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients";s:9:"metadata6";s:180:"Novelli, A; Biancolella, M; Borgiani, P; Cocciadiferro, D; Colona, VL; D'Apice, MR; Rogliani, P; Zaffina, S; Leonardis, F; Campana, A; Raponi, M; Andreoni, M; Grelli, S; Novelli, G";s:9:"metadata7";s:26:"10.1186/s40246-020-00279-z";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:22;a:14:{s:9:"citazione";s:190:"Nuccetelli, M., Pieri, M., Grelli, S., Ciotti, M., Miano, R., Andreoni, M., et al. (2020). SARS-CoV-2 infection serology: a useful tool to overcome lockdown?. CELL DEATH DISCOVERY, 6(1), 38.";s:4:"data";s:4:"2020";s:2:"id";s:20:"PUBBLICAZIONE_402888";s:6:"handle";s:11:"2108/259068";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/07";s:9:"metadata4";N;s:9:"metadata5";s:66:"SARS-CoV-2 infection serology: a useful tool to overcome lockdown?";s:9:"metadata6";s:83:"Nuccetelli, M; Pieri, M; Grelli, S; Ciotti, M; Miano, R; Andreoni, M; Bernardini, S";s:9:"metadata7";s:25:"10.1038/s41420-020-0275-2";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:23;a:14:{s:9:"citazione";s:364:"Salpini, R., Malagnino, V., Piermatteo, L., Mulas, T., Alkhatib, M., Scutari, R., et al. (2020). Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers. MICROORGANISMS, 8(11), 1-12.";s:4:"data";s:4:"2020";s:2:"id";s:20:"PUBBLICAZIONE_404996";s:6:"handle";s:11:"2108/260990";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/17";s:9:"metadata4";N;s:9:"metadata5";s:237:"Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers";s:9:"metadata6";s:277:"Salpini, R; Malagnino, V; Piermatteo, L; Mulas, T; Alkhatib, M; Scutari, R; Teti, E; Cerva, C; La Rosa, KY; Brugneti, M; Bertoli, A; Rossi, B; Holzmayer, V; Gersch, J; Kuhns, M; Cloherty, G; Ceccherini-Silberstein, F; Perno, C-; Iannetta, M; Andreoni, M; Sarmati, L; Svicher, V";s:9:"metadata7";s:29:"10.3390/microorganisms8111819";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:24;a:14:{s:9:"citazione";s:261:"Bordoni, V., Brando, B., Piselli, P., Forini, O., Perna, F.e., Atripaldi, U., et al. (2019). Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study. PLOS ONE, 14(12), e0225415.";s:4:"data";s:7:"2019-12";s:2:"id";s:20:"PUBBLICAZIONE_366025";s:6:"handle";s:11:"2108/226938";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:139:"Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study";s:9:"metadata6";s:367:"Bordoni, V; Brando, B; Piselli, P; Forini, O; Perna, Fe; Atripaldi, U; Carputo, S; Garziano, F; Trento, E; D'Agosto, G; Latini, A; Colafigli, M; Cristaudo, A; Sacchi, A; Andreoni, M; de Carli, G; Orchi, N; Grelli, S; Gatti, A; Cerva, C; Minutolo, A; Potesta, M; Di Martino, Ml; Ortu, F; Selva, P; Pup, Ld; Guarnori, I; Lorenzini, P; Capuano, G; Antinori, A; Agrati, C";s:9:"metadata7";s:28:"10.1371/journal.pone.0225415";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:25;a:14:{s:9:"citazione";s:315:"Campogiani, L., Compagno, M., Coppola, L., Malagnino, V., Maffongelli, G., Saraca, L.m., et al. (2019). Tuberculosis-related hospitalizations in a low-incidence country: A retrospective analysis in two Italian infectious diseases wards. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 17(1), 124.";s:4:"data";s:7:"2019-12";s:2:"id";s:20:"PUBBLICAZIONE_366038";s:6:"handle";s:11:"2108/226949";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:131:"Tuberculosis-related hospitalizations in a low-incidence country: A retrospective analysis in two Italian infectious diseases wards";s:9:"metadata6";s:177:"Campogiani, L; Compagno, M; Coppola, L; Malagnino, V; Maffongelli, G; Saraca, Lm; Francisci, D; Baldelli, F; Fontana, C; Grelli, S; Andreoni, M; Sotgiu, G; Saderi, L; Sarmati, L";s:9:"metadata7";s:22:"10.3390/ijerph17010124";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:26;a:14:{s:9:"citazione";s:159:"Grossi, P.a., Baldanti, F., Andreoni, M., & Perno, C.f. (2019). CMV infection management in transplant patients in Italy. JOURNAL OF CLINICAL VIROLOGY, 104211.";s:4:"data";s:7:"2019-11";s:2:"id";s:20:"PUBBLICAZIONE_366009";s:6:"handle";s:11:"2108/226924";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:56:"CMV infection management in transplant patients in Italy";s:9:"metadata6";s:47:"Grossi, Pa; Baldanti, F; Andreoni, M; Perno, Cf";s:9:"metadata7";s:25:"10.1016/j.jcv.2019.104211";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:27;a:14:{s:9:"citazione";s:403:"Foroghi Biland, L., Ferrari, L., Malagnino, V., Teti, E., Cerva, C., Gentile, A., et al. (2019). Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: A case report. JOURNAL OF MEDICAL CASE REPORTS, 13(1), 299.";s:4:"data";s:10:"2019-09-22";s:2:"id";s:20:"PUBBLICAZIONE_358395";s:6:"handle";s:11:"2108/220437";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:255:"Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: A cas...";s:9:"metadata6";s:134:"Foroghi Biland, L; Ferrari, L; Malagnino, V; Teti, E; Cerva, C; Gentile, A; Aragri, M; Salpini, R; Svicher, V; Andreoni, M; Sarmati, L";s:9:"metadata7";s:25:"10.1186/s13256-019-2232-3";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:28;a:14:{s:9:"citazione";s:255:"Molinaro, S., Resce, G., Alberti, A., Andreoni, M., D'Egidio, P., Leonardi, C., et al. (2019). Barriers to effective management of hepatitis C virus in people who inject drugs: Evidence from outpatient clinics. DRUG AND ALCOHOL REVIEW, 38(6), 644-655-655.";s:4:"data";s:10:"2019-08-23";s:2:"id";s:20:"PUBBLICAZIONE_358397";s:6:"handle";s:11:"2108/220439";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:114:"Barriers to effective management of hepatitis C virus in people who inject drugs: Evidence from outpatient clinics";s:9:"metadata6";s:110:"Molinaro, S; Resce, G; Alberti, A; Andreoni, M; D'Egidio, Ppf; Leonardi, C; Nava, Fa; Pasqualetti, P; Villa, S";s:9:"metadata7";s:17:"10.1111/dar.12978";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:29;a:14:{s:9:"citazione";s:271:"Malagnino, V., Cerva, C., Maffongelli, G., Teti, E., Foroghi Biland, L., Cesta, N., et al. (2019). HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy. SCIENTIFIC REPORTS, 9(1), 11942.";s:4:"data";s:7:"2019-08";s:2:"id";s:20:"PUBBLICAZIONE_358399";s:6:"handle";s:11:"2108/220441";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:138:"HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy";s:9:"metadata6";s:162:"Malagnino, V; Cerva, C; Maffongelli, G; Teti, E; Foroghi Biland, L; Cesta, N; De Masi, M; Stingone, C; Armenia, D; Svicher, V; Salpini, R; Andreoni, M; Sarmati, L";s:9:"metadata7";s:26:"10.1038/s41598-019-46976-1";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:30;a:14:{s:9:"citazione";s:353:"Salpini, R., Battisti, A., Colagrossi, L., Di Carlo, D., Fabeni, L., Piermatteo, L., et al. (2019). A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection. JOURNAL OF VIRAL HEPATITIS, 26(7), 846-855.";s:4:"data";s:10:"2019-07-26";s:2:"id";s:20:"PUBBLICAZIONE_354847";s:6:"handle";s:11:"2108/217472";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:208:"A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection";s:9:"metadata6";s:280:"Salpini, R; Battisti, A; Colagrossi, L; Di Carlo, D; Fabeni, L; Piermatteo, L; Cerva, C; Lichtner, M; Mastroianni, C; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Angelico, M; Sarmati, L; Andreoni, M; Perno, C-; Ceccherini-Silberstein, F; Svicher, V";s:9:"metadata7";s:17:"10.1111/jvh.13101";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:31;a:14:{s:9:"citazione";s:249:"Scutari, R., Alteri, C., Vicenti, I., Carlo, D.D., Zuccaro, V., Incardona, F., et al. (2019). Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE.";s:4:"data";s:10:"2019-07-19";s:2:"id";s:20:"PUBBLICAZIONE_358403";s:6:"handle";s:11:"2108/220445";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:110:"Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors";s:9:"metadata6";s:176:"Scutari, R; Alteri, C; Vicenti, I; Carlo, DD; Zuccaro, V; Incardona, F; Borghi, V; Bezenchek, A; Andreoni, M; Antinori, A; Perno, CF; Cascio, A; Luca, AD; Zazzi, M; Santoro, MM";s:9:"metadata7";s:26:"10.1016/j.jgar.2019.07.015";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:32;a:14:{s:9:"citazione";s:245:"Garaci, F., Picchi, E., Di Giuliano, F., Lanzafame, S., Minosse, S., Manenti, G., et al. (2019). Cerebral Multishell Diffusion Imaging Parameters are Associated with Blood Biomarkers of Disease Severity in HIV Infection. JOURNAL OF NEUROIMAGING.";s:4:"data";s:10:"2019-07-15";s:2:"id";s:20:"PUBBLICAZIONE_354295";s:6:"handle";s:11:"2108/216977";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:122:"Cerebral Multishell Diffusion Imaging Parameters are Associated with Blood Biomarkers of Disease Severity in HIV Infection";s:9:"metadata6";s:145:"Garaci, F; Picchi, E; Di Giuliano, F; Lanzafame, S; Minosse, S; Manenti, G; Pistolese, Ca; Sarmati, L; Teti, E; Andreoni, M; Floris, R; Toschi, N";s:9:"metadata7";s:17:"10.1111/jon.12655";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:33;a:14:{s:9:"citazione";s:327:"Alteri, C., Scutari, R., Stingone, C., Maffongelli, G., Brugneti, M., Falasca, F., et al. (2019). Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success. JOURNAL OF CLINICAL VIROLOGY, 117, 61-67.";s:4:"data";s:10:"2019-07-14";s:2:"id";s:20:"PUBBLICAZIONE_354579";s:6:"handle";s:11:"2108/217249";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:186:"Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success";s:9:"metadata6";s:214:"Alteri, C; Scutari, R; Stingone, C; Maffongelli, G; Brugneti, M; Falasca, F; Martini, S; Bertoli, A; Turriziani, O; Sarmati, L; Coppola, N; Andreoni, M; Santoro, MM; Perno, C-; Ceccherini-Silberstein, F; Svicher, V";s:9:"metadata7";s:25:"10.1016/j.jcv.2019.06.004";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:34;a:14:{s:9:"citazione";s:284:"Campogiani, L., Cerva, C., Maffongelli, G., Teti, E., Pupo, L., Vaccarini, S., et al. (2019). Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir. AIDS RESEARCH AND THERAPY, 16(1), 15.";s:4:"data";s:7:"2019-07";s:2:"id";s:20:"PUBBLICAZIONE_358401";s:6:"handle";s:11:"2108/220443";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:151:"Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir";s:9:"metadata6";s:123:"Campogiani, L; Cerva, C; Maffongelli, G; Teti, E; Pupo, L; Vaccarini, S; Cantonetti, M; Pennica, A; Andreoni, M; Sarmati, L";s:9:"metadata7";s:25:"10.1186/s12981-019-0230-6";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:35;a:14:{s:9:"citazione";s:297:"Parisi, S.g., Basso, M., Scaggiante, R., Andreis, S., Mengoli, C., Cruciani, M., et al. (2019). Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: Complexity and vaccine implications. BMC PUBLIC HEALTH, 19(1), 645.";s:4:"data";s:10:"2019-05-28";s:2:"id";s:20:"PUBBLICAZIONE_354582";s:6:"handle";s:11:"2108/217252";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:169:"Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: Complexity and vaccine implications";s:9:"metadata6";s:145:"Parisi, Sg; Basso, M; Scaggiante, R; Andreis, S; Mengoli, C; Cruciani, M; Del Vecchio, C; Menegotto, N; Zago, D; Sarmati, L; Andreoni, M; Palu, G";s:9:"metadata7";s:25:"10.1186/s12889-019-7004-x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:36;a:14:{s:9:"citazione";s:267:"Fabeni, L., Alteri, C., Berno, G., Scutari, R., Orchi, N., De Carli, G., et al. (2019). Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy. SEXUALLY TRANSMITTED INFECTIONS, 95(8), 619-625.";s:4:"data";s:10:"2019-05-10";s:2:"id";s:20:"PUBBLICAZIONE_354585";s:6:"handle";s:11:"2108/217254";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:129:"Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy";s:9:"metadata6";s:377:"Fabeni, L; Alteri, C; Berno, G; Scutari, R; Orchi, N; De Carli, G; Bertoli, A; Carioti, L; Gori, C; Forbici, F; Salpini, R; Vergori, A; Gagliardini, R; Cicalini, S; Mondi, A; Pinnetti, C; Mazzuti, L; Turriziani, O; Colafigli, M; Borghi, V; Montella, F; Pennica, A; Lichtner, M; Girardi, E; Andreoni, M; Mussini, C; Antinori, A; Ceccherini-Silberstein, F; Perno, CF; Santoro, MM";s:9:"metadata7";s:28:"10.1136/sextrans-2019-054017";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:37;a:14:{s:9:"citazione";s:265:"Armenia, D., Di Carlo, D., Cozzi-Lepri, A., Calcagno, A., Borghi, V., Gori, C., et al. (2019). Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen. ANTIVIRAL THERAPY, 24(5), 321-331.";s:4:"data";s:10:"2019-04-12";s:2:"id";s:20:"PUBBLICAZIONE_354587";s:6:"handle";s:11:"2108/217256";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:134:"Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen";s:9:"metadata6";s:349:"Armenia, D; Di Carlo, D; Cozzi-Lepri, A; Calcagno, A; Borghi, V; Gori, C; Bertoli, A; Gennari, W; Bellagamba, R; Castagna, A; Latini, A; Pinnetti, C; Cicalini, S; Saracino, A; Lapadula, G; Rusconi, S; Castelli, F; Di Giambenedetto, S; Andreoni, M; Di Perri, G; Antinori, A; Mussini, C; Ceccherini-Silberstein, F; Monforte, AD; Perno, CF; Santoro, MM";s:9:"metadata7";s:15:"10.3851/IMP3309";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:38;a:14:{s:9:"citazione";s:303:"Mengoli, C., Basso, M., Andreis, S., Scaggiante, R., Cruciani, M., Ferretto, R., et al. (2019). Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach. PLOS ONE, 14(3), e0213160.";s:4:"data";s:10:"2019-03-11";s:2:"id";s:20:"PUBBLICAZIONE_346634";s:6:"handle";s:11:"2108/211317";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:179:"Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach";s:9:"metadata6";s:199:"Mengoli, C; Basso, M; Andreis, S; Scaggiante, R; Cruciani, M; Ferretto, R; Panese, S; Manfrin, V; Francisci, D; Schiaroli, E; Maffongelli, G; Sarmati, L; Andreoni, M; Baldelli, F; Palu, G; Parisi, Sg";s:9:"metadata7";s:28:"10.1371/journal.pone.0213160";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:39;a:14:{s:9:"citazione";s:279:"Antinori, A., Santoro, M.m., Gagliardini, R., Marchetti, G., Mondi, A., Cento, V., et al. (2019). Italian expert panel consensus statements on two-drug antiretroviral regimens to treat naïve and virologically suppressed HIV-1 infected patients. NEW MICROBIOLOGICA, 42(2), 69-80.";s:4:"data";s:10:"2019-02-20";s:2:"id";s:20:"PUBBLICAZIONE_346637";s:6:"handle";s:11:"2108/211319";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:146:"Italian expert panel consensus statements on two-drug antiretroviral regimens to treat naïve and virologically suppressed HIV-1 infected patients";s:9:"metadata6";s:98:"Antinori, A; Santoro, Mm; Gagliardini, R; Marchetti, G; Mondi, A; Cento, V; Perno, Cf; Andreoni, M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:40;a:14:{s:9:"citazione";s:292:"Sterrantino, G., Borghi, V., Callegaro, A.p., Bruzzone, B., Saladini, F., Maggiolo, F., et al. (2019). Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS.";s:4:"data";s:10:"2019-02-12";s:2:"id";s:20:"PUBBLICAZIONE_346642";s:6:"handle";s:11:"2108/211321";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:141:"Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors";s:9:"metadata6";s:201:"Sterrantino, G; Borghi, V; Callegaro, Ap; Bruzzone, B; Saladini, F; Maggiolo, F; Maffongelli, G; Andreoni, M; De Gennaro, M; Gianotti, N; Bagnarelli, P; Vergori, A; Antinori, A; Zazzi, M; Zaccarelli, M";s:9:"metadata7";s:33:"10.1016/j.ijantimicag.2019.02.007";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:41;a:14:{s:9:"citazione";s:300:"Malagnino, V., Cerva, C., Teti, E., Maffongelli, G., Andreoni, M., & Sarmati, L. (2019). Abnormal elevation of international normalized ratio in a patient during the coadministration of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and warfarin: a case report. AIDS, 33(2), 360-361-361.";s:4:"data";s:10:"2019-02-01";s:2:"id";s:20:"PUBBLICAZIONE_342756";s:6:"handle";s:11:"2108/207944";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:184:"Abnormal elevation of international normalized ratio in a patient during the coadministration of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and warfarin: a case report";s:9:"metadata6";s:72:"Malagnino, V; Cerva, C; Teti, E; Maffongelli, G; Andreoni, M; Sarmati, L";s:9:"metadata7";s:28:"10.1097/QAD.0000000000002097";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:42;a:14:{s:9:"citazione";s:222:"Alteri, C., Scutari, R., Bertoli, A., Armenia, D., Gori, C., Fabbri, G., et al. (2019). Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice. VIRUS GENES.";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_345601";s:6:"handle";s:11:"2108/210456";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:120:"Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice";s:9:"metadata6";s:230:"Alteri, C; Scutari, R; Bertoli, A; Armenia, D; Gori, C; Fabbri, G; Mastroianni, Cm; Cerva, C; Cristaudo, A; Vicenti, I; Bruzzone, B; Zazzi, M; Andreoni, M; Antinori, A; Svicher, V; Ceccherini-Silberstein, F; Perno, Cf; Santoro, Mm";s:9:"metadata7";s:26:"10.1007/s11262-019-01649-z";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:43;a:14:{s:9:"citazione";s:373:"Delle Rose, D., Pezzotti, P., Fontana, C., Altieri, A., Minelli, S., Mariotti, B., et al. (2019). An in-depth analysis of nosocomial bloodstream infections due to Gram-negative bacilli: clinical features, microbiological characteristics and predictors of mortality in a 1 year, prospective study in a large tertiary care Italian hospital. INFECTIOUS DISEASES, 51(1), 12-22.";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_342745";s:6:"handle";s:11:"2108/207934";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:239:"An in-depth analysis of nosocomial bloodstream infections due to Gram-negative bacilli: clinical features, microbiological characteristics and predictors of mortality in a 1 year, prospective study in a large tertiary care Italian hospital";s:9:"metadata6";s:123:"Delle Rose, D; Pezzotti, P; Fontana, C; Altieri, A; Minelli, S; Mariotti, B; Cerretti, R; Leoni, D; Andreoni, M; Sarmati, L";s:9:"metadata7";s:29:"10.1080/23744235.2018.1492149";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:44;a:14:{s:9:"citazione";s:308:"Falcone, M., Tiseo, G., Gutierrez-Gutierrez, B., Raponi, G., Carfagna, P., Rosin, C., et al. (2019). Impact of initial antifungal therapy on the outcome of patients with candidemia and septic shock admitted to medical wards: A propensity score-adjusted analysis. OPEN FORUM INFECTIOUS DISEASES, 6(7), ofz251.";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_361043";s:6:"handle";s:11:"2108/222347";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:160:"Impact of initial antifungal therapy on the outcome of patients with candidemia and septic shock admitted to medical wards: A propensity score-adjusted analysis";s:9:"metadata6";s:174:"Falcone, M; Tiseo, G; Gutierrez-Gutierrez, B; Raponi, G; Carfagna, P; Rosin, C; Luzzati, R; Rose, Dd; Andreoni, M; Farcomeni, A; Venditti, M; Rodriguez-Bano, J; Menichetti, F";s:9:"metadata7";s:19:"10.1093/ofid/ofz251";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:45;a:14:{s:9:"citazione";s:254:"Falcone, M., Tiseo, G., Iraci, F., Raponi, G., Goldoni, P., Delle Rose, D., et al. (2019). Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes. CLINICAL MICROBIOLOGY AND INFECTION, 25(4), 474-480.";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_339798";s:6:"handle";s:11:"2108/205574";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:109:"Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes";s:9:"metadata6";s:248:"Falcone, M; Tiseo, G; Iraci, F; Raponi, G; Goldoni, P; Delle Rose, D; Santino, I; Carfagna, P; Murri, R; Fantoni, M; Fontana, C; Sanguinetti, M; Farcomeni, A; Antonelli, G; Aceti, A; Mastroianni, C; Andreoni, M; Cauda, R; Petrosillo, N; Venditti, M";s:9:"metadata7";s:25:"10.1016/j.cmi.2018.06.020";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:46;a:14:{s:9:"citazione";s:382:"Marcellusi, A., Viti, R., Sarmati, L., Streinu-Cercel, A., Pana, A., Espin, J., et al. (2019). Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of 3 European Countries. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH.";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_357078";s:6:"handle";s:11:"2108/219275";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:41:"Settore SECS-P/03 - Scienza delle Finanze";s:9:"metadata4";N;s:9:"metadata5";s:230:"Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of 3 European Countries";s:9:"metadata6";s:152:"Marcellusi, A; Viti, R; Sarmati, L; Streinu-Cercel, A; Pana, A; Espin, J; Horcajada Gallego, P; Favato, G; Andretta, D; Soro, M; Andreoni, M; Mennini, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:47;a:14:{s:9:"citazione";s:330:"Salpini, R., Surdo, M., Cortese, M., Palumbo, G., Carioti, L., Cappiello, G., et al. (2019). The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro. CLINICAL MICROBIOLOGY AND INFECTION, 25(7).";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_341637";s:6:"handle";s:11:"2108/207002";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:193:"The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.";s:9:"metadata6";s:320:"Salpini, R; Surdo, M; Cortese, M; Palumbo, G; Carioti, L; Cappiello, G; Spanò, A; Trimoulet, P; Fleury, H; Vecchiet, J; Pasquazzi, C; Mirabelli, C; Scutari, R; Sacco, A; Alkhatib, M; Missale, G; Francioso, S; Sarmati, L; Andreoni, M; Angelico, M; Ceccherini-Silberstein, F; Levrero, M; Perno, C; Belloni, L; Svicher, V";s:9:"metadata7";s:25:"10.1016/j.cmi.2018.11.017";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:48;a:14:{s:9:"citazione";s:249:"Trunfio, M., Pinnetti, C., Focà, E., Bai, F., Maffongelli, G., Celani, L., et al. (2019). Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions?. AIDS, 33(4), 759-762.";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_342754";s:6:"handle";s:11:"2108/207942";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:134:"Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions?";s:9:"metadata6";s:159:"Trunfio, M; Pinnetti, C; Focà, E; Bai, F; Maffongelli, G; Celani, L; Cinque, P; Celotti, A; Andreoni, M; Monforte, Ad; D'Ettorre, G; Antinori, A; Calcagno, A";s:9:"metadata7";s:28:"10.1097/QAD.0000000000002091";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:49;a:14:{s:9:"citazione";s:199:"Viganò, M., Andreoni, M., Perno, C.f., Craxì, A., Aghemo, A., Alberti, A., et al. (2019). Real life experiences in HCV management in 2018. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 17(2), 117-128.";s:4:"data";s:4:"2019";s:2:"id";s:20:"PUBBLICAZIONE_342748";s:6:"handle";s:11:"2108/207938";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:47:"Real life experiences in HCV management in 2018";s:9:"metadata6";s:435:"Viganò, M; Andreoni, M; Perno, Cf; Craxì, A; Aghemo, A; Alberti, A; Andreone, P; Babudieri, S; Bonora, S; Brunetto, Mr; Bruno, R; Bruno, S; Calvaruso, V; Caporaso, N; Cartabellotta, F; Ceccherini-Silberstein, F; Cento, V; Ciancio, A; Colombatto, P; Coppola, N; Di Marco, V; Di Perri, G; Fagiuoli, S; Gaeta, Gb; Gasbarrini, A; Lampertico, P; Pellicelli, A; Prestileo, T; Puoti, M; Raimondo, G; Rizzardini, G; Taliani, G; Zignego, Al";s:9:"metadata7";s:29:"10.1080/14787210.2019.1563755";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:50;a:14:{s:9:"citazione";s:252:"Babiloni, C., Noce, G., Pennica, A., Onorati, P., Capotosto, P., Del Percio, C., et al. (2018). Cortical sources of resting state electroencephalographic rhythms probe brain function in naïve HIV individuals. CLINICAL NEUROPHYSIOLOGY, 129(2), 431-441.";s:4:"data";s:10:"2018-12-20";s:2:"id";s:20:"PUBBLICAZIONE_323747";s:6:"handle";s:11:"2108/191958";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:112:"Cortical sources of resting state electroencephalographic rhythms probe brain function in naïve HIV individuals";s:9:"metadata6";s:279:"Babiloni, C; Noce, G; Pennica, A; Onorati, P; Capotosto, P; Del Percio, C; Roma, P; Correr, V; Piccinni, E; Toma, G; Soricelli, A; Di Campli, F; Gianserra, L; Ciullini, L; Aceti, A; Teti, E; Sarmati, L; Crocetti, G; Ferri, R; Catania, V; Pascarelli, Mt; Andreoni, M; Ferracuti, S";s:9:"metadata7";s:28:"10.1016/j.clinph.2017.12.002";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:51;a:14:{s:9:"citazione";s:334:"Basso, M., Andreis, S., Scaggiante, R., Franchin, E., Zago, D., Biasolo, M.a., et al. (2018). Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study. BMC INFECTIOUS DISEASES, 18(1), 683.";s:4:"data";s:10:"2018-12-19";s:2:"id";s:20:"PUBBLICAZIONE_342752";s:6:"handle";s:11:"2108/207940";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:202:"Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study";s:9:"metadata6";s:146:"Basso, M; Andreis, S; Scaggiante, R; Franchin, E; Zago, D; Biasolo, Ma; Del Vecchio, C; Mengoli, C; Sarmati, L; Andreoni, M; Palù, G; Parisi, Sg";s:9:"metadata7";s:25:"10.1186/s12879-018-3591-x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:52;a:14:{s:9:"citazione";s:230:"Alteri, C., Fabeni, L., Scutari, R., Berno, G., Di Carlo, D., Gori, C., et al. (2018). Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence. SCIENTIFIC REPORTS, 8(1), 15739.";s:4:"data";s:10:"2018-10-24";s:2:"id";s:20:"PUBBLICAZIONE_339796";s:6:"handle";s:11:"2108/205572";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:109:"Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence";s:9:"metadata6";s:287:"Alteri, C; Fabeni, L; Scutari, R; Berno, G; Di Carlo, D; Gori, C; Bertoli, A; Vergori, A; Mastrorosa, I; Bellagamba, R; Mussini, C; Colafigli, M; Montella, F; Pennica, A; Mastroianni, CM; Girardi, E; Andreoni, M; Antinori, A; Svicher, V; Ceccherini-Silberstein, F; Perno, CF; Santoro, MM";s:9:"metadata7";s:26:"10.1038/s41598-018-34058-7";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:53;a:14:{s:9:"citazione";s:289:"Antinori, A., Di Biagio, A., Marcotullio, S., Sarmati, L., Andreoni, M., Angarano, G., et al. (2018). Evidence-based renewal of the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. NEW MICROBIOLOGICA, 41(4), 247-255.";s:4:"data";s:7:"2018-10";s:2:"id";s:20:"PUBBLICAZIONE_342670";s:6:"handle";s:11:"2108/207871";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:150:"Evidence-based renewal of the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons";s:9:"metadata6";s:208:"Antinori, A; Di Biagio, A; Marcotullio, S; Sarmati, L; Andreoni, M; Angarano, G; Chirianni, A; d'Arminio Monforte, A; Di Perri, G; Galli, M; Gianotti, N; Girardi, E; Gori, A; Mussini, C; Perno, C; Lazzarin, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:54;a:14:{s:9:"citazione";s:299:"Ceccherini-Silberstein, F., Cozzi Lepri, A., Alteri, C., Merlini, E., Surdo, M., Marchetti, G., et al. (2018). Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 73(12), 3460-3470.";s:4:"data";s:10:"2018-09-20";s:2:"id";s:20:"PUBBLICAZIONE_338618";s:6:"handle";s:11:"2108/204637";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:129:"Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART";s:9:"metadata6";s:200:"Ceccherini-Silberstein, F; Cozzi Lepri, A; Alteri, C; Merlini, E; Surdo, M; Marchetti, G; Capobianchi, MR; De Luca, A; Gianotti, N; Viale, P; Andreoni, M; Antinori, A; Perno, CF; d'Arminio Monforte, A";s:9:"metadata7";s:18:"10.1093/jac/dky350";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:55;a:14:{s:9:"citazione";s:334:"Masetti, C., Lionetti, R., Lupo, M., Siciliano, M., Giannelli, V., Ponziani, F.r., et al. (2018). Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis. JOURNAL OF VIRAL HEPATITIS.";s:4:"data";s:10:"2018-08-16";s:2:"id";s:20:"PUBBLICAZIONE_338620";s:6:"handle";s:11:"2108/204639";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:207:"Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis";s:9:"metadata6";s:311:"Masetti, C; Lionetti, R; Lupo, M; Siciliano, M; Giannelli, V; Ponziani, Fr; Teti, E; Dell'Unto, C; Francioso, S; Brega, A; Montalbano, M; Visco-Comandini, U; Taibi, C; Galati, G; Vespasiani Gentilucci, U; Picardi, A; Andreoni, M; Pompili, M; Pellicelli, Am; D'Offizi, G; Gasbarrini, A; De Santis, A; Angelico, M";s:9:"metadata7";s:17:"10.1111/jvh.12982";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:56;a:14:{s:9:"citazione";s:363:"Parisi, S.g., Andreis, S., Mengoli, C., Menegotto, N., Cavinato, S., Scaggiante, R., et al. (2018). Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment. MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 207(3-4), 183-194.";s:4:"data";s:7:"2018-08";s:2:"id";s:20:"PUBBLICAZIONE_339218";s:6:"handle";s:11:"2108/205079";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:206:"Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment";s:9:"metadata6";s:122:"Parisi, Sg; Andreis, S; Mengoli, C; Menegotto, N; Cavinato, S; Scaggiante, R; Andreoni, M; Palu, G; Basso, M; Cattelan, Am";s:9:"metadata7";s:25:"10.1007/s00430-018-0538-1";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:57;a:14:{s:9:"citazione";s:245:"Colagrossi, L., Salpini, R., Scutari, R., Carioti, L., Battisti, A., Piermatteo, L., et al. (2018). HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets. VIRUSES, 10(7), 363.";s:4:"data";s:10:"2018-07-09";s:2:"id";s:20:"PUBBLICAZIONE_338622";s:6:"handle";s:11:"2108/204641";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:123:"HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets";s:9:"metadata6";s:468:"Colagrossi, L; Salpini, R; Scutari, R; Carioti, L; Battisti, A; Piermatteo, L; Bertoli, A; Fabeni, L; Minichini, C; Trimoulet, P; Fleury, H; Nebuloso, E; De Cristofaro, M; Cappiello, G; Spano, A; Malagnino, V; Mari, T; Barlattani, A; Iapadre, N; Lichtner, M; Mastroianni, C; Lenci, I; Pasquazzi, C; De Sanctis, Gm; Lanza, Ag; Stanzione, M; Stornaiuolo, G; Marignani, M; Sarmati, L; Andreoni, M; Angelico, M; Ceccherini-Silberstein, F; Perno, C-; Coppola, N; Svicher, V";s:9:"metadata7";s:17:"10.3390/v10070363";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:58;a:14:{s:9:"citazione";s:260:"Bertoli, A., Sorbo, M.C., Aragri, M., Lenci, I., Teti, E., Polilli, E., et al. (2018). Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy. SCIENTIFIC REPORTS, 8(1), 8988.";s:4:"data";s:10:"2018-06-12";s:2:"id";s:20:"PUBBLICAZIONE_331656";s:6:"handle";s:11:"2108/198779";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:140:"Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy";s:9:"metadata6";s:432:"Bertoli, A; Sorbo, MC; Aragri, M; Lenci, I; Teti, E; Polilli, E; Di Maio, VC; Gianserra, L; Biliotti, E; Masetti, C; Magni, CF; Babudieri, S; Nicolini, LA; Milana, M; Cacciatore, P; Sarmati, L; Pellicelli, A; Paolucci, S; Craxì, A; Morisco, F; Palitti, VP; Siciliano, M; Coppola, N; Iapadre, N; Puoti, M; Rizzardini, G; Taliani, G; Pasquazzi, C; Andreoni, M; Parruti, G; Angelico, M; Perno, CF; Cento, V; Ceccherini-Silberstein, F";s:9:"metadata7";s:26:"10.1038/s41598-018-26862-y";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:59;a:14:{s:9:"citazione";s:252:"Borderi, M., Angarano, G., Antinori, A., Chirianni, A., Cinque, P., D'Arminio Monforte, A., et al. (2018). Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessment. NEW MICROBIOLOGICA, 41(2), 112-117.";s:4:"data";s:7:"2018-04";s:2:"id";s:20:"PUBBLICAZIONE_339216";s:6:"handle";s:11:"2108/205077";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:108:"Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessment";s:9:"metadata6";s:236:"Borderi, M; Angarano, G; Antinori, A; Chirianni, A; Cinque, P; D'Arminio Monforte, A; Di Biagio, A; Di Perri, G; Galli, M; Gori, A; Lazzarin, A; Mussini, C; Perno, Cf; Quirino, T; Rizzardini, G; Calza, L; Viale, P; Acone, B; Andreoni, M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:60;a:14:{s:9:"citazione";s:201:"Andreoni, M., Babudieri, S., Bruno, S., Colombo, M., Zignego, A.l., Di Marco, V., et al. (2018). Current and future challenges in HCV: insights from an Italian experts panel. INFECTION, 46(2), 147-163.";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_321870";s:6:"handle";s:11:"2108/190334";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";s:35:"Comorbidities; DAAs; HCV; Treatment";s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";s:279:"The recent availability of direct acting antiviral drugs (DAAs) has drastically changed hepatitis C virus (HCV) treatment scenarios, due to the exceedingly high rates of sustained virological response (SVR) and excellent tolerability allowing for treatment at all disease stages.";s:9:"metadata5";s:76:"Current and future challenges in HCV: insights from an Italian experts panel";s:9:"metadata6";s:139:"Andreoni, M; Babudieri, S; Bruno, S; Colombo, M; Zignego, Al; Di Marco, V; Di Perri, G; Perno, Cf; Puoti, M; Taliani, G; Villa, E; Craxi, A";s:9:"metadata7";s:25:"10.1007/s15010-017-1093-1";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:61;a:14:{s:9:"citazione";s:299:"Ceccherini-Silberstein, F., Cozzi Lepri, A., Alteri, C., Merlini, E., Surdo, M., Marchetti, G., et al. (2018). Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 73(12), 3460-3470.";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_406641";s:6:"handle";s:11:"2108/263696";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/07";s:9:"metadata4";N;s:9:"metadata5";s:129:"Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART";s:9:"metadata6";s:200:"Ceccherini-Silberstein, F; Cozzi Lepri, A; Alteri, C; Merlini, E; Surdo, M; Marchetti, G; Capobianchi, MR; De Luca, A; Gianotti, N; Viale, P; Andreoni, M; Antinori, A; Perno, CF; d'Arminio Monforte, A";s:9:"metadata7";s:18:"10.1093/jac/dky350";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:62;a:14:{s:9:"citazione";s:292:"Malagnino, V., Salpini, R., Maffongelli, G., Battisti, A., Fabeni, L., Piermatteo, L., et al. (2018). High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance. PLOS ONE, 13(3), e0195045.";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_337512";s:6:"handle";s:11:"2108/203805";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:162:"High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance";s:9:"metadata6";s:180:"Malagnino, V; Salpini, R; Maffongelli, G; Battisti, A; Fabeni, L; Piermatteo, L; Colagrossi, L; Fini, V; Ricciardi, A; Sarrecchia, C; Perno, Cf; Andreoni, M; Svicher, V; Sarmati, L";s:9:"metadata7";s:28:"10.1371/journal.pone.0195045";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:63;a:14:{s:9:"citazione";s:285:"Santoro, M., Di Carlo, D., Armenia, D., Zaccarelli, M., Pinnetti, C., Colafigli, M., et al. (2018). Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice. ANTIVIRAL THERAPY, 23(3), 249-257.";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_320500";s:6:"handle";s:11:"2108/189072";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:149:"Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice";s:9:"metadata6";s:222:"Santoro, M; Di Carlo, D; Armenia, D; Zaccarelli, M; Pinnetti, C; Colafigli, M; Prati, F; Boschi, A; Antoni, A; Lagi, F; Sighinolfi, L; Gervasoni, C; Andreoni, M; Antinori, A; Mussini, C; Perno, C; Borghi, V; Sterrantino, G";s:9:"metadata7";s:15:"10.3851/IMP3197";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:64;a:14:{s:9:"citazione";s:272:"Taramasso, L., Biagio, A.d., Bovis, F., Nicolini, L.a., Antinori, A., Milazzo, L., et al. (2018). Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir± ribavirin in HIV/HCV co-infected patients. PLOS ONE, 13(2), e0192627.";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_337516";s:6:"handle";s:11:"2108/203803";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:146:"Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir± ribavirin in HIV/HCV co-infected patients";s:9:"metadata6";s:400:"Taramasso, L; Biagio, Ad; Bovis, F; Nicolini, La; Antinori, A; Milazzo, L; Sollima, S; Gubertini, G; Niero, F; Saracino, A; Bruno, R; Borghi, V; Montagnani, F; Cattelan, A; Hasson, H; Taliani, G; Monforte, Ad; Mastroianni, C; Perri, Gd; Bigoni, S; Puoti, M; Spinetti, A; Gori, A; Boffa, N; Cacopardo, B; Giacometti, A; Parruti, G; Vullo, V; Chirianni, A; Teti, E; Pasquazzi, C; Segala, D; Andreoni, M";s:9:"metadata7";s:28:"10.1371/journal.pone.0192627";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:65;a:14:{s:9:"citazione";s:263:"Andreoni, M., Mussi, C., Bellagamba, R., Di Campli, F., Montinaro, V., & Babiloni, C. (2017). Biomarkers of monitoring and functional reserve of physiological systems over time in HIV: expert opinions for effective secondary prevention. NEW MICROBIOLOGICA, 40(4).";s:4:"data";s:10:"2017-10-10";s:2:"id";s:20:"PUBBLICAZIONE_320494";s:6:"handle";s:11:"2108/189067";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:141:"Biomarkers of monitoring and functional reserve of physiological systems over time in HIV: expert opinions for effective secondary prevention";s:9:"metadata6";s:77:"Andreoni, M; Mussi, C; Bellagamba, R; Di Campli, F; Montinaro, V; Babiloni, C";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:66;a:14:{s:9:"citazione";s:314:"Giuliani, E., Vassena, L., Nulls, N., Malagnino, V., Desimio M., G., Andreoni, M., et al. (2017). NK cells of HIV-1-infected patients with poor CD4+ T-cell reconstitution despite suppressive HAART show reduced IFN-γ production and high frequency of autoreactive CD56bright cells. IMMUNOLOGY LETTERS, 190, 185-193.";s:4:"data";s:7:"2017-10";s:2:"id";s:20:"PUBBLICAZIONE_320518";s:6:"handle";s:11:"2108/189089";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:181:"NK cells of HIV-1-infected patients with poor CD4+ T-cell reconstitution despite suppressive HAART show reduced IFN-γ production and high frequency of autoreactive CD56bright cells";s:9:"metadata6";s:97:"Giuliani, E; Vassena, L; Nulls, N; Malagnino, V; Desimio M., G; Andreoni, M; Barnaba, V; Doria, M";s:9:"metadata7";s:27:"10.1016/j.imlet.2017.08.014";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:67;a:14:{s:9:"citazione";s:212:"Cento, V., Aragri, M., Teti, E., Polilli, E., Bertoli, A., Foroghi, L., et al. (2017). Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY.";s:4:"data";s:10:"2017-09-18";s:2:"id";s:20:"PUBBLICAZIONE_320498";s:6:"handle";s:11:"2108/189069";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:85:"Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study";s:9:"metadata6";s:195:"Cento, V; Aragri, M; Teti, E; Polilli, E; Bertoli, A; Foroghi, L; Barbaliscia, S; Di Maio, Vc; Pieri, A; Pace Palitti, V; Sarmati, L; Parruti, G; Andreoni, M; Perno, Cf; Ceccherini-silberstein, F";s:9:"metadata7";s:18:"10.1093/jac/dkx302";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:68;a:14:{s:9:"citazione";s:324:"Parisi, S., Andreis, S., Basso, M., Cavinato, S., Scaggiante, R., Franzetti, M., et al. (2017). Time course of cellular HIV-DNA and low-level HIV viremia in HIV–HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals. MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 206(6), 419-428.";s:4:"data";s:7:"2017-09";s:2:"id";s:20:"PUBBLICAZIONE_320505";s:6:"handle";s:11:"2108/189079";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:173:"Time course of cellular HIV-DNA and low-level HIV viremia in HIV–HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals";s:9:"metadata6";s:111:"Parisi, S; Andreis, S; Basso, M; Cavinato, S; Scaggiante, R; Franzetti, M; Andreoni, M; Palu, G; Cattelan A., M";s:9:"metadata7";s:25:"10.1007/s00430-017-0518-x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:69;a:14:{s:9:"citazione";s:395:"Andreis, S., Basso, M., Scaggiante, R., Cruciani, M., Ferretto, R., Manfrin, V., et al. (2017). Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: impact on susceptibility to first-line strategies including Integrase strand-transfer inhibitors. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 10, 106-112.";s:4:"data";s:10:"2017-07-18";s:2:"id";s:20:"PUBBLICAZIONE_318225";s:6:"handle";s:11:"2108/186941";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";s:114:"Integrase strand transfer inhibitors; chronic HIV infection; primary-recent; transmitted drug resistance mutations";s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";s:354:"to characterize the prevalence of transmitted drug resistance mutations (TDRMs) by plasma analysis of 750 patients at the time of HIV diagnosis from January 1, 2013 to November, 16, 2016 in the Veneto region (Italy), where all drugs included in the recommended first line therapies were prescribed, included integrase strand transfer inhibitors (InNSTI).";s:9:"metadata5";s:241:"Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: impact on susceptibility to first-line strategies including Integrase strand-transfer inhibitors";s:9:"metadata6";s:236:"Andreis, S; Basso, M; Scaggiante, R; Cruciani, M; Ferretto, R; Manfrin, V; Panese, S; Rossi, Mc; Francavilla, E; Boldrin, C; Alvarez, M; Dal Bello, F; Mengoli, C; Turriziani, O; Sarmati, L; Antonelli, G; Andreoni, M; Palu, G; Parisi, Sg";s:9:"metadata7";s:26:"10.1016/j.jgar.2017.05.011";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:70;a:14:{s:9:"citazione";s:227:"Fabeni, L., Berno, G., Fokam, J., Bertoli, A., Alteri, C., Gori, C., et al. (2017). Comparative evaluation of subtyping tools for the surveillance of newly emerging HIV-1 strains. JOURNAL OF CLINICAL MICROBIOLOGY, JCM.00656-17.";s:4:"data";s:10:"2017-07-12";s:2:"id";s:20:"PUBBLICAZIONE_317846";s:6:"handle";s:11:"2108/186616";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:94:"Comparative evaluation of subtyping tools for the surveillance of newly emerging HIV-1 strains";s:9:"metadata6";s:252:"Fabeni, L; Berno, G; Fokam, J; Bertoli, A; Alteri, C; Gori, C; Forbici, F; Takou, D; Vergori, A; Zaccarelli, M; Maffongelli, G; Borghi, V; Latini, A; Pennica, A; Mastroianni, Cm; Montella, F; Mussini, C; Andreoni, M; Antinori, A; Perno, Cf; Santoro, Mm";s:9:"metadata7";s:20:"10.1128/JCM.00656-17";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:71;a:14:{s:9:"citazione";s:266:"Monforte, A.d., Cozzi-Lepri, A., Ceccherini-Silberstein, F., De Luca, A., Caputo, S.l., Castagna, A., et al. (2017). Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort. PLOS ONE, 12(5), e0177402.";s:4:"data";s:10:"2017-05-17";s:2:"id";s:20:"PUBBLICAZIONE_317848";s:6:"handle";s:11:"2108/186618";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:121:"Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort";s:9:"metadata6";s:201:"Monforte, Ad; Cozzi-Lepri, A; Ceccherini-Silberstein, F; De Luca, A; Caputo, Sl; Castagna, A; Mussini, C; Cingolani, A; Tavelli, A; Shanyinde, M; Gori, A; Girardi, E; Andreoni, M; Antinori, A; Puoti, M";s:9:"metadata7";s:28:"10.1371/journal.pone.0177402";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:72;a:14:{s:9:"citazione";s:263:"Moscato, G., Giacobbi, E., Anemona, L., Di Cesare, S., Di Matteo, G., Andreoni, M., et al. (2017). Dysplasia of Granulocytes in a Patient with HPV Disease, Recurrent Infections, and B Lymphopenia: A Novel Variant of WHIM Syndrome?. FRONTIERS IN PEDIATRICS, 5, 95.";s:4:"data";s:10:"2017-05-02";s:2:"id";s:20:"PUBBLICAZIONE_313356";s:6:"handle";s:11:"2108/182455";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:131:"Dysplasia of Granulocytes in a Patient with HPV Disease, Recurrent Infections, and B Lymphopenia: A Novel Variant of WHIM Syndrome?";s:9:"metadata6";s:113:"Moscato, G; Giacobbi, E; Anemona, L; Di Cesare, S; Di Matteo, G; Andreoni, M; Mauriello, A; Moschese, V; Chini, L";s:9:"metadata7";s:23:"10.3389/fped.2017.00095";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:73;a:14:{s:9:"citazione";s:282:"Antinori, A., Di Biagio, A., Marcotullio, S., Andreoni, M., Chirianni, A., D'arminio Monforte, A., et al. (2017). Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016. NEW MICROBIOLOGICA, 40(2), 86-98.";s:4:"data";s:7:"2017-04";s:2:"id";s:20:"PUBBLICAZIONE_317850";s:6:"handle";s:11:"2108/189187";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:133:"Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016";s:9:"metadata6";s:149:"Antinori, A; Di Biagio, A; Marcotullio, S; Andreoni, M; Chirianni, A; D'arminio Monforte, A; Galli, M; Mazzotta, F; Mussini, C; Puoti, M; Lazzarin, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:74;a:14:{s:9:"citazione";s:288:"Gianotti, N., Cozzi-Lepri, A., Antinori, A., Castagna, A., De Luca, A., Celesia, B.m., et al. (2017). Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients. PLOS ONE, 12(2), e0171611.";s:4:"data";s:10:"2017-02-13";s:2:"id";s:20:"PUBBLICAZIONE_312107";s:6:"handle";s:11:"2108/181470";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:158:"Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients";s:9:"metadata6";s:190:"Gianotti, N; Cozzi-Lepri, A; Antinori, A; Castagna, A; De Luca, A; Celesia, Bm; Galli, M; Mussini, C; Pinnetti, C; Spagnuolo, V; D'Arminio Monforte, A; Ceccherini-Silberstein, F; Andreoni, M";s:9:"metadata7";s:28:"10.1371/journal.pone.0171611";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:75;a:14:{s:9:"citazione";s:255:"Di Maio, V., Cento, V., Lenci, I., Aragri, M., Rossi, P., Barbaliscia, S., et al. (2017). Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies. LIVER INTERNATIONAL, 37(4), 514-528.";s:4:"data";s:10:"2017-01-20";s:2:"id";s:20:"PUBBLICAZIONE_312104";s:6:"handle";s:11:"2108/181490";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:127:"Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies";s:9:"metadata6";s:1915:"Di Maio, V; Cento, V; Lenci, I; Aragri, M; Rossi, P; Barbaliscia, S; Melis, M; Verucchi, G; Magni, C; Teti, E; Bertoli, A; Antonucci, F; Bellocchi, M; Micheli, V; Masetti, C; Landonio, S; Francioso, S; Santopaolo, F; Pellicelli, A; Calvaruso, V; Gianserra, L; Siciliano, M; Romagnoli, D; Cozzolongo, R; Grieco, A; Vecchiet, J; Morisco, F; Merli, M; Brancaccio, G; Di Biagio, A; Loggi, E; Mastroianni, C; Pace Palitti, V; Tarquini, P; Puoti, M; Taliani, G; Sarmati, L; Picciotto, A; Vullo, V; Caporaso, N; Paoloni, M; Pasquazzi, C; Rizzardini, G; Parruti, G; Craxi, A; Babudieri, S; Andreoni, M; Angelico, M; Perno, C; Ceccherini Silberstein, F; Mariani, R; Iapadre, N; Grimaldi, A; Cozzolongo, R; Andreone, P; Verucchi, G; Menzaghi, B; Quirino, T; Pisani, V; Torti, C; Vecchiet, J; Bruzzone, B; De Maria, A; Marenco, S; Nicolini, L; Viscoli, C; Casinelli, K; Delle Monache, M; Lichtner, M; Aghemo, A; Boccaccio, V; Bruno, S; Cerrone, M; Colombo, M; D'Arminio Monforte, A; Danieli, E; Donato, F; Gubertini, G; Lleo, A; Magni, C; Mancon, A; Monico, S; Niero, F; Russo, M; Gnocchi, M; Orro, A; Milanesi, L; Baldelli, E; Bertolotti, M; Borghi, V; Mussini, C; Brancaccio, G; Gaeta, G; Lembo, V; Sangiovanni, V; Di Marco, V; Mazzola, A; Petta, S; D'Amico, E; Cacciatore, P; Consorte, A; Pieri, A; Polilli, E; Sozio, F; Antenucci, F; Aragri, M; Baiocchi, L; Barbaliscia, S; Biliotti, E; Biolato, M; Carioti, L; Cerasari, G; Cerva, C; Ciotti, M; D'Ambrosio, C; D'Ettorre, G; De Leonardis, F; De Sanctis, A; Di Maio, V; Di Paolo, D; Furlan, C; Gallo, P; Gasbarrini, A; Giannelli, V; Grieco, S; Lambiase, L; Lattanzi, B; Lenci, I; Lula, R; Malagnino, V; Manuelli, M; Miglioresi, L; Milana, M; Moretti, A; Nosotti, L; Palazzo, D; Pellicelli, A; Romano, M; Sarrecchia, C; Sforza, D; Sorbo, M; Spaziante, M; Svicher, V; Tisone, G; Vespasiani-Gentilucci, U; D'Adamo, G; Mangia, A; Maida, I; Mura, M; Falconi, L; Di Giammartino, D";s:9:"metadata7";s:17:"10.1111/liv.13327";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:76;a:14:{s:9:"citazione";s:243:"Jaffré, J., Armenia, D., Bellocchi, M.c., Wirden, M., Carioti, L., Lambert, S., et al. (2017). Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 72(5), 1537-1539.";s:4:"data";s:10:"2017-01-14";s:2:"id";s:20:"PUBBLICAZIONE_302374";s:6:"handle";s:11:"2108/173126";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:88:"Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation";s:9:"metadata6";s:206:"Jaffré, J; Armenia, D; Bellocchi, Mc; Wirden, M; Carioti, L; Lambert, S; Valantin, M; Nguyen, T; Simon, A; Katlama, C; Andreoni, M; Perno, Cf; Calvez, V; CECCHERINI SILBERSTEIN, F; Marcelin, A; Todesco, E";s:9:"metadata7";s:18:"10.1093/jac/dkw571";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:77;a:14:{s:9:"citazione";s:220:"Armenia, D., Di Carlo, D., Maffongelli, G., Borghi, V., Alteri, C., Forbici, F., et al. (2017). Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens. HIV MEDICINE.";s:4:"data";s:7:"2017-01";s:2:"id";s:20:"PUBBLICAZIONE_290345";s:6:"handle";s:11:"2108/162521";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:109:"Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens";s:9:"metadata6";s:261:"Armenia, D; Di Carlo, D; Maffongelli, G; Borghi, V; Alteri, C; Forbici, F; Bertoli, A; Gori, C; Giuliani, M; Nicastri, E; Zaccarelli, M; Pinnetti, C; Cicalini, S; D'Offizi, G; Ceccherini-Silberstein, F; Mussini, C; Antinori, A; Andreoni, M; Perno, C; Santoro, M";s:9:"metadata7";s:17:"10.1111/hiv.12388";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:78;a:14:{s:9:"citazione";s:403:"Babiloni, C., Pennica, A., Del Percio, C., Noce, G., Cordone, S., Muratori, C., et al. (2017). Corrigendum to “Abnormal cortical sources of resting state electroencephalographic rhythms in single treatment-naïve HIV individuals: A statistical z-score index” [Clin. Neurophysiol. 127 (2016) 1803–1812] (S138824571501559X) (10.1016/j.clinph.2015.12.007)). CLINICAL NEUROPHYSIOLOGY, 128(1), 287-287.";s:4:"data";s:7:"2017-01";s:2:"id";s:20:"PUBBLICAZIONE_317853";s:6:"handle";s:11:"2108/186621";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:255:"Corrigendum to “Abnormal cortical sources of resting state electroencephalographic rhythms in single treatment-naïve HIV individuals: A statistical z-score index” [Clin. Neurophysiol. 127 (2016) 1803–1812] (S138824571501559X) (10.1016/j.clinph.2...";s:9:"metadata6";s:209:"Babiloni, C; Pennica, A; Del Percio, C; Noce, G; Cordone, S; Muratori, C; Ferracuti, S; Donato, N; Di Campli, F; Gianserra, L; Teti, E; Aceti, A; Soricelli, A; Viscione, M; Limatola, C; Andreoni, M; Onorati, P";s:9:"metadata7";s:28:"10.1016/j.clinph.2016.11.002";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:79;a:14:{s:9:"citazione";s:392:"Babiloni, C., Pennica, A., Capotosto, P., Onorati, P., Muratori, C., Ferracuti, S., et al. (2017). Corrigendum to “Brain and cognitive functions in two groups of naïve HIV patients selected for a different plan of antiretroviral therapy: A qEEG study” [Clin. Neurophysiol. 127 (2016) 3455–3469]((S1388245716305089)(10.1016/j.clinph.2016.09.001)). CLINICAL NEUROPHYSIOLOGY, 128(1), 288.";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_313584";s:6:"handle";s:11:"2108/182640";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:253:"Corrigendum to “Brain and cognitive functions in two groups of naïve HIV patients selected for a different plan of antiretroviral therapy: A qEEG study” [Clin. Neurophysiol. 127 (2016) 3455–3469]((S1388245716305089)(10.1016/j.clinph.2016.09.001))";s:9:"metadata6";s:270:"Babiloni, C; Pennica, A; Capotosto, P; Onorati, P; Muratori, C; Ferracuti, S; Roma, P; Correr, V; Piccinni, E; Noce, G; Del Percio, C; Cordone, S; Limatola, C; Soricelli, A; Di Campli, F; Gianserra, L; Ciullini, L; Aceti, A; Viscione, M; Teti, E; Sarmati, L; Andreoni, M";s:9:"metadata7";s:28:"10.1016/j.clinph.2016.11.003";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:80;a:14:{s:9:"citazione";s:244:"Cento, V., Nguyen, T., Di Carlo, D., Biliotti, E., Gianserra, L., Lenci, I., et al. (2017). Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens. PLOS ONE, 12(5), e0177352.";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_313572";s:6:"handle";s:11:"2108/182630";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:124:"Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens";s:9:"metadata6";s:533:"Cento, V; Nguyen, Tht; Di Carlo, D; Biliotti, E; Gianserra, L; Lenci, I; Di Paolo, D; Calvaruso, V; Teti, E; Cerrone, M; Romagnoli, D; Melis, M; Danieli, E; Menzaghi, B; Polilli, E; Siciliano, M; Nicolini, La; Di Biagio, A; Magni, Cf; Bolis, M; Antonucci, Fp; Di Maio, Vc; Alfieri, R; Sarmati, L; Casalino, P; Bernardini, S; Micheli, V; Rizzardini, G; Parruti, G; Quirino, T; Puoti, M; Babudieri, S; D'Arminio Monforte, A; Andreoni, M; Craxì, A; Angelico, M; Pasquazzi, C; Taliani, G; Guedj, J; Perno, Cf; Ceccherini Silberstein, F";s:9:"metadata7";s:28:"10.1371/journal.pone.0177352";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:81;a:14:{s:9:"citazione";s:278:"Fabeni, L., Alteri, C., Di Carlo, D., Orchi, N., Carioti, L., Bertoli, A., et al. (2017). Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 72(10), 2837-2845.";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_327237";s:6:"handle";s:11:"2108/194918";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:129:"Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14";s:9:"metadata6";s:817:"Fabeni, L; Alteri, C; Di Carlo, D; Orchi, N; Carioti, L; Bertoli, A; Gori, C; Forbici, F; Continenza, F; Maffongelli, G; Pinnetti, C; Vergori, A; Mondi, A; Ammassari, A; Borghi, V; Giuliani, M; De Carli, G; Pittalis, S; Grisetti, S; Pennica, A; Mastroianni, C; Montella, F; Cristaudo, A; Mussini, C; Girardi, E; Andreoni, M; Antinori, A; Ceccherini-Silberstein, F; Perno, C; Santoro, M; Capobianchi, M; Navarra, A; Palummieria, ; Abbate, I; D'Arrigo, R; Fusco, F; Mariano, A; Nicastri, E; Nurra, G; Puro, V; Sampaolesi, A; Sciarrone, M; Scognamiglio, P; Selleri, M; Sias, C; Zaccarelli, M; Di Carlo, A; Giuliani, M; Vullo, V; Falciano, M; Errigo, F; Gattari, P; Spizzichino, L; Schito, S; Sarmati, L; Buonomini, Ar; Cerva, C; Mastroianni, C; Lichtner, M; Mercurio, V; Anzalone, E; Pitorri, A; Caterini, A; Barbacci, S";s:9:"metadata7";s:18:"10.1093/jac/dkx231";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:82;a:14:{s:9:"citazione";s:348:"Mengoli, C., Andreis, S., Scaggiante, R., Cruciani, M., Bosco, O., Ferretto, R., et al. (2017). Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 72(1), 220-226.";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_313858";s:6:"handle";s:11:"2108/182929";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:196:"Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy";s:9:"metadata6";s:165:"Mengoli, C; Andreis, S; Scaggiante, R; Cruciani, M; Bosco, O; Ferretto, R; Leoni, D; Maffongelli, G; Basso, M; Torti, C; Sarmati, L; Andreoni, M; Palu, G; Parisi, Sg";s:9:"metadata7";s:18:"10.1093/jac/dkw348";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:83;a:14:{s:9:"citazione";s:307:"Parisi, S.G., Basso, M., Mengoli, C., Scaggiante, R., Andreis, S., Franzetti M., M., et al. (2017). Liver stiffness is not associated with short- and long-term plasma HIV RNA replication in immunocompetent patients with HIV infection and with HIV/HCV coinfection. ANNALS OF GASTROENTEROLOGY, 30(5), 534-541.";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_320514";s:6:"handle";s:11:"2108/189087";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:162:"Liver stiffness is not associated with short- and long-term plasma HIV RNA replication in immunocompetent patients with HIV infection and with HIV/HCV coinfection";s:9:"metadata6";s:161:"Parisi, SG; Basso, M; Mengoli, C; Scaggiante, R; Andreis, S; Franzetti M., M; Cattelan A., M; Zago, D; Cruciani, M; Andreoni, M; Piovesan, S; Palu, G; Alberti, A";s:9:"metadata7";s:22:"10.20524/aog.2017.0175";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:84;a:14:{s:9:"citazione";s:351:"Petta, S., Marzioni, M., Russo, P., Aghemo, A., Alberti, A., Ascione, A., et al. (2017). Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study. THE LANCET. GASTROENTEROLOGY & HEPATOLOGY, 2(6), 427-434.";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_311272";s:6:"handle";s:11:"2108/180614";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:34:"Settore MED/12 - Gastroenterologia";s:9:"metadata4";N;s:9:"metadata5";s:203:"Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study";s:9:"metadata6";s:2462:"Petta, S; Marzioni, M; Russo, P; Aghemo, A; Alberti, A; Ascione, A; Antinori, A; Bruno, R; Bruno, S; Chirianni, A; Gaeta, G; Giannini, E; Merli, M; Messina, V; Montilla, S; Perno, Cf; Puoti, M; Raimondo, G; Rendina, Lm; Silberstein, F; Villa, E; Zignego, A; Pani, L; Craxi, A; Tabone, M; Andreoni, M; Teti, E; Angelico, M; Persico, M; Masarone, M; Chiodera, A; Solinas, A; delle Monache, M; Cecere, R; Maria Schimizzi, A; Piovesan, S; Campagnolo, D; Chiara Piras, M; Zolfino, T; Paolo Russo, F; Morelli, O; Sangiovanni, V; Onofrio, M; Iodice, V; Izzi, A; Pirisi, M; Danieli, E; Vinci, M; Rizzardini, G; Fagiuoli, S; Pasulo, L; D'Arminio Monforte, A; Zuin, M; Giorgini, A; Simeone, F; Piali, G; Lo Guercio, C; Federico, A; Brancaccio, G; Marrone, A; Abbati, G; Boarini, C; Borghi, V; Bernabucci, V; Corti, G; Monti, M; Rizzetto, M; Martini, S; Andreone, P; Gianstefani, A; Lenzi, M; Verucchi, G; Toniutto, P; Borgia, G; Caporaso, N; Morisco, F; Nardone, G; Angrisani, D; Giacometti, A; Benedetti, A; Tarantino, G; Marsetti, F; Tavio, M; Novara, S; Antonia Santantonio, T; Serviddio, G; Brunetto, M; Coco, B; Angarano, G; Milella, M; Barone, M; DI LEO, A; Ettore Sansonno, D; Cacciola, I; Boffa, N; Saracco, G; Di Biagio, A; Picciotto, A; DE DONATO, F; Calvaruso, V; Corradori, S; Ferrari, C; Orlandini, A; Maida, I; Torti, C; Chessa, L; Felder, M; Vespasiani Gentilucci, U; Angeli, P; Romano, A; Ludovico Rapaccini, G; Miele, L; Cima, S; Luisa Russo, M; Cozzolongo, R; Onnelli, G; D'Offizi, G; Lionetti, R; Montalbano, M; Guerra, M; Di Perri, G; Boglione, L; Capra, F; Carolo, G; Ieluzzi, D; Antonini, C; Termite, A; Madonia, S; Tarquini, P; Parruti, G; Vecchiet, G; Falasca, K; Menzaghi, B; Quirino, T; Dentone, C; Maria Piscaglia, A; Rossi, C; Giordani, M; Fontanella, L; Cassola, G; Russello, M; Cristaudo, A; Giacomet, V; Colombo, M; Donato, F; Durante, E; Cosco, L; Marignani, M; Quartini, M; Memoli, M; Ganga, R; Ponti, L; Soria, A; Grazia Rumi, M; Gulminetti, R; Maserati, R; Mondelli, M; Lazzarin, A; Rita Parisi, M; Canovari, B; Avancini, I; Pravadelli, C; Blanc, P; Pasquazzi, C; Maria Mastroianni, C; Lichtner, M; Distefano, M; Magnani, S; Paganin, S; Erne, E; Gatti, P; Tundi, P; Calabrese, P; Gasbarrini, A; Grieco, A; Coppola, N; Del Poggio, P; Levrero, M; Talliani, G; Vullo, V; Cauda, R; La Monica, S; Potenza, D; Rizzo, S; Castelli, F; Marie Pigozzi, G; Ciancio, A; Romagnoli, D; Barchetti, F; Ivanovic, J; Longo, O; Petraglia, S; Paola Trotta, M";s:9:"metadata7";s:29:"10.1016/S2468-1253(17)30048-1";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:85;a:14:{s:9:"citazione";s:311:"Ricciardi, A., Gentilotti, E., Coppola, L., Maffongelli, G., Cerva, C., Malagnino, V., et al. (2017). Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients. PLOS ONE, 12(5), e0176881.";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_313576";s:6:"handle";s:11:"2108/182634";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:181:"Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients";s:9:"metadata6";s:193:"Ricciardi, A; Gentilotti, E; Coppola, L; Maffongelli, G; Cerva, C; Malagnino, V; Mari, A; Di Veroli, A; Berrilli, F; Apice, F; Toschi, N; Di Cave, D; Giuseppe Parisi, S; Andreoni, M; Sarmati, L";s:9:"metadata7";s:28:"10.1371/journal.pone.0176881";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:86;a:14:{s:9:"citazione";s:331:"Russo, M., Nardi, P., Saitto, G., Sordillo, P., Colella, D.f., Andreoni, M., et al. (2017). Paravalvular leak of a mechanical mitral valve prosthesis associated with Burkholderia cepacia subacute endocarditis: A rare case successfully treated by multidisciplinary approach. KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 14(3), 200-202.";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_323214";s:6:"handle";s:11:"2108/191514";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:180:"Paravalvular leak of a mechanical mitral valve prosthesis associated with Burkholderia cepacia subacute endocarditis: A rare case successfully treated by multidisciplinary approach";s:9:"metadata6";s:94:"Russo, M; Nardi, P; Saitto, G; Sordillo, P; Colella, Df; Andreoni, M; Pellegrino, A; Ruvolo, G";s:9:"metadata7";s:23:"10.5114/kitp.2017.70535";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:87;a:14:{s:9:"citazione";s:388:"Sarmati, L., Andreoni, M., Antonelli, G., Arcese, W., Bruno, R., Coppola, N., et al. (2017). Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper. CLINICAL MICROBIOLOGY AND INFECTION, 23(12), 935-940.";s:4:"data";s:4:"2017";s:2:"id";s:20:"PUBBLICAZIONE_347699";s:6:"handle";s:11:"2108/212174";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:240:"Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper";s:9:"metadata6";s:208:"Sarmati, L; Andreoni, M; Antonelli, G; Arcese, W; Bruno, R; Coppola, N; Gaeta, Gb; Galli, M; Girmenia, C; Mikulska, M; Pane, F; Perno, Cf; Picardi, M; Puoti, M; Rambaldi, A; Svicher, V; Taliani, G; Gentile, G";s:9:"metadata7";s:25:"10.1016/j.cmi.2017.06.023";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:88;a:14:{s:9:"citazione";s:335:"Armenia, D., Di Carlo, D., Calcagno, A., Vendemiati, G., Forbici, F., Bertoli, A., et al. (2016). Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, dkw512.";s:4:"data";s:10:"2016-12-20";s:2:"id";s:20:"PUBBLICAZIONE_302355";s:6:"handle";s:11:"2108/173068";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:189:"Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen";s:9:"metadata6";s:306:"Armenia, D; Di Carlo, D; Calcagno, A; Vendemiati, G; Forbici, F; Bertoli, A; Berno, G; Carta, S; Continenza, F; Fedele, V; Bellagamba, R; Cicalini, S; Ammassari, A; Libertone, R; Zaccarelli, M; Ghisetti, V; Andreoni, M; Ceccherini-Silberstein, F; Bonora, S; Di Perri, G; Antinori, A; Perno, Cf; Santoro, MM";s:9:"metadata7";s:18:"10.1093/jac/dkw512";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:89;a:14:{s:9:"citazione";s:308:"Alteri, C., Surdo, M., Di Maio, V., Di Santo, F., Costa, G., Parrotta, L., et al. (2016). The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate + emtricitabine-containing HAART both in vivo and in vitro. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 7, 1-7.";s:4:"data";s:7:"2016-12";s:2:"id";s:20:"PUBBLICAZIONE_290338";s:6:"handle";s:11:"2108/162513";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:165:"The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate + emtricitabine-containing HAART both in vivo and in vitro";s:9:"metadata6";s:356:"Alteri, C; Surdo, M; Di Maio, V; Di Santo, F; Costa, G; Parrotta, L; Romeo, I; Gori, C; Santoro, M; Fedele, V; Carta, S; Continenza, F; Pinnetti, C; Bellagamba, R; Liuzzi, G; Orchi, N; Latini, A; Bertoli, A; Girardi, E; Alcaro, S; Giuliani, M; Petrosillo, N; Andreoni, M; Antinori, A; Monforte, A; Ceccherini-Silberstein, F; Artese, A; Perno, C; Svicher, V";s:9:"metadata7";s:26:"10.1016/j.jgar.2016.06.005";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:90;a:14:{s:9:"citazione";s:283:"Vassena, L., Giuliani, E., Buonomini, A.r., Malagnino, V., Andreoni, M., & Doria, M. (2016). Brief report: L-selectin (CD62L) is downregulated on CD4+ and CD8+ T lymphocytes of HIV-1-infected individuals naive for ART. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 72(5), 492-497.";s:4:"data";s:10:"2016-08-15";s:2:"id";s:20:"PUBBLICAZIONE_318058";s:6:"handle";s:11:"2108/189195";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:124:"Brief report: L-selectin (CD62L) is downregulated on CD4+ and CD8+ T lymphocytes of HIV-1-infected individuals naive for ART";s:9:"metadata6";s:75:"Vassena, L; Giuliani, E; Buonomini, Ar; Malagnino, V; Andreoni, M; Doria, M";s:9:"metadata7";s:28:"10.1097/QAI.0000000000000999";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:91;a:14:{s:9:"citazione";s:373:"Cerva, C., Colagrossi, L., Maffongelli, G., Salpini, R., Di Carlo, D., Malagnino, V., et al. (2016). Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor. CLINICAL MICROBIOLOGY AND INFECTION, 22(11), 946.e1-946.e8.";s:4:"data";s:10:"2016-07-27";s:2:"id";s:20:"PUBBLICAZIONE_290349";s:6:"handle";s:11:"2108/164129";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:211:"Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor";s:9:"metadata6";s:254:"Cerva, C; Colagrossi, L; Maffongelli, G; Salpini, R; Di Carlo, D; Malagnino, V; Battisti, A; Ricciardi, A; Pollicita, M; Bianchi, A; Picardi, A; Cudillo, L; Cerretti, R; Angelis, G; Cantonetti, M; Andreoni, M; Perno, CF; Arcese, W; Svicher, V; Sarmati, L";s:9:"metadata7";s:25:"10.1016/j.cmi.2016.07.021";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:92;a:14:{s:9:"citazione";s:312:"Moscato, G., Di Matteo, G., Ciotti, M., Di Bonito, P., Andreoni, M., & Moschese, V. (2016). Dual response to human papilloma virus vaccine in an immunodeficiency disorder: Resolution of plantar warts and persistence of condylomas. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 30(7), 1212-1213.";s:4:"data";s:7:"2016-07";s:2:"id";s:20:"PUBBLICAZIONE_262834";s:6:"handle";s:11:"2108/142448";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:137:"Dual response to human papilloma virus vaccine in an immunodeficiency disorder: Resolution of plantar warts and persistence of condylomas";s:9:"metadata6";s:77:"Moscato, GMF; Di Matteo, G; Ciotti, M; Di Bonito, P; Andreoni, M; Moschese, V";s:9:"metadata7";s:17:"10.1111/jdv.13133";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:93;a:14:{s:9:"citazione";s:269:"Winston, A., Stohr, W., Antinori, A., Arenas-Pinto, A., Llibre, J.m., Amieva, H., et al. (2016). Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy. HIV MEDICINE, 17(6), 471-478.";s:4:"data";s:7:"2016-06";s:2:"id";s:20:"PUBBLICAZIONE_302365";s:6:"handle";s:11:"2108/173421";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:141:"Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy";s:9:"metadata6";s:2754:"Winston, A; Stohr, W; Antinori, A; Arenas-Pinto, A; Llibre, Jm; Amieva, H; Cabie, A; Williams, I; Di Perri, G; Tellez, Mj; Rockstroh, J; Babiker, A; Pozniak, A; Raffi, F; Richert, L; Dedes, N; Chene, G; Allavena, C; Autran, B; Bucciardini, R; Vella, S; Horban, A; Arribas, J; Boffito, M; Pillay, D; Franquet, X; Schwarze, S; Grarup, J; Fischer, A; Wallet, C; Diallo, A; Molina, J-; Saillard, J; Moecklinghoff, C; Stellbrink, H-; Leeuwen, R; Gatell, J; Sandstrom, E; Flepp, M; Ewings, F; George, Ec; Hudson, F; Pearce, G; Quercia, R; Rogatto, F; Leavitt, R; Nguyen, B-; Goebel, F; Marcotullio, S; Kaur, N; Sasieni, P; Spencer-Drake, C; Peto, T; Miller, V; Chene, G; Arnault, F; Boucherie, C; Fischer, A; Jean, D; Paniego, V; Rouch, E; Schwimmer, C; Soussi, M; Taieb, A; Termote, M; Touzeau, G; Wallet, C; Cursley, A; Dodds, W; Hoppe, A; Kummeling, I; Pacciarini, F; Paton, N; Russell, C; Taylor, K; Ward, D; Aagaard, B; Eid, M; Gey, D; Jensen, B; Jakobsen, M-; Jansson, Po; Jensen, K; Joensen, Z; Larsen, E; Pahl, C; Pearson, M; Nielsen, B; Reilev, S; Christ, I; Lathouwers, D; Manting, C; Mendy, B; Metro, A; Couffin-Cadiergues, S; Knellwolf, A-; Palmisiano, L; Aznar, E; Barea, C; Cotarelo, M; Esteban, H; Girbau, I; Moyano, B; Ramirez, M; Saiz, C; Sanchez, I; Yllescas, M; Binelli, A; Colasanti, V; Massella, M; Anagnostou, O; Gioukari, V; Touloumi, G; Schmied, B; Rieger, A; Vetter, N; Wit, S; Florence, E; Vandekerckhove, L; Gerstoft, J; Mathiesen, L; Katlama, C; Cabie, A; Cheret, A; Dupon, M; Ghosn, J; Girard, P-; Goujard, C; Levy, Y; Morlat, P; Neau, D; Obadia, M; Perre, P; Piroth, L; Reynes, J; Tattevin, P; Ragnaud, J; Weiss, L; Yazdan, Y; Yeni, P; Zucman, D; Behrens, G; Esser, S; Fatkenheuer, G; Hoffmann, C; Jessen, H; Schmidt, R; Stephan, C; Unger, S; Hatzakis, A; Daikos, Gl; Papadopoulos, A; Skoutelis, A; Banhegyi, D; Mallon, P; Mulcahy, F; Andreoni, M; Bonora, S; Castelli, F; Monforte, A; Galli, M; Lazzarin, A; Mazzotta, F; Carlo, T; Vullo, V; Prins, J; Richter, C; Verhagen, D; Eeden, A; Doroana, M; Antunes, F; Maltez, F; Sarmento-Castro, R; Garcia, J; Aldeguer, J; Clotet, B; Domingo, P; Gatell, Jm; Knobel, H; Marquez, M; Miralles, M; Portilla, J; Soriano, V; Thalme, A; Blaxhult, A; Gisslen, M; Fox, J; Gompels, M; Herieka, E; Johnson, M; Leen, C; Teague, A; Boyd, M; Moller, N; Frosig, E; Moing, V; Wit, Fwnm; Kowalska, J; Berenguer, J; Moreno, S; Muhller, Nj; Torok, E; Post, F; Angus, B; Calvez, V; Boucher, C; Collins, S; Dunn, D; Lambert, S; Marcelin, A-; Perno, C; White, E; Ammassari, A; Stoehr, W; Schmidt, R; Odermarsky, M; Smith, C; Thiebaut, R; Laserna, B; Castagna, A; Furrer, H-; Mocroft, A; Reiss, P; Fragola, V; Lauriola, M; Murri, R; Nieuwkerk, P; Spire, B; Volny-Anne, A; West, B; Maria, J; Braggion, M; Foca, E";s:9:"metadata7";s:17:"10.1111/hiv.12344";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:94;a:14:{s:9:"citazione";s:299:"Gregson, J., Tang, M., Ndembi, N., Hamers, R.L., Marconi, V.C., Brooks, K., et al. (2016). Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: A multicentre retrospective cohort study. THE LANCET INFECTIOUS DISEASES, 16(5), 565-575.";s:4:"data";s:7:"2016-05";s:2:"id";s:20:"PUBBLICAZIONE_385096";s:6:"handle";s:11:"2108/243388";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/07";s:9:"metadata4";N;s:9:"metadata5";s:159:"Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: A multicentre retrospective cohort study";s:9:"metadata6";s:880:"Gregson, J; Tang, M; Ndembi, N; Hamers, RL; Marconi, VC; Brooks, K; Theys, K; Arruda, M; Garcia, F; Monge, S; Kanki, PJ; Kumarasamy, N; Kerschberger, B; Mor, O; Charpentier, C; Todesco, E; Rokx, C; Gras, L; Halvas, EK; Sunpath, H; Carlo, DD; Antinori, A; Andreoni, M; Latini, A; Mussini, C; Aghokeng, A; Sonnerborg, A; Neogi, U; Fessel, WJ; Agolory, S; Yang, C; Blanco, JL; Juma, JM; Smit, E; Schmidt, D; Watera, C; Asio, J; Kirungi, W; Tostevin, A; Clumeck, N; Goedhals, D; Bester, PA; Sabin, C; Mukui, I; Santoro, M; Perno, CF; Hunt, G; Morris, L; Pillay, D; Schulter, E; Reyes-Teran, G; Romero, K; Avila-Rios, S; Sirivichayakul, S; Ruxrungtham, K; Mekprasan, S; Dunn, D; Kaleebu, P; Raizes, E; Kantor, R; Gupta, RK; Rhee, S-; Shafer, RW; de Wit, TFR; Diero, L; Camacho, R; Gunthard, HF; Hoffmann, CJ; Di Carlo, D; El-Hay, T; van Vuuren, C; de Oliveira, T; Murakami-Ogasawara, A";s:9:"metadata7";s:29:"10.1016/S1473-3099(15)00536-8";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:95;a:14:{s:9:"citazione";s:283:"Antinori, A., Marcotullio, S., Andreoni, M., Chirianni, A., D'arminio Monforte, A., Di Biagio, A., et al. (2016). Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015. NEW MICROBIOLOGICA, 39(2), 93-109.";s:4:"data";s:7:"2016-04";s:2:"id";s:20:"PUBBLICAZIONE_318057";s:6:"handle";s:11:"2108/189227";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:133:"Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015";s:9:"metadata6";s:149:"Antinori, A; Marcotullio, S; Andreoni, M; Chirianni, A; D'arminio Monforte, A; Di Biagio, A; Galli, M; Mazzotta, F; Mussini, C; Puoti, M; Lazzarin, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:96;a:14:{s:9:"citazione";s:254:"Andreoni, M., d'Angela, D., Mancusi, R.L., Sarrecchia, C., & Spandonaro, F. (2016). Epidemiological burden estimates for pathologies with a non constant risk: an application to HCV in Italy according to age, Metavir score, and genotype. MEDICINE, 95(42).";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_294655";s:6:"handle";s:11:"2108/166283";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:38:"Settore SECS-P/06 - Economia Applicata";s:9:"metadata4";N;s:9:"metadata5";s:151:"Epidemiological burden estimates for pathologies with a non constant risk: an application to HCV in Italy according to age, Metavir score, and genotype";s:9:"metadata6";s:69:"Andreoni, M; d'Angela, D; Mancusi, RL; Sarrecchia, C; Spandonaro, F;";s:9:"metadata7";s:27:"10.1097/MD.0000000000005143";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:97;a:14:{s:9:"citazione";s:282:"Babiloni, C., Pennica, A., Capotosto, P., Onorati, P., Muratori, C., Ferracuti, S., et al. (2016). Brain and cognitive functions in two groups of naïve HIV patients selected for a different plan of antiretroviral therapy: A qEEG study. CLINICAL NEUROPHYSIOLOGY, 127(11), 3455-3469.";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_313631";s:6:"handle";s:11:"2108/182686";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:136:"Brain and cognitive functions in two groups of naïve HIV patients selected for a different plan of antiretroviral therapy: A qEEG study";s:9:"metadata6";s:270:"Babiloni, C; Pennica, A; Capotosto, P; Onorati, P; Muratori, C; Ferracuti, S; Roma, P; Correr, V; Piccinni, E; Noce, G; Del Percio, C; Cordone, S; Limatola, C; Soricelli, A; Di Campli, F; Gianserra, L; Ciullini, L; Aceti, A; Viscione, M; Teti, E; Sarmati, L; Andreoni, M";s:9:"metadata7";s:28:"10.1016/j.clinph.2016.09.001";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:98;a:14:{s:9:"citazione";s:287:"Babiloni, C., Pennica, A., Del Percio, C., Noce, G., Cordone, S., Muratori, C., et al. (2016). Abnormal cortical sources of resting state electroencephalographic rhythms in single treatment-naïve HIV individuals: A statistical z-score index. CLINICAL NEUROPHYSIOLOGY, 127(3), 1803-1812.";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_318063";s:6:"handle";s:11:"2108/186799";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:146:"Abnormal cortical sources of resting state electroencephalographic rhythms in single treatment-naïve HIV individuals: A statistical z-score index";s:9:"metadata6";s:209:"Babiloni, C; Pennica, A; Del Percio, C; Noce, G; Cordone, S; Muratori, C; Ferracuti, S; Donato, N; Di Campli, F; Gianserra, L; Teti, E; Aceti, A; Soricelli, A; Viscione, M; Limatola, C; Andreoni, M; Onorati, P";s:9:"metadata7";s:28:"10.1016/j.clinph.2015.12.007";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:99;a:14:{s:9:"citazione";s:231:"Babiloni, C., Pennica, A., Nullc, N.p., Noce, G., Cordone, S., Lopez, S., et al. (2016). Antiretroviral therapy affects the z-score index of deviant cortical EEG rhythms in naïve HIV individuals. NEUROIMAGE. CLINICAL, 12, 144-156.";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_318056";s:6:"handle";s:11:"2108/189229";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:106:"Antiretroviral therapy affects the z-score index of deviant cortical EEG rhythms in naïve HIV individuals";s:9:"metadata6";s:258:"Babiloni, C; Pennica, A; Nullc, Np; Noce, G; Cordone, S; Lopez, S; Berry, K; Muratori, C; Ferracuti, S; Roma, P; Correr, V; Nullf, Nc; Gianserra, L; Ciullini, L; Aceti, A; Soricelli, A; Teti, E; Viscione, M; Limatola, C; Onorati, P; Capotosto, P; Andreoni, M";s:9:"metadata7";s:26:"10.1016/j.nicl.2016.06.005";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:100;a:14:{s:9:"citazione";s:328:"Delle Rose, D., Pezzotti, P., Fortunato, E., Sordillo, P., Gini, S., Boros, S., et al. (2016). Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 35(9), 1531-1539.";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_297685";s:6:"handle";s:11:"2108/169143";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:31:"Settore MED/41 - Anestesiologia";s:9:"metadata4";s:1736:"The purpose of this study was to assess the main clinical predictors and microbiological features of ventilator-associated pneumonia (VAP) in the Intensive Care Unit (ICU) environment. This work is a retrospective analysis over one year from September 2010 to September 2011. Patients' risk factors, causes of admission, comorbidities and respiratory specimens collected in six Italian ICUs were reviewed. Incidence and case fatality rate of VAP were evaluated. After stratification for VAP development, univariate and multivariate analyses were performed to assess the impact of patients' conditions on the onset of this infection. A total of 1,647 ICU patients (pts) were considered. Overall, 115 patients (6.9 %) experienced at least one episode of VAP. The incidence rate for VAP was 5.82/1,000 pts-days, with a case fatality rate of 44.3 %. Multivariate analysis showed that admission for neurological disorders (aIRR 4.12, CI 1.24-13.68, p = 0.02) and emergency referral to ICU from other hospitals (aIRR 2.11, CI 1.03-4.31, p = 0.04) were associated with higher risk of VAP, whereas a tendency to a higher risk of infection was detected for admission due to respiratory disease, cardiac disease, trauma and for having obesity or renal failure. A total of 372 microbiological isolates from respiratory specimens were collected in VAP patients. The most common species were Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa, showing high resistance rates to carbapenems. Neurological disorders and emergency referral at the admission into the ICU are significantly associated with the onset of VAP. A high incidence of multi-drug resistant Gram- species was detected in the respiratory specimens.";s:9:"metadata5";s:149:"Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals";s:9:"metadata6";s:271:"Delle Rose, D; Pezzotti, P; Fortunato, E; Sordillo, P; Gini, S; Boros, S; Meledandri, M; Gallo, M; Prignano, G; Caccese, R; D'Ambrosio, M; Citterio, G; Rocco, ML; Leonardis, F; Natoli, S; Fontana, C; Favaro, M; Celeste, MG; Franci, T; Testore, GP; Andreoni, M; Sarmati, L";s:9:"metadata7";s:25:"10.1007/s10096-016-2694-9";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:101;a:14:{s:9:"citazione";s:322:"Di Maio, V., Cento, V., Di Paolo, D., Aragri, M., De Leonardis, F., Tontodonati, M., et al. (2016). HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 71(3), 739-750.";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_253738";s:6:"handle";s:11:"2108/133470";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:166:"HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels";s:9:"metadata6";s:2229:"Di Maio, V; Cento, V; Di Paolo, D; Aragri, M; De Leonardis, F; Tontodonati, M; Micheli, V; Bellocchi, M; Antonucci, F; Bertoli, A; Lenci, I; Milana, M; Gianserra, L; Melis, M; Di Biagio, A; Sarrecchia, C; Sarmati, L; Landonio, S; Francioso, S; Lambiase, L; Nicolini, L; Marenco, S; Nosotti, L; Giannelli, V; Siciliano, M; Romagnoli, D; Pellicelli, A; Vecchiet, J; Magni, C; Babudieri, S; Mura, M; Taliani, G; Mastroianni, C; Vespasiani Gentilucci, U; Romano, M; Morisco, F; Gasbarrini, A; Vullo, V; Bruno, S; Baiguera, C; Pasquazzi, C; Tisone, G; Picciotto, A; Andreoni, M; Parruti, G; Rizzardini, G; Angelico, M; Perno, CF; Ceccherini Silberstein, F; Mariani, R; Paoloni, M; Iapadre, N; Grimaldi, A; Menzaghi, B; Quirino, T; Vecchiet, J; Bruzzone, B; De Maria, A; Di Biagio, A; Marenco, S; Nicolini, L; Picciotto, A; Viscoli, C; Casinelli, K; Monache, M; Lichtner, M; Mastroianni, C; Aghemo, A; Bruno, S; Cerrone, M; Colombo, M; Monforte, A; Danieli, E; Donato, F; Gubertini, G; Landonio, S; Magni, C; Mancon, A; Micheli, V; Monico, S; Niero, F; Puoti, M; Rizzardini, G; Russo, M; Alfieri, R; Gnocchi, M; Orro, A; Milanesi, L; Baldelli, E; Bertolotti, M; Borghi, V; Mussini, C; Romagnoli, D; Brancaccio, G; Caporaso, N; Gaeta, G; Lembo, V; Morisco, F; Calvaruso, V; Craxì, A; Di Marco, V; Mazzola, A; Petta, S; D'Amico, E; Cacciatore, P; Consorte, A; Palitti, V; Parruti, G; Pieri, A; Polilli, E; Tontodonati, M; Andreoni, M; Angelico, M; Antenucci, F; Antonucci, F; Aragri, M; Armenia, D; Baiocchi, L; Bellocchi, M; Biliotti, E; Biolato, M; Carioti, L; Cento, V; Cerasari, G; Cerva, C; Ciotti, M; D'Ambrosio, C; D'Ettorre, G; De Leonardis, F; De Sanctis, A; Di Maio, V; Di Paolo, D; Francioso, S; Furlan, C; Gallo, P; Gasbarrini, A; Giannelli, V; Gianserra, L; Grieco, A; Grieco, S; Lambiase, L; Lattanzi, B; Lenci, I; Malagnino, V; Manuelli, M; Merli, M; Miglioresi, L; Milana, M; Nosotti, L; Palazzo, D; Pasquazzi, C; Pellicelli, A; Romano, M; Santopaolo, F; Santoro, M; Sarmati, L; Sarrecchia, C; Sforza, D; Siciliano, M; Sorbo, M; Spaziante, M; Svicher, V; Taliani, G; Teti, E; Tisone, G; Vespasiani Gentilucci, U; Vullo, V; Mangia, A; Babudieri, S; Maida, I; Melis, M; Mura, M; Falconi, L; Di Giammartino, D; Tarquini, P";s:9:"metadata7";s:18:"10.1093/jac/dkv403";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:102;a:14:{s:9:"citazione";s:246:"Maffongelli, G., Alterib, C., Gentilotti, E., Bertoli, A., Ricciardi, A., Malagnino, V., et al. (2016). Impact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy. AIDS.";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_253986";s:6:"handle";s:11:"2108/133866";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:135:"Impact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy";s:9:"metadata6";s:151:"Maffongelli, G; Alterib, C; Gentilotti, E; Bertoli, A; Ricciardi, A; Malagnino, V; Svicher, V; Santoro, Mm; Dori, L; Perno, Cf; Andreoni, M; Sarmati, L";s:9:"metadata7";s:28:"10.1097/QAD.0000000000000977";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:103;a:14:{s:9:"citazione";s:222:"Marcellusi, A., Viti, R., Russo, S., Andreoni, M., Antinori, A., & Mennini, F.S. (2016). Early treatment in HIV patients: a cost–utility analysis from the Italian perspective. CLINICAL DRUG INVESTIGATION, 36(5), 377-387.";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_318061";s:6:"handle";s:11:"2108/186797";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:87:"Early treatment in HIV patients: a cost–utility analysis from the Italian perspective";s:9:"metadata6";s:71:"Marcellusi, A; Viti, R; Russo, S; Andreoni, M; Antinori, A; Mennini, FS";s:9:"metadata7";s:25:"10.1007/s40261-016-0382-2";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:104;a:14:{s:9:"citazione";s:216:"Salpini, R., Fokam, J., Ceccarelli, L., Santoro, M., Nanfack, A., Sosso, S., et al. (2016). High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians. CURRENT HIV RESEARCH, 14(2), 165-171.";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_253989";s:6:"handle";s:11:"2108/133684";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:85:"High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians";s:9:"metadata6";s:159:"Salpini, R; Fokam, J; Ceccarelli, L; Santoro, M; Nanfack, A; Sosso, S; Kowo, M; Cento, V; Torimiro, J; Sarmati, L; Andreoni, M; Colizzi, V; Perno, Cf; Njoya, O";s:9:"metadata7";s:33:"10.2174/1570162X13666150930114742";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:105;a:14:{s:9:"citazione";s:307:"Zaccarelli, M., Santoro, M.m., Armenia, D., Borghi, V., Gennari, W., Gori, C., et al. (2016). Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA. JOURNAL OF CLINICAL VIROLOGY, 82, 94-100.";s:4:"data";s:4:"2016";s:2:"id";s:20:"PUBBLICAZIONE_290346";s:6:"handle";s:11:"2108/162527";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:170:"Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA";s:9:"metadata6";s:240:"Zaccarelli, M; Santoro, Mm; Armenia, D; Borghi, V; Gennari, W; Gori, C; Forbici, F; Bertoli, A; Fabeni, L; Giannetti, A; Cicalini, S; Bellagamba, R; Andreoni, M; Mastroianni, Cm; Mussini, C; Ceccherini-Silberstein, F; Perno, CF; Antinori, A";s:9:"metadata7";s:25:"10.1016/j.jcv.2016.07.007";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:106;a:14:{s:9:"citazione";s:280:"Giuliani, E., Vassena, L., Desimio, M.g., Buonomini, A.r., Malagnino, V., Andreoni, M., et al. (2015). Expression and Function of NKG2D Is Impaired in CD8+ T Cells of Chronically HIV-1-Infected Patients Without ART. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 70(4), 347-356.";s:4:"data";s:10:"2015-12-01";s:2:"id";s:20:"PUBBLICAZIONE_318066";s:6:"handle";s:11:"2108/186801";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:111:"Expression and Function of NKG2D Is Impaired in CD8+ T Cells of Chronically HIV-1-Infected Patients Without ART";s:9:"metadata6";s:88:"Giuliani, E; Vassena, L; Desimio, Mg; Buonomini, Ar; Malagnino, V; Andreoni, M; Doria, M";s:9:"metadata7";s:28:"10.1097/QAI.0000000000000792";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:107;a:14:{s:9:"citazione";s:232:"Andreoni, M., Marcotullio, S., Puro, V., De Carli, G., Tambussi, G., Nozza, S., et al. (2015). An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project. NEW MICROBIOLOGICA, 38(4), 443-490.";s:4:"data";s:7:"2015-11";s:2:"id";s:20:"PUBBLICAZIONE_253990";s:6:"handle";s:11:"2108/133863";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:100:"An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project";s:9:"metadata6";s:411:"Andreoni, M; Marcotullio, S; Puro, V; De Carli, G; Tambussi, G; Nozza, S; Gori, A; Rusconi, S; Santoro, Mm; Clementi, M; Perno, Cf; d'Arminio Monforte, A; Maggiolo, F; Castagna, A; De Luca, A; Galli, M; Giacomelli, A; Borderi, M; Guaraldi, G; Calcagno, A; Di Perri, G; Bonora, S; Mussini, C; Di Biagio, A; Puoti, M; Bruno, R; Zuccaro, V; Antinori, A; Cinque, P; Croce, D; Restelli, U; Rizzardini, G; Lazzarin, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:108;a:14:{s:9:"citazione";s:263:"Salpini, R., Colagrossi, L., Bellocchi, M., Surdo, M., Becker, C., Alteri, C., et al. (2015). Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. HEPATOLOGY, 61(3), 823-833.";s:4:"data";s:7:"2015-11";s:2:"id";s:20:"PUBBLICAZIONE_208328";s:6:"handle";s:10:"2108/99049";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:140:"Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression";s:9:"metadata6";s:340:"Salpini, R; Colagrossi, L; Bellocchi, M; Surdo, M; Becker, C; Alteri, C; Aragri, M; Ricciardi, A; Armenia, D; Pollicita, M; Di Santo, F; Carioti, L; Louzoun, Y; Mastroianni, C; Lichtner, M; Paoloni, M; Esposito, M; D'Amore, C; Marrone, A; Marignani, M; Sarrecchia, C; Sarmati, L; Andreoni, M; Angelico, M; Verhejen, J; Perno, CF; Svicher, V";s:9:"metadata7";s:17:"10.1002/hep.27604";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:109;a:14:{s:9:"citazione";s:271:"Surdo, M., Bertoli, A., Colucci, G., Sarmati, L., Andreoni, M., Perno, C.F., et al. (2015). Total HIV-1 DNA detection and quantification in peripheral blood by COBAS®AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 54(2), e57-e59.";s:4:"data";s:10:"2015-09-24";s:2:"id";s:20:"PUBBLICAZIONE_253958";s:6:"handle";s:11:"2108/133646";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:118:"Total HIV-1 DNA detection and quantification in peripheral blood by COBAS®AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0";s:9:"metadata6";s:106:"Surdo, M; Bertoli, A; Colucci, G; Sarmati, L; Andreoni, M; Perno, CF; Ceccherini Silberstein, F; Ciotti, M";s:9:"metadata7";s:22:"10.1515/cclm-2015-0647";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:110;a:14:{s:9:"citazione";s:289:"Antinori, A., Marcotullio, S., Andreoni, M., Ammassari, A., d'Arminio Monforte, A., Galli, M., et al. (2015). Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014. NEW MICROBIOLOGICA, 38(3), 299-328.";s:4:"data";s:7:"2015-07";s:2:"id";s:20:"PUBBLICAZIONE_318206";s:6:"handle";s:11:"2108/186933";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:142:"Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014";s:9:"metadata6";s:147:"Antinori, A; Marcotullio, S; Andreoni, M; Ammassari, A; d'Arminio Monforte, A; Galli, M; Girardi, E; Mazzotta, F; Mussini, C; Puoti, M; Lazzarin, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:111;a:14:{s:9:"citazione";s:254:"Fabeni, L., Berno, G., Svicher, V., Ceccherini-Silberstein, F., Gori, C., Bertoli, A., et al. (2015). Genotypic tropism testing in HIV-1 proviral DNA can provide useful information at low-level viremia. JOURNAL OF CLINICAL MICROBIOLOGY, 53(9), 2935-2941.";s:4:"data";s:7:"2015-07";s:2:"id";s:20:"PUBBLICAZIONE_253960";s:6:"handle";s:11:"2108/133648";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:99:"Genotypic tropism testing in HIV-1 proviral DNA can provide useful information at low-level viremia";s:9:"metadata6";s:223:"Fabeni, L; Berno, G; Svicher, V; Ceccherini-Silberstein, F; Gori, C; Bertoli, A; Mussini, C; Lichtner, M; Zaccarelli, M; Ammassari, A; Pinnetti, C; Cicalini, S; Mastroianni, C; Andreoni, M; Antinori, A; Perno, C; Santoro, M";s:9:"metadata7";s:20:"10.1128/JCM.00893-15";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:112;a:14:{s:9:"citazione";s:147:"Antinori, A., Andreoni, M., Perno, C.f., & Lazzarin, A. (2015). HEFFICON: HIV Effectiveness Italian Conference. NEW MICROBIOLOGICA, 38(2), 149-184.";s:4:"data";s:7:"2015-04";s:2:"id";s:20:"PUBBLICAZIONE_318213";s:6:"handle";s:11:"2108/186937";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:46:"HEFFICON: HIV Effectiveness Italian Conference";s:9:"metadata6";s:48:"Antinori, A; Andreoni, M; Perno, Cf; Lazzarin, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:113;a:14:{s:9:"citazione";s:264:"Cento, V., Di Paolo, D., Di Carlo, D., Micheli, V., Tontodonati, M., De Leonardis, F., et al. (2015). Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome. DIGESTIVE AND LIVER DISEASE, 47(2), 157-163.";s:4:"data";s:7:"2015-02";s:2:"id";s:20:"PUBBLICAZIONE_231192";s:6:"handle";s:11:"2108/113118";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:116:"Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome";s:9:"metadata6";s:408:"Cento, V; Di Paolo, D; Di Carlo, D; Micheli, V; Tontodonati, M; De Leonardis, F; Aragri, M; Antonucci, F; Di Maio, V; Mancon, A; Lenci, I; Manunta, A; Taliani, G; Di Biagio, A; Nicolini, L; Nosotti, L; Sarrecchia, C; Siciliano, M; Landonio, S; Pellicelli, A; Gasbarrini, A; Vecchiet, J; Magni, C; Babudieri, S; Mura, M; Andreoni, M; Parruti, G; Rizzardini, G; Angelico, M; Perno, C; Ceccherini-Silberstein, F";s:9:"metadata7";s:25:"10.1016/j.dld.2014.11.010";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:114;a:14:{s:9:"citazione";s:312:"Armenia, D., Fabeni, L., Alteri, C., Di Pinto, D., Di Carlo, D., Bertoli, A., et al. (2015). HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 70(6), 1865-1873.";s:4:"data";s:4:"2015";s:2:"id";s:20:"PUBBLICAZIONE_253968";s:6:"handle";s:11:"2108/133655";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:161:"HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia";s:9:"metadata6";s:308:"Armenia, D; Fabeni, L; Alteri, C; Di Pinto, D; Di Carlo, D; Bertoli, A; Gori, C; Carta, S; Fedele, V; Forbici, F; D'Arrigo, R; Svicher, V; Berno, G; Pizzi, D; Nicastri, E; Sarmati, L; Pinnetti, C; Ammassari, A; D'Offizi, G; Latini, A; Andreoni, M; Antinori, A; Ceccherini-Silberstein, F; Perno, C; Santoro, M";s:9:"metadata7";s:18:"10.1093/jac/dkv029";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:115;a:14:{s:9:"citazione";s:277:"Camoni, L., Raimondo, M., Dorrucci, M., Regine, V., Salfa, M.c., Suligoi, B., et al. (2015). Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy. AIDS RESEARCH AND HUMAN RETROVIRUSES, 31(3), 282-287.";s:4:"data";s:4:"2015";s:2:"id";s:20:"PUBBLICAZIONE_299776";s:6:"handle";s:11:"2108/182628";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:129:"Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy";s:9:"metadata6";s:2916:"Camoni, L; Raimondo, M; Dorrucci, M; Regine, V; Salfa, Mc; Suligoi, B; Di Giammartino, D; Parruti, G; Di Stefano, P; Paoloni, M; D'Alessandro, M; Grimaldi, A; Sciotti, Mp; Pizzigallo, E; Vecchiett, J; De Stefano, C; La Gala, A; De Stefano, G; Linzalone, A; Cesario, F; Cosco, L; Caroleo, B; Foti, G; Serrao, N; Lucchino, D; Chirianni, A; Abrescia, N; Pempinello, R; Izzo, Cm; Borgia, G; Filippini, P; Sagnelli, E; Iodice, A; Megna, As; D'Alessio, G; Acone, N; Mazzeo, M; Sacchini, D; Ferrari, C; Degli Antoni, A; Magnani, G; Mussini, C; Borghi, V; Viale, P; Colangeli, V; Sighinolfi, L; Libanore, M; Govoni, A; Cancellieri, C; Bassi, P; Arlotti, M; Luzzati, R; Bassetti, M; Tirelli, U; Vaccher, E; Moise, G; Palamara, G; Bernardi, S; Falciano, M; Vullo, V; D'Ettore, G; Renda, V; Guariglia, C; Taliani, G; Mezzaroma, I; Paoletti, F; Ajassa, C; Gastaldi, R; Andreoni, M; Sarmati, L; Montella, F; Antinori, A; Giannetti, A; Pietrosillo, N; Girardi, E; Pennica, A; Cauda, R; Colafigli, M; Di Gianbenedetto, S; Caterini, A; Monarca, R; Barbacci, Sa; Ramponi, Gn; Marchili, M; Anzalone, E; Lichtner, M; Ferrea, G; Cassola, G; Viscoli, C; Mazzarello, G; Setti, M; Artioli, S; Riccio, G; Finocchio, Gc; Anselmo, M; Rizzi, M; Scalzini, A; Castelli, F; Quirino, T; Santoro, D; Pan, A; Zoncada, A; Bonfanti, P; Vigano, P; Villa, M; Tinelli, M; Perboni, G; Palvarini, L; Costa, P; Puoti, M; Galli, M; Rizzardini, G; Monforte, Ad; Lazzarin, A; Castagna, A; Gori, A; Minoli, L; Filice, G; Grossi, P; Giacometti, A; Tavio, M; Montroni, M; Butini, L; Osimani, P; Petrelli, E; Chiodera, A; Vittucci, P; Sabbatini, P; Pasqualini, C; Valle, M; Zoppi, M; Mantia, E; Schettino, G; Deseraca, M; Vitullo, D; Bargiacchi, O; Orofino, G; Bramato, C; Busso, M; Salassa, B; Farenga, M; Bonora, S; Leo, G; Poletti, F; Gobber, M; Cristina, G; Gabiano, C; Mian, P; Moling, O; Paternoster, C; Dorigoni, N; Fontana, T; Angarano, G; Ladisa, N; La Rovere, D; Fico, C; Bulla, F; Santantonio, T; Grisorio, B; Chiriaco, P; Congedo, P; Tundo, P; Resta, F; Cristiano, L; Mura, Ms; Madeddu, G; Mesina, P; Piga, S; Campus, M; Manconi, Pe; Ortu, F; Salvo, A; Baretti, C; La Sala, R; Bellissima, P; Bonfante, S; Galvagna, S; Celesia, Bm; La Rosa, R; Maiuzzo, S; Guarnieri, L; Bruno, S; Picerno, I; Tripodi, N; Farinella, Em; Occhino, C; Titone, L; Colomba, C; Prestileo, T; Saitta, M; Dones, P; Boncoraglio, R; Davi, A; Franco, A; Portelli, V; Savalli, F; Geraci, C; Chimenti, M; Luchi, S; Catalani, C; Trezzi, M; Aquilini, D; Sani, S; Nencioni, C; Carli, T; Mazzotta, F; Lo Caputo, S; Zuccati, G; Iapoce, R; Consolini, R; Bartolozzi, D; Bartoloni, A; Bartalesi, F; De Luca, A; De Martino, M; Tacconi, D; Tini, S; Baldelli, F; Francisci, D; Frongillo, Rf; Traverso, A; Francavilla, E; Ferretto, R; Marranconi, F; Manfrin, V; Cortese, P; Rossi, C; Cattelan, F; Petrucci, A; Brugnaro, P; Sgarabotto, D; Scaggiante, R; Cattelan, A; Bosco, O; Concia, E; Rovere, P";s:9:"metadata7";s:21:"10.1089/aid.2014.0154";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:116;a:14:{s:9:"citazione";s:315:"Delle Rose, D., Sordillo, P., Gini, S., Cerva, C., Boros, S., Rezza, G., et al. (2015). Microbiologic characteristics and predictors of mortality in bloodstream infections in intensive care unit patients: A 1-year, large, prospective surveillance study in 5 Italian hospitals. AMERICAN JOURNAL OF INFECTION CONTROL.";s:4:"data";s:4:"2015";s:2:"id";s:20:"PUBBLICAZIONE_234057";s:6:"handle";s:11:"2108/115339";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";s:103:"Bloodstream infections; Intensive care unit; Klebsiella pneumoniae; Microbiology; Mortality; Predictors";s:9:"metadata3";s:31:"Settore MED/41 - Anestesiologia";s:9:"metadata4";N;s:9:"metadata5";s:187:"Microbiologic characteristics and predictors of mortality in bloodstream infections in intensive care unit patients: A 1-year, large, prospective surveillance study in 5 Italian hospitals";s:9:"metadata6";s:262:"Delle Rose, D; Sordillo, P; Gini, S; Cerva, C; Boros, S; Rezza, G; Meledandri, M; Gallo, M; Prignano, G; Caccese, R; D'Ambrosio, M; Citterio, G; Rocco, M; Leonardis, F; Natoli, S; Fontana, C; Favaro, M; Celeste, M; Franci, T; Testore, GP; Andreoni, M; Sarmati, L";s:9:"metadata7";s:26:"10.1016/j.ajic.2015.06.023";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:117;a:14:{s:9:"citazione";s:260:"Fabeni, L., Alteri, C., Orchi, N., Gori, C., Bertoli, A., Forbici, F., et al. (2015). Recent transmission clustering of HIV-1 C and CRF17-BF strains characterized by NNRTI-related mutations among newly diagnosed men in central Italy. PLOS ONE, 10(8), e0135325.";s:4:"data";s:4:"2015";s:2:"id";s:20:"PUBBLICAZIONE_254005";s:6:"handle";s:11:"2108/133892";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:146:"Recent transmission clustering of HIV-1 C and CRF17-BF strains characterized by NNRTI-related mutations among newly diagnosed men in central Italy";s:9:"metadata6";s:258:"Fabeni, L; Alteri, C; Orchi, N; Gori, C; Bertoli, A; Forbici, F; Montella, F; Pennica, A; De Carli, G; Giuliani, M; Continenza, F; Pinnetti, C; Nicastri, E; Ceccherini-Silberstein, F; Mastroianni, C; Girardi, E; Andreoni, M; Antinori, A; Santoro, M; Perno, C";s:9:"metadata7";s:28:"10.1371/journal.pone.0135325";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:118;a:14:{s:9:"citazione";s:205:"Sarmati, L., D'Ettorre, G., Parisi, S.g., & Andreoni, M. (2015). HIV replication at low copy number and its correlation with the HIV reservoir: A clinical perspective. CURRENT HIV RESEARCH, 13(3), 250-257.";s:4:"data";s:4:"2015";s:2:"id";s:20:"PUBBLICAZIONE_313920";s:6:"handle";s:11:"2108/182976";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";s:108:"HIV drug resistance; HIV reservoir; HIV-DNA; Low-level HIV viraemia; Residual viraemia; Virological failure;";s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:101:"HIV replication at low copy number and its correlation with the HIV reservoir: A clinical perspective";s:9:"metadata6";s:49:"Sarmati, L; D'Ettorre, G; Parisi, Sg; Andreoni, M";s:9:"metadata7";s:33:"10.2174/1570162X13666150407142539";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:119;a:14:{s:9:"citazione";s:188:"Andreoni, M. (2014). [Simplification of antiretroviral therapy: proposal for a score for the evaluation of patients with suppressed viremia]. RECENTI PROGRESSI IN MEDICINA, 105(12), 462-8.";s:4:"data";s:7:"2014-12";s:2:"id";s:20:"PUBBLICAZIONE_318219";s:6:"handle";s:11:"2108/186939";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";s:177:"Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Drug Therapy, Combination; HIV Infections; Humans; Medication Adherence; Quality of Life; Viremia";s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";s:967:"Simplification of a suppressive triple antiretroviral therapy to a dual or monotherapy has demonstrated safety and efficacy in a high proportion of stable patients. The key rationales behind regimen simplification are to improve the patient's quality of life and to maintain long-term compliance, without enhancing the risk of virological failure. A simplified startegy offers the potential advantages of a decreased risk of toxicities associated with the use of nucleoside analogue reverse transcriptase inhibitors. Moreover, the use of high genetic barrier antiretroviral drugs (basically, PIs/r) in dual regimen or in monotherapy regimen minimises the selection of drug-resistant HIV variants. The aim of this paper is to present a score that taking into account all the data in the literature relating to the simplification studies to monotherapy with PI/r allows the clinician to have more information to choose with less chance of error by the patient simplify.";s:9:"metadata5";s:119:"[Simplification of antiretroviral therapy: proposal for a score for the evaluation of patients with suppressed viremia]";s:9:"metadata6";s:11:"Andreoni, M";s:9:"metadata7";s:18:"10.1701/1706.18618";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:120;a:14:{s:9:"citazione";s:275:"Mirabelli, C., Surdo, M., Van Hemert, F., Lian, Z., Salpini, R., Cento, V., et al. (2014). Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection. JOURNAL OF INFECTION.";s:4:"data";s:10:"2014-11-06";s:2:"id";s:20:"PUBBLICAZIONE_214490";s:6:"handle";s:11:"2108/113050";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:161:"Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection";s:9:"metadata6";s:401:"Mirabelli, C; Surdo, M; Van Hemert, F; Lian, Z; Salpini, R; Cento, V; Cortese, M; Aragri, M; Pollicita, M; Alteri, C; Bertoli, A; Berkhout, B; Micheli, V; Gubertini, G; Santoro, M; Romano, S; Visca, M; Bernassola, M; Longo, R; De Sanctis, G; Trimoulet, P; Fleury, H; Marino, N; Mazzotta, F; Cappiello, G; Spanò, A; Sarrecchia, C; Zhang, J; Andreoni, M; Angelico, M; Verheyen, J; Perno, C; Svicher, V";s:9:"metadata7";s:26:"10.1016/j.jinf.2014.10.015";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:121;a:14:{s:9:"citazione";s:263:"Mengoli, C., Andreis, S., Scaggiante, R., Cruciani, M., Bosco, O., Ferretto, R., et al. (2014). Structural-equation-modelling of the tropism impact on achieving viral suppression within six months in naïve HIV patients. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY.";s:4:"data";s:7:"2014-11";s:2:"id";s:20:"PUBBLICAZIONE_213113";s:6:"handle";s:11:"2108/100696";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:124:"Structural-equation-modelling of the tropism impact on achieving viral suppression within six months in naïve HIV patients.";s:9:"metadata6";s:157:"Mengoli, C; Andreis, S; Scaggiante, R; Cruciani, M; Bosco, O; Ferretto, R; Leone, D; Maffongelli, G; Basso, M; Sarmati, L; Andreoni, M; Palù, G; Parisi, SG";s:9:"metadata7";s:22:"10.7448/IAS.17.4.19679";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:122;a:14:{s:9:"citazione";s:308:"Ricciardi, A., Sordillo, P., Ceccarelli, L., Maffongelli, G., Calisti, G., Di Pietro, B., et al. (2014). 18-Fluoro-2-deoxyglucose positron emission tomography-computed tomography: an additional tool in the diagnosis of prosthetic valve endocarditis. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 28, 219-224.";s:4:"data";s:7:"2014-11";s:2:"id";s:20:"PUBBLICAZIONE_213105";s:6:"handle";s:11:"2108/100694";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:144:"18-Fluoro-2-deoxyglucose positron emission tomography-computed tomography: an additional tool in the diagnosis of prosthetic valve endocarditis.";s:9:"metadata6";s:167:"Ricciardi, A; Sordillo, P; Ceccarelli, L; Maffongelli, G; Calisti, G; Di Pietro, B; Caracciolo, CR; Schillaci, O; Pellegrino, A; Chiariello, L; Andreoni, M; Sarmati, L";s:9:"metadata7";s:26:"10.1016/j.ijid.2014.04.028";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:123;a:14:{s:9:"citazione";s:356:"Armignacco, O., Andreoni, M., Sagnelli, E., Puoti, M., Bruno, R., Gaeta, G., et al. (2014). Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease. NEW MICROBIOLOGICA, 37(4), 423-438.";s:4:"data";s:10:"2014-10-01";s:2:"id";s:20:"PUBBLICAZIONE_214486";s:6:"handle";s:11:"2108/113034";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:227:"Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease";s:9:"metadata6";s:433:"Armignacco, O; Andreoni, M; Sagnelli, E; Puoti, M; Bruno, R; Gaeta, G; Perno, C; Santantonio, T; Bonfanti, P; Bonora, S; Borderi, M; Castagna, A; d'Arminio Monforte, A; De Luca, A; Grossi, P; Guaraldi, G; Maggiolo, F; Mussini, C; Sagnelli, C; Tavio, M; Torti, C; Uberti-Foppa, C; Andreoni, M; Angarano, G; Antinori, A; Armignacco, O; Carosi, G; Chirianni, A; Di Perri, G; Galli, M; Lazzarin, A; Rizzardini, G; Sagnelli, E; Taliani, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:124;a:14:{s:9:"citazione";s:251:"Armenia, D., Soulie, C., Di Carlo, D., Fabeni, L., Gori, C., Forbici, F., et al. (2014). A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART. PLOS ONE, 9(8).";s:4:"data";s:7:"2014-08";s:2:"id";s:20:"PUBBLICAZIONE_213108";s:6:"handle";s:11:"2108/100778";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:146:"A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART.";s:9:"metadata6";s:268:"Armenia, D; Soulie, C; Di Carlo, D; Fabeni, L; Gori, C; Forbici, F; Svicher, V; Bertoli, A; Sarmati, L; Giuliani, M; Latini, A; Boumis, E; Zaccarelli, M; Bellagamba, R; Andreoni, M; Marcelin, AG; Calvez, V; Antinori A; Ceccherini-Silberstein, F; Perno, CF; Santoro, MM";s:9:"metadata7";s:28:"10.1371/journal.pone.0105853";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:125;a:14:{s:9:"citazione";s:279:"Mennini, F.S., Marcellusi, A., Andreoni, M., Gasbarrini, A., Salomone, S., & Craxì, A. (2014). Health policy model: Long-term Predictive results associated with the management of hepatitis C virus-induced diseases in Italy. CLINICOECONOMICS AND OUTCOMES RESEARCH, 6(1), 303-310.";s:4:"data";s:7:"2014-06";s:2:"id";s:20:"PUBBLICAZIONE_261291";s:6:"handle";s:11:"2108/140595";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:30:"Settore SECS-S/04 - Demografia";s:9:"metadata4";N;s:9:"metadata5";s:127:"Health policy model: Long-term Predictive results associated with the management of hepatitis C virus-induced diseases in Italy";s:9:"metadata6";s:82:"Mennini, FS; Marcellusi, A; Andreoni, M; Gasbarrini, A; Salomone, S; Craxì, A";s:9:"metadata7";s:19:"10.2147/CEOR.S62092";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:126;a:14:{s:9:"citazione";s:278:"Marcotullio, S., Ammassari, A., Andreoni, M., Antinori, A., Bonora, S., d'Arminio Monforte, A., et al. (2014). Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology. NEW MICROBIOLOGICA, 37(2), 163-175.";s:4:"data";s:7:"2014-04";s:2:"id";s:20:"PUBBLICAZIONE_185037";s:6:"handle";s:10:"2108/89704";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:130:"Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology";s:9:"metadata6";s:212:"Marcotullio, S; Ammassari, A; Andreoni, M; Antinori, A; Bonora, S; d'Arminio Monforte, A; Di Perri, G; Galli, M; Gervasoni, C; Iardino, R; Ippolito, G; Lo Caputo, S; Nozza, S; Perno, C; Rizzardini, G; Lazzarin, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:127;a:14:{s:9:"citazione";s:245:"Santoro, M., Fabeni, L., Armenia, D., Alteri, C., Di Pinto, D., Forbici, F., et al. (2014). Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels. CLINICAL INFECTIOUS DISEASES, 58(8), 1156-1164.";s:4:"data";s:7:"2014-04";s:2:"id";s:20:"PUBBLICAZIONE_185030";s:6:"handle";s:10:"2108/89703";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:104:"Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels";s:9:"metadata6";s:312:"Santoro, M; Fabeni, L; Armenia, D; Alteri, C; Di Pinto, D; Forbici, F; Bertoli, A; Di Carlo, D; Gori, C; Carta, S; Fedele, V; D'Arrigo, R; Berno, G; Ammassari, A; Pinnetti, C; Nicastri, E; Latini, A; Tommasi, C; Boumis, E; Petrosillo, N; D'Offizi, G; Andreoni, M; Ceccherini Silberstein, F; Antinori, A; Perno, C";s:9:"metadata7";s:18:"10.1093/cid/ciu020";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:128;a:14:{s:9:"citazione";s:345:"Meini, G., Rossetti, B., Bianco, C., Ceccherini-Silberstein, F., Di Giambenedetto, S., Sighinolfi, L., et al. (2014). Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 69(3), 735-741.";s:4:"data";s:7:"2014-03";s:2:"id";s:20:"PUBBLICAZIONE_231076";s:6:"handle";s:11:"2108/113011";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";s:46:"HIV type 1; V3; genotype interpretation; gp120";s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:171:"Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy";s:9:"metadata6";s:1449:"Meini, G; Rossetti, B; Bianco, C; Ceccherini-Silberstein, F; Di Giambenedetto, S; Sighinolfi, L; Monno, L; Castagna, A; Rozera, G; D'arminio Monforte, A; Zazzi, M; De Luca, A; Moroni, M; Armignacco, O; Iardino, R; Ippolito, G; Perno, Cf; Von Schloesser, F; Cozzi-Lepri, A; Girardi, E; Balotta, C; Borderi, M; Capobianchi, Mr; Cinque, P; Di Biagio, A; Gianotti, N; Guaraldi, G; Lichtner, M; Marcotullio, S; Rusconi, S; Formenti, T; Galli, L; Lorenzini, P; Giacometti, A; Costantini, A; Angarano, G; Santoro, C; Maggiolo, F; Suardi, C; Viale, P; Vanino, E; Verucchi, G; Castelli, F; Quiros Roldan, E; Minardi, C; Quirino, T; Abeli, C; Manconi, Pe; Piano, P; Vecchiet, J; Falasca, K; Segala, D; Mazzotta, F; Lo Caputo, S; Cassola, G; Viscoli, G; Alessandrini, A; Piscopo, R; Mazzarello, G; Mastroianni, C; Belvisi, V; Bonfanti, P; Caramma, I; Castelli, Ap; Galli, M; Lazzarin, A; Rizzardini, G; Puoti, M; Ridolfo, Al; Piolini, R; Salpietro, S; Carenzi, L; Moioli, Mc; Cicconi, P; Marchetti, G; Mussini, C; Puzzolante, C; Gori, A; Lapadula, G; Abrescia, N; Chirianni, A; Guida, Mg; Gargiulo, M; Baldelli, F; Francisci, D; Parruti, G; Ursini, T; Magnani, G; Ursitti, Ma; Cauda, R; Andreoni, M; Antinori, A; Vullo, V; Cingolani, A; D'Avino, A; Ammassari, A; Gallo, L; Nicastri, E; Acinapura, R; Capozzi, M; Libertone, R; Tebano, G; Cattelan, A; Mura, Ms; Madeddu, G; Caramello, P; Di Perri, G; Orofino, Gc; Bonora, S; Sciandra, M; Pellizzer, G; Manfrin, V";s:9:"metadata7";s:18:"10.1093/jac/dkt426";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:129;a:14:{s:9:"citazione";s:247:"Svicher, V., Alteri, C., Montano, M., Nori, A., D'Arrigo, R., Andreoni, M., et al. (2014). Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. INFECTION, 42(1), 61-71.";s:4:"data";s:7:"2014-02";s:2:"id";s:20:"PUBBLICAZIONE_185024";s:6:"handle";s:10:"2108/89706";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:130:"Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group";s:9:"metadata6";s:898:"Svicher, V; Alteri, C; Montano, M; Nori, A; D'Arrigo, R; Andreoni, M; Angarano, G; Antinori, A; Antonelli, G; Allice, T; Bagnarelli, P; Baldanti, F; Bertoli, A; Borderi, M; Boeri, E; Bon, I; Bruzzone, B; Barresi, R; Calderisi, S; Callegaro, A; Capobianchi, M; Gargiulo, F; Castelli, F; Cauda, R; Ceccherini-Silberstein, F; Clementi, M; Chirianni, A; Colafigli, M; D'Arminio Monforte, A; De Luca, A; Di Biagio, A; Di Nicuolo, G; Di Perri, G; Di Santo, F; Fadda, G; Galli, M; Gennari, W; Ghisetti, V; Costantini, A; Gori, A; Gulminetti, R; Leoncini, F; Maffongelli, G; Maggiolo, F; Maserati, R; Mazzotta, F; Meini, G; Micheli, V; Monno, L; Mussini, C; Nozza, S; Paolucci, S; Palù, G; Parisi, S; Parruti, G; Pignataro, A; Quirino, T; Re, M; Rizzardini, G; Sanguinetti, M; Santangelo, R; Scaggiante, R; Sterrantino, G; Turriziani, O; Vatteroni, M; Viscoli, C; Vullo, V; Zazzi, M; Lazzarin, A; Perno, C";s:9:"metadata7";s:25:"10.1007/s15010-013-0510-3";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:130;a:14:{s:9:"citazione";s:257:"Cudillo, L., Ceresoli, E., Sarmati, L., Mariotti, B., Viscione, M., De Majo, A., et al. (2014). Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report. BONE MARROW TRANSPLANTATION, 49(4), 595-596.";s:4:"data";s:4:"2014";s:2:"id";s:20:"PUBBLICAZIONE_198258";s:6:"handle";s:10:"2108/95088";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:116:"Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report.";s:9:"metadata6";s:111:"Cudillo, L; Ceresoli, E; Sarmati, L; Mariotti, B; Viscione, M; De Majo, A; Di Veroli, A; Andreoni, M; Arcese, W";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:131;a:14:{s:9:"citazione";s:268:"d'Arminio Monforte, A., Gianotti, N., Cozzi-Lepri, A., Pinnetti, C., Andreoni, M., di Perri, G., et al. (2014). Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting. ANTIVIRAL THERAPY, 19(3), 319-324.";s:4:"data";s:4:"2014";s:2:"id";s:20:"PUBBLICAZIONE_185032";s:6:"handle";s:10:"2108/89882";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:120:"Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting";s:9:"metadata6";s:266:"d'Arminio Monforte, A; Gianotti, N; Cozzi-Lepri, A; Pinnetti, C; Andreoni, M; di Perri, G; Galli, M; Poli, A; Costantini, A; Orofino, G; Maggiolo, F; Mazzarello, G; Celesia, B; Luciani, F; Lazzarin, A; Sighinolfi, L; Rizzardini, G; Bonfanti, P; Perno, C; Antinori, A";s:9:"metadata7";s:15:"10.3851/IMP2687";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:132;a:14:{s:9:"citazione";s:233:"Surdo, M., Balestra, E., Saccomandi, P., Di Santo, F., Montano, M., Di Carlo, D., et al. (2013). Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages. PLOS ONE, 8(7), e68076-e68076.";s:4:"data";s:10:"2013-07-09";s:2:"id";s:20:"PUBBLICAZIONE_185031";s:6:"handle";s:10:"2108/89908";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:104:"Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages";s:9:"metadata6";s:162:"Surdo, M; Balestra, E; Saccomandi, P; Di Santo, F; Montano, M; Di Carlo, D; Sarmati, L; Aquaro, S; Andreoni, M; Svicher, V; Perno, C. F; Ceccherini Silberstein, F";s:9:"metadata7";s:28:"10.1371/journal.pone.0068076";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:133;a:14:{s:9:"citazione";s:286:"Parisi, S.G., Andreis, S., Mengoli, C., Scaggiante, R., Cruciani, M., Ferretto, R., et al. (2013). A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects. BMC INFECTIOUS DISEASES.";s:4:"data";s:7:"2013-07";s:2:"id";s:20:"PUBBLICAZIONE_213116";s:6:"handle";s:11:"2108/101168";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:162:"A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects.";s:9:"metadata6";s:167:"Parisi, SG; Andreis, S; Mengoli, C; Scaggiante, R; Cruciani, M; Ferretto, R; Manfrin, V; Panese, S; Basso, M; Boldrin, C; Bressan, S; Sarmati, L; Andreoni, M; Palù, G";s:9:"metadata7";s:24:"10.1186/1471-2334-13-314";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:134;a:14:{s:9:"citazione";s:246:"Cento, V., Van Hemert, F., Neumann Fraune, M., Mirabelli, C., Di Maio, V., Salpini, R., et al. (2013). Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen. JOURNAL OF INFECTION, 67(4), 303-312.";s:4:"data";s:10:"2013-06-22";s:2:"id";s:20:"PUBBLICAZIONE_158902";s:6:"handle";s:10:"2108/75669";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:104:"Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen";s:9:"metadata6";s:321:"Cento, V; Van Hemert, F; Neumann Fraune, M; Mirabelli, C; Di Maio, V; Salpini, R; Bertoli, A; Micheli, V; Gubertini, G; Romano, S; Visca, M; De Sanctis, G; Berkhout, B; Marino, N; Mazzotta, F; Cappiello, G; Spanò, A; Sarrecchia, C; CECCHERINI SILBERSTEIN, F; Andreoni, M; Angelico, M; Verheyen, J; Perno, Cf; Svicher, V";s:9:"metadata7";s:26:"10.1016/j.jinf.2013.05.008";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:135;a:14:{s:9:"citazione";s:278:"Salpini, R., Alteri, C., Cento, V., Pollicita, M., Micheli, V., Gubertini, G., et al. (2013). Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. JOURNAL OF MEDICAL VIROLOGY, 85(6), 996-1004.";s:4:"data";s:7:"2013-06";s:2:"id";s:20:"PUBBLICAZIONE_158905";s:6:"handle";s:10:"2108/75677";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:137:"Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice";s:9:"metadata6";s:182:"Salpini, R; Alteri, C; Cento, V; Pollicita, M; Micheli, V; Gubertini, G; De Sanctis, G; Visca, M; Romano, S; Sarrecchia, C; Andreoni, M; Angelico, M; Parruti, G; Svicher, V; Perno, C";s:9:"metadata7";s:17:"10.1002/jmv.23567";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:136;a:14:{s:9:"citazione";s:212:"Santoro, M., Armenia, D., Alteri, C., Flandre, P., Calcagno, A., Santoro, M., et al. (2013). Impact of pre-therapy viral load on virological response to modern first-line HAART. ANTIVIRAL THERAPY, 18(7), 867-876.";s:4:"data";s:10:"2013-01-23";s:2:"id";s:20:"PUBBLICAZIONE_156781";s:6:"handle";s:10:"2108/74567";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:83:"Impact of pre-therapy viral load on virological response to modern first-line HAART";s:9:"metadata6";s:365:"Santoro, M; Armenia, D; Alteri, C; Flandre, P; Calcagno, A; Santoro, M; Gori, C; Fabeni, L; Bellagamba, R; Borghi, V; Forbici, F; Latini, A; Palamara, G; Libertone, R; Tozzi, V; Boumis, E; Tommasi, C; Pinnetti, C; Ammassari, A; Nicastri, E; Buonomini, A; Svicher, V; Andreoni, M; Narciso, P; Mussini, C; Antinori, A; Ceccherini-Silberstein, F; Di Perri, G; Perno, C";s:9:"metadata7";s:15:"10.3851/IMP2531";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:137;a:14:{s:9:"citazione";s:251:"Mve Mvondo, C., D'Auria, F., Sordillo, P., Pellegrino, A., Andreoni, M., & Chiariello, L. (2013). Candida parapsilosis endocarditis on a prosthetic aortic valve with unclear echocardiographic features. CARDIOVASCULAR JOURNAL OF AFRICA, 23(24(3)), 7-8.";s:4:"data";s:4:"2013";s:2:"id";s:20:"PUBBLICAZIONE_172143";s:6:"handle";s:10:"2108/83289";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/23 - Chirurgia Cardiaca";s:9:"metadata4";N;s:9:"metadata5";s:103:"Candida parapsilosis endocarditis on a prosthetic aortic valve with unclear echocardiographic features.";s:9:"metadata6";s:81:"Mve Mvondo, C; D'Auria, F; Sordillo, P; Pellegrino, A; Andreoni, M; Chiariello, L";s:9:"metadata7";s:21:"10.5830/CVJA-2013-006";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:138;a:14:{s:9:"citazione";s:278:"Salpini, R., Alteri, C., Cento, V., Pollicita, M., Micheli, V., Gubertini, G., et al. (2013). Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. JOURNAL OF MEDICAL VIROLOGY, 85(6), 996-1004.";s:4:"data";s:4:"2013";s:2:"id";s:20:"PUBBLICAZIONE_208348";s:6:"handle";s:10:"2108/99238";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:138:"Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.";s:9:"metadata6";s:184:"Salpini, R; Alteri, C; Cento, V; Pollicita, M; Micheli, V; Gubertini, G; De Sanctis, GM; Visca, M; Romano, S; Sarrecchia, C; Andreoni, M; Angelico, M; Parruti, G; Svicher, V; Perno, CF";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:139;a:14:{s:9:"citazione";s:257:"Svicher, V., Cento, V., Rozera, G., Abbate, I., Santoro, M., Armenia, D., et al. (2013). The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing. PLOS ONE, 8(1).";s:4:"data";s:4:"2013";s:2:"id";s:20:"PUBBLICAZIONE_156780";s:6:"handle";s:10:"2108/74568";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:151:"The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing";s:9:"metadata6";s:256:"Svicher, V; Cento, V; Rozera, G; Abbate, I; Santoro, M; Armenia, D; Fabeni, L; Bruselles, A; Latini, A; Palamara, G; Micheli, V; Rizzardini, G; Gori, C; Forbici, F; Ippolito, G; Andreoni, M; Antinori, A; Ceccherini Silberstein, F; Capobianchi, M; Perno, CF";s:9:"metadata7";s:28:"10.1371/journal.pone.0053603";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:140;a:14:{s:9:"citazione";s:314:"Sarmati, L., Parisi, S.G., Montano, M., Andreis, S., Scaggiante, R., Galgani, A., et al. (2012). Nevirapine use, prolonged antiretroviral therapy and high CD4 nadir values are strongly correlated with undetectable HIV-DNA and -RNA levels and CD4 cell gain. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 67(12), 2932-2938.";s:4:"data";s:7:"2012-12";s:2:"id";s:20:"PUBBLICAZIONE_213409";s:6:"handle";s:11:"2108/100895";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:159:"Nevirapine use, prolonged antiretroviral therapy and high CD4 nadir values are strongly correlated with undetectable HIV-DNA and -RNA levels and CD4 cell gain.";s:9:"metadata6";s:163:"Sarmati, L; Parisi, SG; Montano, M; Andreis, S; Scaggiante, R; Galgani, A; Viscione, M; Maffongelli, G; Ricciardi, A; Andreoni, C; Boros, S; Palù, G; Andreoni, M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:141;a:14:{s:9:"citazione";s:249:"Andreoni, M., Giacometti, A., Maida, I., Meraviglia, P., Ripamonti, D., & Sarmati, L. (2012). HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 16(11), 1473-1483.";s:4:"data";s:7:"2012-10";s:2:"id";s:20:"PUBBLICAZIONE_213397";s:6:"handle";s:11:"2108/100892";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:78:"HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications.";s:9:"metadata6";s:77:"Andreoni, M; Giacometti, A; Maida, I; Meraviglia, P; Ripamonti, D; Sarmati, L";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:142;a:14:{s:9:"citazione";s:246:"Santoro, M., Armenia, D., Fabeni, L., Santoro, M., Gori, C., Forbici, F., et al. (2012). The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients. CLINICAL MICROBIOLOGY AND INFECTION, 18(8).";s:4:"data";s:10:"2012-08-03";s:2:"id";s:20:"PUBBLICAZIONE_139056";s:6:"handle";s:10:"2108/68004";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:112:"The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients";s:9:"metadata6";s:235:"Santoro, M; Armenia, D; Fabeni, L; Santoro, M; Gori, C; Forbici, F; Svicher, V; Bertoli, A; Dori, L; Surdo, M; Balestra, E; Palamara, G; Girardi, E; Angarano, G; Andreoni, M; Narciso, P; Antinori, A; Ceccherini Silberstein, F; Perno, C";s:9:"metadata7";s:32:"10.1111/j.1469-0691.2012.03905.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:143;a:14:{s:9:"citazione";s:247:"Ceccarelli, L., Calisti, G., Delle Rose, D., Ricciardi, A., Maffongelli, G., Sordillo, P., et al. (2012). Dapsone hypersensitivity syndrome complicated by Scedosporium apiospermum pneumonia in an immunocompetent patient. INFECTION, 40(4), 459-462.";s:4:"data";s:7:"2012-08";s:2:"id";s:20:"PUBBLICAZIONE_213391";s:6:"handle";s:11:"2108/100891";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:114:"Dapsone hypersensitivity syndrome complicated by Scedosporium apiospermum pneumonia in an immunocompetent patient.";s:9:"metadata6";s:109:"Ceccarelli, L; Calisti, G; Delle Rose, D; Ricciardi, A; Maffongelli, G; Sordillo, P; Sarmati, L; Andreoni, M.";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:144;a:14:{s:9:"citazione";s:287:"Marcotullio, S., Andreoni, M., Antinori, A., d'Arminio Monforte, A., Di Perri, G., Galli, M., et al. (2012). The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection. NEW MICROBIOLOGICA, 35(3), 259-277.";s:4:"data";s:7:"2012-07";s:2:"id";s:20:"PUBBLICAZIONE_144485";s:6:"handle";s:10:"2108/69749";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:141:"The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection";s:9:"metadata6";s:214:"Marcotullio,S; Andreoni,M; Antinori, A; d'Arminio Monforte, A; Di Perri, G; Galli, M; Ippolito, G; Perno, CF; Rizzardini, G; Lazzarin, A; Cinque, P; Fares, G; Foglia, E; Gervasoni, C; Murri, R; Nozza, S; Rusconi, S";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:145;a:14:{s:9:"citazione";s:317:"Greco, E., Quintiliani, G., Santucci, M., Serafino, A., Ciccaglione, A., Marcantonio, C., et al. (2012). Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(21), E1360-E1360-8.";s:4:"data";s:10:"2012-05-22";s:2:"id";s:20:"PUBBLICAZIONE_208168";s:6:"handle";s:11:"2108/100309";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:106:"Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection";s:9:"metadata6";s:286:"Greco, E; Quintiliani, G; Santucci, M; Serafino, A; Ciccaglione, A; Marcantonio, C; Papi, M; Maulucci, G; Delogu, G; Martino, A; Goletti, D; Sarmati, L; Andreoni, M; Altieri, A; Alma, M; Caccamo, N; Di Liberto, D; De Spirito, M; Savage, N; Nisini, R; Dieli, F; Ottenhoff, T; Fraziano, M";s:9:"metadata7";s:23:"10.1073/pnas.1200484109";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:146;a:14:{s:9:"citazione";s:275:"Antinori, A., Marcotullio, S., Ammassari, A., Andreoni, M., Angarano, G., Armignacco, O., et al. (2012). Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011. NEW MICROBIOLOGICA, 35(2), 113-159.";s:4:"data";s:7:"2012-04";s:2:"id";s:20:"PUBBLICAZIONE_139057";s:6:"handle";s:10:"2108/67988";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:133:"Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011";s:9:"metadata6";s:327:"Antinori, A; Marcotullio, S; Ammassari, A; Andreoni, M; Angarano, G; Armignacco, O; Carosi, G; Cinque, P; d'Arminio Monforte, A; Di Perri, G; Ensoli, B; Floridia, M; Galli, M; Mastroianni, C; Matteelli, A; Mazzotta, F; Moroni, M; Pal, G; Puoti, M; Puro, V; Rizzardini, G; Sagnelli, E; Vella, S; Vullo, V; Lazzarin, A; Perno, CF";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:147;a:14:{s:9:"citazione";s:275:"Parisi, S.G., Andreis, S., Mengoli, C., Scaggiante, R., Ferretto, R., Manfrin, V., et al. (2012). Baseline cellular HIV DNA load predicts HIV DNA decline and residual HIV plasma levels during effective antiretroviral therapy. JOURNAL OF CLINICAL MICROBIOLOGY, 50(2), 258-263.";s:4:"data";s:7:"2012-02";s:2:"id";s:20:"PUBBLICAZIONE_213415";s:6:"handle";s:11:"2108/100896";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:127:"Baseline cellular HIV DNA load predicts HIV DNA decline and residual HIV plasma levels during effective antiretroviral therapy.";s:9:"metadata6";s:156:"Parisi, SG; Andreis, S; Mengoli, C; Scaggiante, R; Ferretto, R; Manfrin, V; Cruciani, M; Giobbia, M; Boldrin, C; Basso, M; Andreoni, M; Palù, G; Sarmati, L";s:9:"metadata7";s:20:"10.1128/JCM.06022-11";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:148;a:14:{s:9:"citazione";s:166:"Andreoni, M., & Perno, C. (2012). Positioning of HIV-protease inhibitors in clinical practice. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 16(1), 10-18.";s:4:"data";s:7:"2012-01";s:2:"id";s:20:"PUBBLICAZIONE_158929";s:6:"handle";s:10:"2108/75676";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:59:"Positioning of HIV-protease inhibitors in clinical practice";s:9:"metadata6";s:21:"Andreoni, M; Perno, C";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:149;a:14:{s:9:"citazione";s:235:"Svicher, V., Cento, V., Bernassola, M., Neumann-Fraune, M., Van Hemert, F., Chen, M., et al. (2012). Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. ANTIVIRAL RESEARCH, 93(1), 86-93.";s:4:"data";s:7:"2012-01";s:2:"id";s:20:"PUBBLICAZIONE_162612";s:6:"handle";s:10:"2108/77109";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:100:"Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection.";s:9:"metadata6";s:302:"Svicher, V; Cento, V; Bernassola, M; Neumann-Fraune, M; Van Hemert, F; Chen, M; Salpini, R; Liu, C; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gori, C; Ceccherini-Silberstein, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; Zhang, JM; Verheyen, J; Cappiello, G; Perno, CF";s:9:"metadata7";s:31:"10.1016/j.antiviral.2011.10.022";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:150;a:14:{s:9:"citazione";s:166:"Andreoni, M., & Perno, C. (2012). Positioning of HIV-protease inhibitors in clinical practice. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 16(1), 10-18.";s:4:"data";s:4:"2012";s:2:"id";s:20:"PUBBLICAZIONE_138914";s:6:"handle";s:10:"2108/67948";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:59:"Positioning of HIV-protease inhibitors in clinical practice";s:9:"metadata6";s:21:"Andreoni, M; Perno, C";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:151;a:14:{s:9:"citazione";s:260:"Ceccarelli, L., Salpini, R., Moudourou, S., Cento, V., Santoro, M., Fokam, J., et al. (2012). Characterization of drug resistance mutations in naive and ART-treated patients infected with HIV-1 in Yaounde, Cameroon. JOURNAL OF MEDICAL VIROLOGY, 84(5), 721-727.";s:4:"data";s:4:"2012";s:2:"id";s:20:"PUBBLICAZIONE_138901";s:6:"handle";s:10:"2108/67928";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:120:"Characterization of drug resistance mutations in naive and ART-treated patients infected with HIV-1 in Yaounde, Cameroon";s:9:"metadata6";s:175:"Ceccarelli, L; Salpini, R; Moudourou, S; Cento, V; Santoro, M; Fokam, J; Takou, D; Nanfack, A; Dori, L; Torimiro, J; Sarmati, L; Andreoni, M; Perno, C; Colizzi, V; Cappelli, G";s:9:"metadata7";s:17:"10.1002/jmv.23244";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:152;a:14:{s:9:"citazione";s:236:"Cento, V., Mirabelli, C., Salpini, R., Dimonte, S., Artese, A., Costa, G., et al. (2012). HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors. PLOS ONE, 7(7), e39652-e39652.";s:4:"data";s:4:"2012";s:2:"id";s:20:"PUBBLICAZIONE_144484";s:6:"handle";s:10:"2108/69748";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:114:"HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors";s:9:"metadata6";s:231:"Cento, V; Mirabelli, C; Salpini, R; Dimonte, S; Artese, A; Costa, G; Mercurio, F; Svicher, V; Parrotta, L; Bertoli, A; Ciotti, M; Di Paolo, D; Sarrecchia, C; Andreoni, M; Alcaro, S; Angelico, M; Perno, Cf; CECCHERINI SILBERSTEIN, F";s:9:"metadata7";s:28:"10.1371/journal.pone.0039652";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:153;a:14:{s:9:"citazione";s:288:"Cento, V., Van Hemert, F., Di Maio, V., Salpini, R., Mirabelli, C., Bertoli, A., et al. (2012). Novel reverse transcriptase mutations specifically associated with selected anti-Hbv treatment can induce alterations and stop-codons in Hbv S antigen. In JOURNAL OF HEPATOLOGY (pp.S198-S199).";s:4:"data";s:4:"2012";s:2:"id";s:20:"PUBBLICAZIONE_138902";s:6:"handle";s:10:"2108/67927";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:150:"Novel reverse transcriptase mutations specifically associated with selected anti-Hbv treatment can induce alterations and stop-codons in Hbv S antigen";s:9:"metadata6";s:282:"Cento, V; Van Hemert, F; Di Maio, V; Salpini, R; Mirabelli, C; Bertoli, A; Gori, C; Micheli, V; Gubertini, G; Longo, R; Romano, S; Visca, M; De Sanctis, G; Marino, N; Mazzotta, F; Cappiello, G; Sarrecchia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Perno, C; Svicher, V";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:154;a:14:{s:9:"citazione";s:237:"Nicastri, E., Dori, L., Buonomini, A.R., Tommasi, C., De Nardo, P., Bellagamba, R., et al. (2012). HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy. AIDS, 26(11), 1451-1452.";s:4:"data";s:4:"2012";s:2:"id";s:20:"PUBBLICAZIONE_160732";s:6:"handle";s:10:"2108/77732";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:112:"HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy";s:9:"metadata6";s:151:"Nicastri, E; Dori, L; Buonomini, AR; Tommasi, C; De Nardo, P; Bellagamba, R; Corpolongo, A; Montano, M; Sordillo, P; Volpi, A; Sarmati, L; Andreoni, M;";s:9:"metadata7";s:28:"10.1097/QAD.0b013e3283550b47";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:155;a:14:{s:9:"citazione";s:218:"Salpini, R., Ceccarelli, L., Fokam, J., Nanfack, A., Torimiro, J., Sarmati, L., et al. (2012). HBV, HCV, HDV AND HEV COINFECTIONS IN A COHORT OF HIV POSITIVE PATIENTS IN CAMEROON. In JOURNAL OF HEPATOLOGY (pp.S66-S66).";s:4:"data";s:4:"2012";s:2:"id";s:20:"PUBBLICAZIONE_138903";s:6:"handle";s:10:"2108/68013";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:83:"HBV, HCV, HDV AND HEV COINFECTIONS IN A COHORT OF HIV POSITIVE PATIENTS IN CAMEROON";s:9:"metadata6";s:117:"Salpini, R; Ceccarelli, L; Fokam, J; Nanfack, A; Torimiro, J; Sarmati, L; Andreoni, M; Colizzi, V; Perno, C; Njoya, O";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:156;a:14:{s:9:"citazione";s:242:"Svicher, V., Alteri, C., Montano, M., D'Arrigo, R., Andreoni, M., Angarano, G., et al. (2012). Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA Study Group. NEW MICROBIOLOGICA, 35(1), 17-25.";s:4:"data";s:4:"2012";s:2:"id";s:20:"PUBBLICAZIONE_138911";s:6:"handle";s:10:"2108/67952";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:112:"Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA Study Group";s:9:"metadata6";s:930:"Svicher, V; Alteri, C; Montano, M; D'Arrigo, R; Andreoni, M; Angarano, G; Antinori, A; Antonelli, G; Allice, T; Bagnarelli, P; Baldanti, F; Bertoli, A; Borderi, M; Boeri, E; Bon, I; Bruzzone, B; Callegaro, A; Capobianchi, M; Carosi, G; Cauda, R; Ceccherini-Silberstein, F; Clementi, M; Chirianni, A; Colafigli, M; Monforte, A; De Luca, A; Di Biagio, A; Di Nicuolo, G; Di Perri, G; Di Pietro, M; Di Santo, F; Fabeni, L; Fadda, G; Galli, M; Gennari, W; Ghisetti, V; Giacometti, A; Gori, C; Gori, A; Gulminetti, R; Leoncini, F; Maffongelli, G; Maggiolo, F; Manca, G; Gargiulo, F; Martinelli, C; Maserati, R; Mazzotta, F; Meini, G; Micheli, V; Monno, L; Mussini, C; Narciso, P; Nozza, S; Paolucci, S; Palu, G; Parisi, S; Parruti, G; Pignataro, A; Pollicita, M; Quirino, T; Re, M; Rizzardini, G; Santangelo, R; Scaggiante, R; Sterrantino, G; Turriziani, O; Vatteroni, M; Vecchi, L; Viscoli, C; Vullo, V; Zazzi, M; Lazzarin, A; Perno, C";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:157;a:14:{s:9:"citazione";s:340:"Svicher, V., Mirabelli, C., Cento, V., Salpini, R., Di Maio, V., Bertoli, A., et al. (2012). Key patterns of HBX and pre-S1/S2 mutations are involved in mechanisms underlying HBV-induced hepatocellular carcinoma in vivo. Paper presented at 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Barcelona, SPAIN.";s:4:"data";s:4:"2012";s:2:"id";s:20:"PUBBLICAZIONE_138904";s:6:"handle";s:10:"2108/67964";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:126:"Key patterns of HBX and pre-S1/S2 mutations are involved in mechanisms underlying HBV-induced hepatocellular carcinoma in vivo";s:9:"metadata6";s:305:"Svicher, V; Mirabelli, C; Cento, V; Salpini, R; Di Maio, V; Bertoli, A; Alteri, C; Pollicita, M; Gori, C; Micheli, V; Salso, A; Gubertini, G; Trimoulet, P; Fleury, H; Vecchiet, J; Iapadre, N; Barlattani, A; Mari, T; Pasquazzi, C; Sarrechia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Perno, C";s:9:"metadata7";s:29:"10.1016/S0168-8278(12)60500-5";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:158;a:14:{s:9:"citazione";s:300:"Ceccarelli, L., Salpini, R., Sarmati, L., Svicher, V., Bertoli, A., Sordillo, P., et al. (2011). Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy. JOURNAL OF INFECTION, 65(2).";s:4:"data";s:10:"2011-11-23";s:2:"id";s:19:"PUBBLICAZIONE_85114";s:6:"handle";s:10:"2108/51801";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:173:"Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy";s:9:"metadata6";s:126:"Ceccarelli, L; Salpini, R; Sarmati, L; Svicher, V; Bertoli, A; Sordillo, P; Ricciardi, A; Perno, C; Andreoni, M; Sarrecchia, C";s:9:"metadata7";s:26:"10.1016/j.jinf.2011.11.021";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:159;a:14:{s:9:"citazione";s:231:"Svicher, V., Cento, V., Bernassola, M., Neumann-Fraune, M., Hemert, F., Chen, M., et al. (2011). Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. ANTIVIRAL RESEARCH, 93(1), 86-93.";s:4:"data";s:10:"2011-11-09";s:2:"id";s:19:"PUBBLICAZIONE_81005";s:6:"handle";s:10:"2108/50411";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:99:"Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection";s:9:"metadata6";s:297:"Svicher, V; Cento, V; Bernassola, M; Neumann-Fraune, M; Hemert, F; Chen, M; Salpini, R; Liu, C; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gori, C; Ceccherini-Silberstein, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; Zhang, J; Verheyen, J; Cappiello, G; Perno, C";s:9:"metadata7";s:31:"10.1016/j.antiviral.2011.10.022";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:160;a:14:{s:9:"citazione";s:287:"Sarrecchia, C., Svicher, V., Volpi, A., Salpini, R., Ceccarelli, L., Sordillo, P., et al. (2011). Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. INFECTION.";s:4:"data";s:10:"2011-06-15";s:2:"id";s:19:"PUBBLICAZIONE_58916";s:6:"handle";s:10:"2108/18073";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:177:"Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance";s:9:"metadata6";s:111:"Sarrecchia, C; Svicher, V; Volpi, A; Salpini, R; Ceccarelli, L; Sordillo, P; Bertoli, A; Perno, CF; Andreoni, M";s:9:"metadata7";s:25:"10.1007/s15010-011-0127-3";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:161;a:14:{s:9:"citazione";s:255:"Antinori, A., Marcotullio, S., Ammassari, A., Andreoni, M., Angarano, G., Carosi, G., et al. (2011). Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic-clinical Management of HIV-1 Infected Persons. NEW MICROBIOLOGICA, 34, 109-146.";s:4:"data";s:7:"2011-04";s:2:"id";s:19:"PUBBLICAZIONE_35350";s:6:"handle";s:10:"2108/22166";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:120:"Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic-clinical Management of HIV-1 Infected Persons";s:9:"metadata6";s:302:"Antinori, A; Marcotullio, S; Ammassari, A; Andreoni, M; Angarano, G; Carosi, G; Cinque, P; D' Arminio Monforte, A; Di Perri, G; Ensoli, B; Ferrazzi, E; Galli, M; Mastroianni, C; Matteelli, A; Mazzotta, F; Moroni, M; Pal, G; Puoti, M; Puro, V; Rizzardini, G; Sagnelli, E; Suter, F; Vella, S; Lazzarin, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:162;a:14:{s:9:"citazione";s:255:"Antinori, A., Marcotullio, S., Ammassari, A., Andreoni, M., Angarano, G., Carosi, G., et al. (2011). Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic-clinical Management of HIV-1 Infected Persons. NEW MICROBIOLOGICA, 34, 109-146.";s:4:"data";s:7:"2011-04";s:2:"id";s:19:"PUBBLICAZIONE_39351";s:6:"handle";s:10:"2108/18333";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:120:"Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic-clinical Management of HIV-1 Infected Persons";s:9:"metadata6";s:313:"Antinori, A; Marcotullio, S; Ammassari, A; Andreoni, M; Angarano, G; Carosi, G; Cinque, P; D' Arminio Monforte, A; Di Perri, G; Ensoli, B; Ferrazzi, E; Galli, M; Mastroianni, C; Matteelli, A; Mazzotta, F; Moroni, M; Pal, G; Puoti, M; Puro, V; Rizzardini, G; Sagnelli, E; Suter, F; Vella, S; Lazzarin, A; Perno, CF";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:163;a:14:{s:9:"citazione";s:296:"Parisi, S.G., Andreoni, C., Sarmati, L., Boldrin, C., Buonomini, A.R., Andreis, S., et al. (2011). HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects. JOURNAL OF CLINICAL MICROBIOLOGY, 49(4), 1441-1445.";s:4:"data";s:7:"2011-04";s:2:"id";s:19:"PUBBLICAZIONE_35353";s:6:"handle";s:9:"2108/9006";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:144:"HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects";s:9:"metadata6";s:183:"Parisi, SG; Andreoni, C; Sarmati, L; Boldrin, C; Buonomini, AR; Andreis, S; Scaggiante, R; Cruciani, M; Bosco, O; Manfrin, V; d'Ettorre, G; Mengoli, C; Vullo, V; Palù, G; Andreoni, M";s:9:"metadata7";s:20:"10.1128/JCM.02564-10";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:164;a:14:{s:9:"citazione";s:251:"Svicher, V., Balestra, E., Cento, V., Sarmati, L., Dori, L., Vandenbroucke, I., et al. (2011). HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro. ANTIVIRAL RESEARCH, 90(1), 42-53.";s:4:"data";s:7:"2011-04";s:2:"id";s:19:"PUBBLICAZIONE_35811";s:6:"handle";s:10:"2108/18796";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:121:"HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro";s:9:"metadata6";s:240:"Svicher, V; Balestra, E; Cento, V; Sarmati, L; Dori, L; Vandenbroucke, I; D'Arrigo, R; Buonomini, AR; Van Marck, H; Surdo, M; Saccomandi, P; Mostmans, W; Aerssens, J; Aquaro, S; Stuyver, LJ; Andreoni, M; Ceccherini-Silberstein, F; Perno, CF";s:9:"metadata7";s:31:"10.1016/j.antiviral.2011.02.005";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:165;a:14:{s:9:"citazione";s:242:"Maserati, R., Brandolini, M., Cattelan, A., Orani, A., Sighinolfi, L., Andreoni, M., et al. (2011). Once-a-day (QD) vs. Twice-daily (BID) Nevirapine as Simplification in PI-Treated Patients after 2 mos. of BID Induction. CURRENT HIV RESEARCH.";s:4:"data";s:10:"2011-03-29";s:2:"id";s:19:"PUBBLICAZIONE_35348";s:6:"handle";s:10:"2108/51346";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:119:"Once-a-day (QD) vs. Twice-daily (BID) Nevirapine as Simplification in PI-Treated Patients after 2 mos. of BID Induction";s:9:"metadata6";s:114:"Maserati, R; Brandolini, M; Cattelan, A; Orani, A; Sighinolfi, L; Andreoni, M; Uglietti, A; Guaraldi, G; Sotgiu, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:166;a:14:{s:9:"citazione";s:249:"Parisi, S.G., Boldrin, C., Andreis, S., Ferretto, R., Fuser, R., Malena, M., et al. (2011). KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection. JOURNAL OF MEDICAL VIROLOGY, 83(3), 384-390.";s:4:"data";s:7:"2011-03";s:2:"id";s:19:"PUBBLICAZIONE_35331";s:6:"handle";s:9:"2108/8971";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:111:"KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection";s:9:"metadata6";s:189:"Parisi, SG; Boldrin, C; Andreis, S; Ferretto, R; Fuser, R; Malena, M; Manfrin, V; Panese, S; Scaggiante, R; Dori, L; Sarmati, L; Biasolo, MA; Nicastri, E; Andreoni, M; Cruciani, M; Palù, G";s:9:"metadata7";s:17:"10.1002/jmv.21987";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:167;a:14:{s:9:"citazione";s:254:"D'Ettorre, G., Forcina, G., Ceccarelli, G., Andreotti, M., Andreoni, C., Rizza, C., et al. (2011). Adherence and genotypic drug resistance mutations in HIV-1-infected patients failing current antiretroviral therapy. JOURNAL OF CHEMOTHERAPY, 23(1), 24-27.";s:4:"data";s:7:"2011-02";s:2:"id";s:19:"PUBBLICAZIONE_35326";s:6:"handle";s:9:"2108/8986";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:115:"Adherence and genotypic drug resistance mutations in HIV-1-infected patients failing current antiretroviral therapy";s:9:"metadata6";s:152:"D'Ettorre, G; Forcina, G; Ceccarelli, G; Andreotti, M; Andreoni, C; Rizza, C; Massetti, AP; Sarmati, L; Mastroianni, CM; Vella, S; Andreoni, M; Vullo, V";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:168;a:14:{s:9:"citazione";s:325:"Cento, V., Svicher, V., Rozera, G., Abbate, I., Santoro, M., Armenia, D., et al. (2011). The Genotypic False Positive Rate Determined by Population V3-Sequencing can Predict the Burden of X4 Quasispecies Detected by Pyrosequencing. Paper presented at 3th ICAR – Italian Conference on AIDS and Retroviruses, Firenze, Italia.";s:4:"data";s:4:"2011";s:2:"id";s:19:"PUBBLICAZIONE_87131";s:6:"handle";s:10:"2108/51956";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:141:"The Genotypic False Positive Rate Determined by Population V3-Sequencing can Predict the Burden of X4 Quasispecies Detected by Pyrosequencing";s:9:"metadata6";s:221:"Cento, V; Svicher, V; Rozera, G; Abbate, I; Santoro, M; Armenia, D; Fabeni, L; Palamara, G; Latini, A; Rizzardini, G; Micheli, V; Buonomini, A; Antinori, A; Andreoni, M; Perno, C; Capobianchi, M; Ceccherini-Silberstein, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:169;a:14:{s:9:"citazione";s:269:"Santoro, M., Armenia, D., Fabeni, L., Santoro, M., Gori, C., Forbici, F., et al. (2011). The Lowest X4 Geno2Pheno-False Positive Rate Is Associated with Greater CD4-Depletion. Paper presented at 3th ICAR – Italian Conference on AIDS and Retroviruses, Firenze, Italia.";s:4:"data";s:4:"2011";s:2:"id";s:19:"PUBBLICAZIONE_87569";s:6:"handle";s:10:"2108/52061";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:85:"The Lowest X4 Geno2Pheno-False Positive Rate Is Associated with Greater CD4-Depletion";s:9:"metadata6";s:185:"Santoro, M; Armenia, D; Fabeni, L; Santoro, M; Gori, C; Forbici, F; Cento, V; Svicher, V; Bertoli, A; Dori, L; Andreoni, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf";s:9:"metadata7";s:25:"10.1007/s15010-011-0090-z";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:170;a:14:{s:9:"citazione";s:287:"Sarrecchia, C., Svicher, V., Volpi, A., Salpini, R., Ceccarelli, L., Sordillo, P., et al. (2011). Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. INFECTION.";s:4:"data";s:4:"2011";s:2:"id";s:20:"PUBBLICAZIONE_208350";s:6:"handle";s:10:"2108/99313";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:178:"Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance.";s:9:"metadata6";s:111:"Sarrecchia, C; Svicher, V; Volpi, A; Salpini, R; Ceccarelli, L; Sordillo, P; Bertoli, A; Perno, CF; Andreoni, M";s:9:"metadata7";s:26:"10.1007/s15010-011-0127-3.";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:171;a:14:{s:9:"citazione";s:316:"Surdo, M., Balestra, E., Saccomandi, P., Di Santo, F., Svicher, V., Alteri, C., et al. (2011). Dual mixed (but not X4) tropic-HIV-1 isolates can replicate in human primary macrophages and are inhibited by CCR5- inhibitors. Paper presented at 3th ICAR – Italian Conference on AIDS and Retroviruses, Firenze, Italia.";s:4:"data";s:4:"2011";s:2:"id";s:19:"PUBBLICAZIONE_86953";s:6:"handle";s:10:"2108/51937";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:126:"Dual mixed (but not X4) tropic-HIV-1 isolates can replicate in human primary macrophages and are inhibited by CCR5- inhibitors";s:9:"metadata6";s:172:"Surdo, M; Balestra, E; Saccomandi, P; Di Santo, F; Svicher, V; Alteri, C; Cento, V; Pollicita, M; Scopelliti, F; Andreoni, M; Aquaro, S; Ceccherini-silberstein, F; Perno, C";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:172;a:14:{s:9:"citazione";s:247:"Svicher, V., Alteri, C., Artese, A., Zhang, J., Costa, G., Mercurio, F., et al. (2011). Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage. ANTIVIRAL THERAPY, 16(7), 1035-1045.";s:4:"data";s:4:"2011";s:2:"id";s:19:"PUBBLICAZIONE_81048";s:6:"handle";s:10:"2108/51672";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:121:"Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage";s:9:"metadata6";s:199:"Svicher, V; Alteri, C; Artese, A; Zhang, J; Costa, G; Mercurio, F; D'Arrigo, R; Alcaro, S; Palù, G; Clementi, M; Zazzi, M; Andreoni, M; Antinori, A; Lazzarin, A; Ceccherini-Silberstein, F; Perno, C";s:9:"metadata7";s:15:"10.3851/IMP1862";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:173;a:14:{s:9:"citazione";s:317:"Svicher, V., Cento, V., Bernassola, M., Neumann Fraune, M., Salpini, R., Longo, R., et al. (2011). Specific HBSAG Genetic- Determinants are associated with occult HBV-infection in vivo and HBSAG detection. Paper presented at 46th Annual meeting of the European Association for the study of the liver, Berlin, Germany.";s:4:"data";s:4:"2011";s:2:"id";s:19:"PUBBLICAZIONE_86791";s:6:"handle";s:10:"2108/51911";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:105:"Specific HBSAG Genetic- Determinants are associated with occult HBV-infection in vivo and HBSAG detection";s:9:"metadata6";s:290:"Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Salpini, R; Longo, R; Visca, M; Romano, S; Michieli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Verheyen, J; Cappiello, G; Perno, Cf";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:174;a:14:{s:9:"citazione";s:331:"Svicher, V., Cento, V., Bernassola, M., Neumann-Fraune, M., Chen, M., Salpini, R., et al. (2011). Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection. Paper presented at International Workshop on HIV & Hepatitis virus Drug Resistance and curative strategies, Los Cabos (Mexico).";s:4:"data";s:4:"2011";s:2:"id";s:19:"PUBBLICAZIONE_86590";s:6:"handle";s:10:"2108/51895";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:104:"Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection";s:9:"metadata6";s:317:"Svicher, V; Cento, V; Bernassola, M; Neumann-Fraune, M; Chen, M; Salpini, R; Chang, L; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; Ceccherini Silberstein, F; Zhan, JM; Verheyen, J; Cappiello, G; Perno, CF";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:175;a:14:{s:9:"citazione";s:314:"Friis-Møller, N., Thiébaut, R., Reiss, P., Weber, R., Monforte, A.D., De Wit, S., et al. (2010). Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 17(5), 491-501.";s:4:"data";s:7:"2010-10";s:2:"id";s:19:"PUBBLICAZIONE_35342";s:6:"handle";s:10:"2108/39776";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:134:"Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study";s:9:"metadata6";s:210:"Friis-Møller, N; Thiébaut, R; Reiss, P; Weber, R; Monforte, AD; De Wit, S; El-Sadr, W; Fontas, E; Worm, S; Kirk, O; Phillips, A; Sabin, CA; Lundgren, JD; Law, MG; Perno, C; DAD study group; [...]; Andreoni, M";s:9:"metadata7";s:28:"10.1097/HJR.0b013e328336a150";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:176;a:14:{s:9:"citazione";s:200:"Turriziani, O., Andreoni, M., & Antonelli, G. (2010). Resistant viral variants in cellular reservoirs of human immunodeficiency virus infection. CLINICAL MICROBIOLOGY AND INFECTION, 16(10), 1518-1524.";s:4:"data";s:7:"2010-10";s:2:"id";s:19:"PUBBLICAZIONE_35337";s:6:"handle";s:10:"2108/39939";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:89:"Resistant viral variants in cellular reservoirs of human immunodeficiency virus infection";s:9:"metadata6";s:40:"Turriziani, O; Andreoni, M; Antonelli, G";s:9:"metadata7";s:32:"10.1111/j.1469-0691.2010.03329.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:177;a:14:{s:9:"citazione";s:351:"Ceccherini-Silberstein, F., Van Baelen, K., Armenia, D., Trignetti, M., Rondelez, E., Fabeni, L., et al. (2010). Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 54(9), 3938-3948.";s:4:"data";s:7:"2010-09";s:2:"id";s:19:"PUBBLICAZIONE_35676";s:6:"handle";s:9:"2108/8973";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:180:"Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors";s:9:"metadata6";s:234:"Ceccherini-Silberstein, F; Van Baelen, K; Armenia, D; Trignetti, M; Rondelez, E; Fabeni, L; Scopelliti, F; Pollicita, M; Van Wesenbeeck, L; Van Eygen, V; Dori, L; Sarmati, L; Aquaro, S; Palamara, G; Andreoni, M; Stuyver, LJ; Perno, CF";s:9:"metadata7";s:20:"10.1128/AAC.01720-09";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:178;a:14:{s:9:"citazione";s:242:"Sarmati, L., Parisi, S.G., Andreoni, C., Nicastri, E., Buonomini, A.R., Boldrin, C., et al. (2010). Switching of inferred tropism caused by HIV during interruption of antiretroviral therapy. JOURNAL OF CLINICAL MICROBIOLOGY, 48(7), 2586-2588.";s:4:"data";s:7:"2010-07";s:2:"id";s:19:"PUBBLICAZIONE_35341";s:6:"handle";s:10:"2108/39777";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:89:"Switching of inferred tropism caused by HIV during interruption of antiretroviral therapy";s:9:"metadata6";s:153:"Sarmati, L; Parisi, SG; Andreoni, C; Nicastri, E; Buonomini, AR; Boldrin, C; Dori, L; Montano, M; Tommasi, C; Andreis, S; Vullo, V; Palù, G; Andreoni, M";s:9:"metadata7";s:20:"10.1128/JCM.02125-09";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:179;a:14:{s:9:"citazione";s:299:"Svicher, V., D'Arrigo, R., Alteri, C., Andreoni, M., Angarano, G., Antinori, A., et al. (2010). Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group. NEW MICROBIOLOGICA, 33(3), 195-206.";s:4:"data";s:7:"2010-07";s:2:"id";s:19:"PUBBLICAZIONE_35813";s:6:"handle";s:10:"2108/39772";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:166:"Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group";s:9:"metadata6";s:721:"Svicher, V; D'Arrigo, R; Alteri, C; Andreoni, M; Angarano, G; Antinori, A; Antonelli, G; Bagnarelli, P; Baldanti, F; Bertoli, A; Borderi, M; Boeri, E; Bonn, I; Bruzzone, B; Callegaro, AP; Cammarota, R; Canducci, F; Ceccherini-Silberstein, F; Clementi, M; Monforte, AD; De Luca, A; Di Biagio, A; Di Gianbenedetto, S; Di Perri, G; Di Pietro, M; Fabeni, L; Fadda, G; Galli, M; Gennari, W; Ghisetti, V; Giacometti, A; Gori, A; Leoncini, F; Maggiolo, F; Maserati, R; Mazzotta, F; Micheli, V; Meini, G; Monno, L; Mussini, C; Nozza, S; Paolucci, S; Parisi, S; Pecorari, M; Pizzi, D; Quirino, T; Re, MC; Rizzardini, G; Santangelo, R; Soria, A; Stazi, F; Sterrantino, G; Turriziani, O; Viscoli, C; Vullo, V; Lazzarin, A; Perno, CF";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:180;a:14:{s:9:"citazione";s:303:"Baroncelli, S., Villani, P., Weimer, L., Ladisa, N., Francisci, D., Tommasi, C., et al. (2010). Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration. THE ANNALS OF PHARMACOTHERAPY, 44(5), 838-843.";s:4:"data";s:7:"2010-05";s:2:"id";s:19:"PUBBLICAZIONE_35675";s:6:"handle";s:9:"2108/8980";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:159:"Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration";s:9:"metadata6";s:1178:"Baroncelli, S; Villani, P; Weimer, L; Ladisa, N; Francisci, D; Tommasi, C; Vullo, V; Preziosi, R; Cicalini, S; Cusato, M; Galluzzo, C; Floridia, M; Regazzi, M; Bucciardini, R; Floridia, M; Weimer, L; Fragola, V; Massella, M; Baroncelli, S; Galluzzo, C; Pirillo, M; Mancini, M; Amici, R; Cara, A; Bona, R; Leone, P; Filati, P; Franco, M; Donnini, S; Mirra, M; Di Gregorio, M; Lucattini, S; Fucili, L; Baldelli, F; Francisci, D; Martinelli, L; Masini, G; Bastianelli, S; Angarano, G; Ladisa, N; Volpe, A; Vullo, V; D'Ettorre, G; Ceccarelli, G; Andreoni, M; Sarmati, L; Delle Rose, D; Montano, M; Tozzi, V; Libertone, R; Pucillo, L; Narciso, P; Bellagamba, R; Tommasi, C; Petrosillo, N; Cicalini, S; Ghinelli, F; Sighinolfi, L; Segala, D; Armignacco, O; Preziosi, R; Ferrari, C; Degli Antoni, A; Cavalli, A; Parruti, G; Sozio, F; Cosentino, L; Dionisio, D; Vivarelli, A; Manconi, P; Ortu, F; Di Martino, M; Viale, P; Verucchi, G; Borderi, M; Piergentili, B; Motta, R; Del Gobbo, R; Mataloni Paggi, A; Silvestri, C; Scalise, G; Giacometti, A; Cirioni, O; Sebastianelli, S; Marchionni, E; Gabrielli, E; Mura, M; Mannazzu, M; Cattari, G; Coinu, G; Guaraldi, G; Beghetto, B; Nardini, G";s:9:"metadata7";s:17:"10.1345/aph.1M688";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:181;a:14:{s:9:"citazione";s:264:"Sarmati, L., Beltrame, A., Dori, L., Maffongelli, G., Cudillo, L., De Angelis, G., et al. (2010). Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis. AMERICAN JOURNAL OF HEMATOLOGY, 85(5), 380-383.";s:4:"data";s:7:"2010-05";s:2:"id";s:20:"PUBBLICAZIONE_254709";s:6:"handle";s:11:"2108/248320";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:117:"Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis";s:9:"metadata6";s:162:"Sarmati, L; Beltrame, A; Dori, L; Maffongelli, G; Cudillo, L; De Angelis, G; Picardi, A; Ottaviani, L; Cefalo, MG; Venditti, A; Amadori, S; Arcese, W; Andreoni, M";s:9:"metadata7";s:17:"10.1002/ajh.21685";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:182;a:14:{s:9:"citazione";s:264:"Sarmati, L., Beltrame, A., Dori, L., Maffongelli, G., Cudillo, L., De Angelis, G., et al. (2010). Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis. AMERICAN JOURNAL OF HEMATOLOGY, 85(5), 380-383.";s:4:"data";s:7:"2010-05";s:2:"id";s:19:"PUBBLICAZIONE_35338";s:6:"handle";s:10:"2108/39936";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:117:"Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis";s:9:"metadata6";s:161:"Sarmati, L; Beltrame, A; Dori, L; Maffongelli, G; Cudillo, L; De Angelis, G; Picardi, A; Ottaviani, L; Cefalo, M; Venditti, A; Amadori, S; Arcese, W; Andreoni, M";s:9:"metadata7";s:17:"10.1002/ajh.21685";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:183;a:14:{s:9:"citazione";s:233:"Battagin, G., Sarmati, L., Sordillo, P., Picchi, G., Calisti, G., Ceccarelli, L., et al. (2010). Complication of nasal piercing by Staphylococcus aureus endocarditis: a case report and a review of literature. CASES JOURNAL, 3(3), 37.";s:4:"data";s:7:"2010-02";s:2:"id";s:19:"PUBBLICAZIONE_35792";s:6:"handle";s:10:"2108/10264";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/23 - Chirurgia Cardiaca";s:9:"metadata4";N;s:9:"metadata5";s:111:"Complication of nasal piercing by Staphylococcus aureus endocarditis: a case report and a review of literature.";s:9:"metadata6";s:127:"Battagin, G; Sarmati, L; Sordillo, P; Picchi, G; Calisti, G; Ceccarelli, L; Pellegrino, A; Nardi, P; Chiariello, L; Andreoni, M";s:9:"metadata7";s:23:"10.1186/1757-1626-3-37.";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:184;a:14:{s:9:"citazione";s:156:"Dori, L., Buonomini, A.R., Viscione, M., Sarmati, L., & Andreoni, M. (2010). A case of rhabdomiolysis associated with raltegravir use. AIDS, 24(3), 473-475.";s:4:"data";s:10:"2010-01-28";s:2:"id";s:19:"PUBBLICAZIONE_35673";s:6:"handle";s:9:"2108/8972";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:56:"A case of rhabdomiolysis associated with raltegravir use";s:9:"metadata6";s:60:"Dori, L; Buonomini, AR; Viscione, M; Sarmati, L; Andreoni, M";s:9:"metadata7";s:28:"10.1097/QAD.0b013e328334cc4a";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:185;a:14:{s:9:"citazione";s:266:"Beltrame, A., Sarmati, L., Cudillo, L., Cerretti, R., Picardi, A., Anemona, L., et al. (2009). A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 13(6), 488-492.";s:4:"data";s:7:"2009-11";s:2:"id";s:20:"PUBBLICAZIONE_115490";s:6:"handle";s:10:"2108/59311";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/08 - Anatomia Patologica";s:9:"metadata4";N;s:9:"metadata5";s:108:"A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient";s:9:"metadata6";s:108:"Beltrame, A; Sarmati, L; Cudillo, L; Cerretti, R; Picardi, A; Anemona, L; Fontana, C; Andreoni, M; Arcese, W";s:9:"metadata7";s:26:"10.1016/j.ijid.2009.01.020";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:186;a:14:{s:9:"citazione";s:268:"Beltrame, A., Sarmati, L., Cudillo, L., Cerretti, R., Picardi, A., Anemona, L., et al. (2009). A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 13(6), e488-e492.";s:4:"data";s:7:"2009-11";s:2:"id";s:20:"PUBBLICAZIONE_254680";s:6:"handle";s:11:"2108/248318";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore MED/15";s:9:"metadata4";N;s:9:"metadata5";s:108:"A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient";s:9:"metadata6";s:108:"Beltrame, A; Sarmati, L; Cudillo, L; Cerretti, R; Picardi, A; Anemona, L; Fontana, C; Andreoni, M; Arcese, W";s:9:"metadata7";s:26:"10.1016/j.ijid.2009.01.020";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:187;a:14:{s:9:"citazione";s:248:"Antinori, A., Ammassari, A., Torti, C., Marconi, P., Andreoni, M., Angarano, G., et al. (2009). Italian consensus statement on management of HIV-infected individuals with advanced disease naïve to antiretroviral therapy. INFECTION, 37(3), 270-282.";s:4:"data";s:7:"2009-06";s:2:"id";s:19:"PUBBLICAZIONE_82385";s:6:"handle";s:10:"2108/26687";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:124:"Italian consensus statement on management of HIV-infected individuals with advanced disease naïve to antiretroviral therapy";s:9:"metadata6";s:321:"Antinori, A; Ammassari, A; Torti, C; Marconi, P; Andreoni, M; Angarano, G; Bonora, S; Castagna, A; Cauda, R; Clerici, M; Monforte, A; De Luca, A; Di Perri, G; Galli, M; Girardi, E; Gori, A; Lazzarin, A; Lo Caputo, S; Mazzotta, F; Montella, F; Mussini, C; Perno, C; Puoti, M; Rizzardini, G; Rusconi, S; Vullo, V; Carosi, G";s:9:"metadata7";s:25:"10.1007/s15010-008-8134-8";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:188;a:14:{s:9:"citazione";s:306:"Bonora, S., Nicastri, E., Calcagno, A., Gonzalez De Requena, D., D'Ettorre, G., Sarmati, L., et al. (2009). Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation. JOURNAL OF MEDICAL VIROLOGY, 81(3), 400-405.";s:4:"data";s:7:"2009-03";s:2:"id";s:19:"PUBBLICAZIONE_33733";s:6:"handle";s:9:"2108/9004";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:152:"Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation";s:9:"metadata6";s:135:"Bonora, S; Nicastri, E; Calcagno, A; Gonzalez De Requena, D; D'Ettorre, G; Sarmati, L; Palmisano, L; Vullo, V; Di Perri, G; Andreoni, M";s:9:"metadata7";s:17:"10.1002/jmv.21405";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:189;a:14:{s:9:"citazione";s:222:"Bonora S., N.E. (2009). Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: A cross-sectional evaluation. JOURNAL OF MEDICAL VIROLOGY, 81(3), 400-405.";s:4:"data";s:4:"2009";s:2:"id";s:18:"PUBBLICAZIONE_7927";s:6:"handle";s:10:"2108/39205";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:152:"Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: A cross-sectional evaluation";s:9:"metadata6";s:128:"Bonora S., Nicastri E., Calcagno A., De Requena D.G., D'Ettorre G., Sarmati L., Palmisano L., Vullo V., Di Perri G., Andreoni M.";s:9:"metadata7";s:17:"10.1002/jmv.21405";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:190;a:14:{s:9:"citazione";s:235:"Monini, P., Sgadari, C., Grosso, M.g., Bellino, S., Di Biagio, A., Toschi, E., et al. (2009). Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir. AIDS, 23(4), 534-538.";s:4:"data";s:4:"2009";s:2:"id";s:20:"PUBBLICAZIONE_320048";s:6:"handle";s:11:"2108/188660";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:118:"Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir";s:9:"metadata6";s:545:"Monini, P; Sgadari, C; Grosso, Mg; Bellino, S; Di Biagio, A; Toschi, E; Bacigalupo, I; Sabbatucci, M; Cencioni, G; Salvi, E; Leone, P; Ensoli, B; Barillari, G; Moracci, G; Carratelli, L; Gatti, G; Brambilla, L; Brambati, M; Ferrucci, S; De Pita, O; Pilla, Ma; Di Carlo, A; Giuliani, M; Cottoni, F; Cuccuru, Ma; Calvieri, S; Clerico, R; Potenza, C; Tirelli, U; Simonelli, C; Martellotta, F; Strumia, R; Borghi, A; Del Giacco, S; Moi, L; Piludu, G; Sirianni, Mc; Campagna, M; Sarmati, L; Andreoni, M; Bianchini, G; Sheldon, J; Milzer, J; Schulz, T";s:9:"metadata7";s:28:"10.1097/QAD.0b013e3283262a8d";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:191;a:14:{s:9:"citazione";s:161:"Sarmati L., A.C. (2009). Prognostic factors of long-term CD4+ count-guided interruption of antiretroviral treatment. JOURNAL OF MEDICAL VIROLOGY, 81(3), 481-487.";s:4:"data";s:4:"2009";s:2:"id";s:18:"PUBBLICAZIONE_8444";s:6:"handle";s:10:"2108/39202";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:90:"Prognostic factors of long-term CD4+ count-guided interruption of antiretroviral treatment";s:9:"metadata6";s:157:"Sarmati L., Andreoni C., Nicastri E., Tommasi C., Buonomini A., D'Ettorre G., Corpolongo A., Dori L., Montano M., Volpi A., Narciso P., Vullo V., Andreoni M.";s:9:"metadata7";s:17:"10.1002/jmv.21424";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:192;a:14:{s:9:"citazione";s:193:"Sarrecchia, C., Volpi, A., Sordillo, P., & Andreoni, M. (2009). Multidrug resistance after lamivudine therapy for chronic hepatitis B. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 13, 133-134.";s:4:"data";s:4:"2009";s:2:"id";s:20:"PUBBLICAZIONE_112962";s:6:"handle";s:10:"2108/57610";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:69:"Multidrug resistance after lamivudine therapy for chronic hepatitis B";s:9:"metadata6";s:49:"Sarrecchia, C; Volpi, A; Sordillo, P; Andreoni, M";s:9:"metadata7";s:26:"10.1016/j.ijid.2008.08.005";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:193;a:14:{s:9:"citazione";s:212:"Nicastri E., P.L. (2008). HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (< 400 HIV-RNA cp/ml) during different antiretroviral regimens. CURRENT HIV RESEARCH, 6(3), 261-266.";s:4:"data";s:4:"2008";s:2:"id";s:19:"PUBBLICAZIONE_13363";s:6:"handle";s:10:"2108/38768";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:148:"HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (< 400 HIV-RNA cp/ml) during different antiretroviral regimens";s:9:"metadata6";s:179:"Nicastri E., Palmisano L., Sarmati L., D'Ettorre G., Parisi S., Andreotti M., Buonomini A., Pirillo F.M., Narciso P., Bellagamba R., Vullo V., Montano M., Di Perri G., Andreoni M.";s:9:"metadata7";s:26:"10.2174/157016208784325010";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:194;a:14:{s:9:"citazione";s:193:"Tommasi, C., Nicastri, E., Corpolongo, A., Ivanovic, J., Notari, S., Ascenzi, P., et al. (2008). Stopping antiretroviral therapy: Role for therapeutic drug monitoring [1]. AIDS, 22(2), 315-316.";s:4:"data";s:4:"2008";s:2:"id";s:18:"PUBBLICAZIONE_5041";s:6:"handle";s:10:"2108/38016";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:73:"Stopping antiretroviral therapy: Role for therapeutic drug monitoring [1]";s:9:"metadata6";s:100:"Tommasi, C; Nicastri, E; Corpolongo, A; Ivanovic, J; Notari, S; Ascenzi, P; Andreoni, M; Narciso, P;";s:9:"metadata7";s:28:"10.1097/QAD.0b013e3282f3054f";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:195;a:14:{s:9:"citazione";s:245:"Antinori, A., Trotta, M., Lorenzini, P., Torti, C., Gianotti, N., Maggiolo, F., et al. (2007). Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutation. ANTIVIRAL THERAPY, 12(8), 1175-1183.";s:4:"data";s:4:"2007";s:2:"id";s:19:"PUBBLICAZIONE_81721";s:6:"handle";s:10:"2108/45961";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:112:"Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutation";s:9:"metadata6";s:169:"Antinori, A; Trotta, M; Lorenzini, P; Torti, C; Gianotti, N; Maggiolo, F; Ceccherini-Silberstein, F; Nasto, P; Castagna, A; De Luca, A; Mussini, C; Andreoni, M; Perno, C";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:196;a:14:{s:9:"citazione";s:183:"Nicastri E., L.S. (2007). Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: A systematic review. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 60(4), 724-732.";s:4:"data";s:4:"2007";s:2:"id";s:18:"PUBBLICAZIONE_3559";s:6:"handle";s:10:"2108/37751";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:101:"Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: A systematic review";s:9:"metadata6";s:133:"Nicastri E., Leone S., Angeletti C., Palmisano L., Sarmati L., Chiesi A., Geraci A., Vella S., Narciso P., Corpolongo A., Andreoni M.";s:9:"metadata7";s:18:"10.1093/jac/dkm302";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:197;a:14:{s:9:"citazione";s:146:"Sarmati L., B.S. (2007). Human herpesvirus 8 and human herpesvirus 2 infections in prison population. JOURNAL OF MEDICAL VIROLOGY, 79(2), 167-173.";s:4:"data";s:4:"2007";s:2:"id";s:19:"PUBBLICAZIONE_17529";s:6:"handle";s:10:"2108/37733";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:75:"Human herpesvirus 8 and human herpesvirus 2 infections in prison population";s:9:"metadata6";s:121:"Sarmati L., Babudieri S., Longo B., Starnini G., Carbonara S., Monarca R., Buonomini A.R., Dori L., Rezza G., Andreoni M.";s:9:"metadata7";s:17:"10.1002/jmv.20774";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:198;a:14:{s:9:"citazione";s:255:"Sarmati, L., Parisi, S.G., Nicastri, E., D'Ettorre, G., Andreoni, C., Dori, L., et al. (2007). Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens. JOURNAL OF MEDICAL VIROLOGY, 79(7), 880-886.";s:4:"data";s:4:"2007";s:2:"id";s:19:"PUBBLICAZIONE_21988";s:6:"handle";s:10:"2108/37726";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:114:"Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens";s:9:"metadata6";s:152:"Sarmati, L; Parisi, SG; Nicastri, E; D'Ettorre, G; Andreoni, C; Dori, L; Gatti, F; Montano, M; Buonomini, AR; Boldrin, C; Palu, G; Vullo, V; Andreoni, M";s:9:"metadata7";s:17:"10.1002/jmv.20914";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:199;a:14:{s:9:"citazione";s:224:"Carosi, G., Torti, C., Andreoni, M., Angarano, G., Antinori, A., Bonora, S., et al. (2006). Key questions in antiretroviral therapy: Italian Consensus Workshop (2005). JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 57(6), 1055-1064.";s:4:"data";s:7:"2006-06";s:2:"id";s:19:"PUBBLICAZIONE_82362";s:6:"handle";s:10:"2108/28990";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:74:"Key questions in antiretroviral therapy: Italian Consensus Workshop (2005)";s:9:"metadata6";s:293:"Carosi, G; Torti, C; Andreoni, M; Angarano, G; Antinori, A; Bonora, S; Borderi, M; Castagna, A; Castelli, F; Cauda, R; Chiodo, F; D'arminio-Monforte, A; De Luca, A; Di Perri, G; Dianzani, F; Filice, G; Galli, M; Lazzarin, A; Maggiolo, F; Maserati, R; Mazzotta, F; Moroni, M; Perno, C; Vullo, V";s:9:"metadata7";s:18:"10.1093/jac/dkl113";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:200;a:14:{s:9:"citazione";s:285:"Antinori, A., Trotta, M., Nasta, P., Bini, T., Bonora, S., Castagna, A., et al. (2006). Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients. ANTIVIRAL THERAPY, 11(2), 233-243.";s:4:"data";s:4:"2006";s:2:"id";s:19:"PUBBLICAZIONE_82379";s:6:"handle";s:10:"2108/26940";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:161:"Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients";s:9:"metadata6";s:172:"Antinori, A; Trotta, M; Nasta, P; Bini, T; Bonora, S; Castagna, A; Zaccarelli, M; Quirino, T; Landonio, S; Merli, S; Tozzi, V; Di Perri, G; Andreoni, M; Perno, C; Carosi, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:201;a:14:{s:9:"citazione";s:188:"Babudieri S., L.B. (2005). Correlates of HIV, HBV, and HCV infections in a prison inmate population: Results from a multicentre study in Italy. JOURNAL OF MEDICAL VIROLOGY, 76(3), 311-317.";s:4:"data";s:4:"2005";s:2:"id";s:19:"PUBBLICAZIONE_14235";s:6:"handle";s:10:"2108/34141";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:115:"Correlates of HIV, HBV, and HCV infections in a prison inmate population: Results from a multicentre study in Italy";s:9:"metadata6";s:246:"Babudieri S., Longo B., Sarmati L., Starnini G., Dori L., Suligoi B., Carbonara S., Monarca R., Quercia G., Florenzano G., Novati S., Sardu A., Iovinella V., Casti A., Romano A., Uccella I., Maida I., Brunetti B., Mura M.S., Andreoni M., Rezza G.";s:9:"metadata7";s:17:"10.1002/jmv.20375";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:202;a:14:{s:9:"citazione";s:200:"Nicastri E., C.A. (2005). Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART. JOURNAL OF MEDICAL VIROLOGY, 76(2), 153-160.";s:4:"data";s:4:"2005";s:2:"id";s:19:"PUBBLICAZIONE_20700";s:6:"handle";s:10:"2108/34137";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:128:"Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART";s:9:"metadata6";s:96:"Nicastri E., Chiesi A., Angeletti C., Sarmati L., Palmisano L., Geraci A., Andreoni M., Vella S.";s:9:"metadata7";s:17:"10.1002/jmv.20352";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:203;a:14:{s:9:"citazione";s:245:"Nicastri, E., Angeletti, C., Palmisano, L., Sarmati, L., Chiesi, A., Geraci, A., et al. (2005). Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS, 19(6), 577-583.";s:4:"data";s:4:"2005";s:2:"id";s:19:"PUBBLICAZIONE_19814";s:6:"handle";s:10:"2108/34139";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:126:"Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy";s:9:"metadata6";s:96:"Nicastri, E; Angeletti, C; Palmisano, L; Sarmati, L; Chiesi, A; Geraci, A; Andreoni, M; Vella, S";s:9:"metadata7";s:35:"10.1097/01.aids.0000163934.22273.06";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:204;a:14:{s:9:"citazione";s:346:"Sarmati, L., Parisi, S.G., Nicastri, E., D'Ettorre, G., Palmisano, L., Andreotti, M., et al. (2005). Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy. JOURNAL OF CLINICAL MICROBIOLOGY, 43(12), 6183-6185.";s:4:"data";s:4:"2005";s:2:"id";s:18:"PUBBLICAZIONE_1075";s:6:"handle";s:10:"2108/34143";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:191:"Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy";s:9:"metadata6";s:167:"Sarmati, L; Parisi, SG; Nicastri, E; D'Ettorre, G; Palmisano, L; Andreotti, M; Andreoni, C; Giuliano, M; Gatti, F; Boldrin, C; Palu, G; Vullo, V; Vella, S; Andreoni, M";s:9:"metadata7";s:32:"10.1128/JCM.43.12.6183-6185.2005";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:205;a:14:{s:9:"citazione";s:241:"Suligoi B., D.R. (2005). Infection with human immunodeficiency virus, herpes simplex virus type 2, and human herpes virus 8 in remote villages of southwestern Papua New Guinea. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 72(1), 33-36.";s:4:"data";s:4:"2005";s:2:"id";s:18:"PUBBLICAZIONE_4275";s:6:"handle";s:10:"2108/34142";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:150:"Infection with human immunodeficiency virus, herpes simplex virus type 2, and human herpes virus 8 in remote villages of southwestern Papua New Guinea";s:9:"metadata6";s:89:"Suligoi B., Danaya R.T., Sarmati L., Owen I.L., Boros S., Pozio E., Andreoni M., Rezza G.";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:206;a:14:{s:9:"citazione";s:228:"Volpi, A., Sarmati, L., Suligoi, B., Montano, M., Rezza, G., & Andreoni, M. (2004). Correlates of human herpes virus-8 and herpes simplex virus type 2 infections in Northern Cameroon. JOURNAL OF MEDICAL VIROLOGY, 74(3), 467-472.";s:4:"data";s:7:"2004-11";s:2:"id";s:20:"PUBBLICAZIONE_213378";s:6:"handle";s:11:"2108/106920";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:99:"Correlates of human herpes virus-8 and herpes simplex virus type 2 infections in Northern Cameroon.";s:9:"metadata6";s:67:"Volpi, A; Sarmati, L; Suligoi, B; Montano, M; Rezza, G; Andreoni, M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:207;a:14:{s:9:"citazione";s:332:"D'Ettorre, G., Forcina, G., Andreotti, M., Sarmati, L., Palmisano, L., Andreoni, M., et al. (2004). Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 135(2), 280-285.";s:4:"data";s:4:"2004";s:2:"id";s:18:"PUBBLICAZIONE_1740";s:6:"handle";s:10:"2108/31416";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:176:"Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy";s:9:"metadata6";s:114:"D'Ettorre, G; Forcina, G; Andreotti, M; Sarmati, L; Palmisano, L; Andreoni, M; Vella, S; Mastroianni, Cm; Vullo, V";s:9:"metadata7";s:32:"10.1111/j.1365-2249.2004.02373.x";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:208;a:14:{s:9:"citazione";s:167:"Nicastri E., S.L. (2004). Non-B HIV type 1 subtypes: Replicative capacity and response to antiretroviral therapy. AIDS RESEARCH AND HUMAN RETROVIRUSES, 20(8), 816-818.";s:4:"data";s:4:"2004";s:2:"id";s:18:"PUBBLICAZIONE_7675";s:6:"handle";s:10:"2108/31401";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:86:"Non-B HIV type 1 subtypes: Replicative capacity and response to antiretroviral therapy";s:9:"metadata6";s:149:"Nicastri E., Sarmati L., D'Ettorre G., Parisi S.G., Palmisano L., Montano M., Buonomini A.R., Galluzzo C., Vullo V., Concia E., Vella S., Andreoni M.";s:9:"metadata7";s:24:"10.1089/0889222041725271";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:209;a:14:{s:9:"citazione";s:220:"Nicastri, E., Sarmati, L., Dori, L., Montano, M., D'Ettorre, G., Buonomini, A.R., et al. (2004). Viral growth assay to evaluate the replicative capacity of HIV-1 isolates. JOURNAL OF VIROLOGICAL METHODS, 115(2), 199-205.";s:4:"data";s:4:"2004";s:2:"id";s:19:"PUBBLICAZIONE_21617";s:6:"handle";s:10:"2108/31391";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:73:"Viral growth assay to evaluate the replicative capacity of HIV-1 isolates";s:9:"metadata6";s:119:"Nicastri, E; Sarmati, L; Dori, L; Montano, M; D'Ettorre, G; Buonomini, AR; Parisi, SG; Concia, E; Vullo, V; Andreoni, M";s:9:"metadata7";s:30:"10.1016/j.jviromet.2003.09.032";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:210;a:14:{s:9:"citazione";s:211:"Sarmati L., M.M. (2004). Discordant response to HAART: Reduction of viremia and replicative capacity of HIV strains in patients after genotype guided change of therapy. NEW MICROBIOLOGICA, 27(2 SUPPL. 1), 95-98.";s:4:"data";s:4:"2004";s:2:"id";s:18:"PUBBLICAZIONE_1373";s:6:"handle";s:10:"2108/31422";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:142:"Discordant response to HAART: Reduction of viremia and replicative capacity of HIV strains in patients after genotype guided change of therapy";s:9:"metadata6";s:84:"Sarmati L., Montano M., Dori L., Buonomini A.R., D'Ettorre G., Vullo V., Andreoni M.";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:211;a:14:{s:9:"citazione";s:232:"Sarmati, L., Nicastri, E., Montano, M., Dori, L., Buonomini, A.R., D'Ettorre, G., et al. (2004). Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy. JOURNAL OF MEDICAL VIROLOGY, 72(4), 511-516.";s:4:"data";s:4:"2004";s:2:"id";s:19:"PUBBLICAZIONE_14937";s:6:"handle";s:10:"2108/31400";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:89:"Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy";s:9:"metadata6";s:118:"Sarmati, L; Nicastri, E; Montano, M; Dori, L; Buonomini, AR; D'Ettorre, G; Gatti, F; Parisi, SG; Vallo, V; Andreoni, M";s:9:"metadata7";s:17:"10.1002/jmv.20030";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:212;a:14:{s:9:"citazione";s:239:"Sarmati, L., Ticconi, C., Santangelo, R., Montano, M., Pietropolli, A., Rezza, G., et al. (2004). Human herpesvirus-8 infection in pregnancy and labor: Lack of evidence of vertical transmission. JOURNAL OF MEDICAL VIROLOGY, 72(3), 462-466.";s:4:"data";s:4:"2004";s:2:"id";s:19:"PUBBLICAZIONE_16714";s:6:"handle";s:10:"2108/31397";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:95:"Human herpesvirus-8 infection in pregnancy and labor: Lack of evidence of vertical transmission";s:9:"metadata6";s:88:"Sarmati, L; Ticconi, C; Santangelo, R; Montano, M; Pietropolli, A; Rezza, G; Andreoni, M";s:9:"metadata7";s:17:"10.1002/jmv.20012";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:213;a:14:{s:9:"citazione";s:219:"Schinaia, N., Kodra, Y., Sarmati, L., Andreoni, M., Bino, S., Qyra, S., et al. (2004). Prevalence of HHV-8 infection in Albanian adults and association with HBV and HCV. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 19(5), 467-469.";s:4:"data";s:4:"2004";s:2:"id";s:19:"PUBBLICAZIONE_17159";s:6:"handle";s:10:"2108/31394";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:81:"Prevalence of HHV-8 infection in Albanian adults and association with HBV and HCV";s:9:"metadata6";s:74:"Schinaia, N; Kodra, Y; Sarmati, L; Andreoni, M; Bino, S; Qyra, S; Rezza, G";s:9:"metadata7";s:34:"10.1023/B:EJEP.0000027358.38997.66";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:214;a:14:{s:9:"citazione";s:190:"Nicastri, E., Sarmati, L., Andreoni, M., & Parisi, S.G. (2003). Human immunodeficiency virus polymorphisms and zidovudine resistance. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 47(8), 2714-2715.";s:4:"data";s:7:"2003-08";s:2:"id";s:20:"PUBBLICAZIONE_213373";s:6:"handle";s:11:"2108/106927";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:68:"Human immunodeficiency virus polymorphisms and zidovudine resistance";s:9:"metadata6";s:48:"Nicastri, E; Sarmati, L; Andreoni, M; Parisi, SG";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:215;a:14:{s:9:"citazione";s:175:"Nicastri E., S.L. (2003). Human immunodeficiency virus polymorphisms and zidovudine resistance [3] (multiple letters). ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 47(8), 2714-2715.";s:4:"data";s:4:"2003";s:2:"id";s:18:"PUBBLICAZIONE_1496";s:6:"handle";s:10:"2108/49471";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:91:"Human immunodeficiency virus polymorphisms and zidovudine resistance [3] (multiple letters)";s:9:"metadata6";s:101:"Nicastri E., Sarmati L., Andreoni M., Parisi S.G., Sturmer M., Doerr H.-W., Staszewski S., Hertogs K.";s:9:"metadata7";s:31:"10.1128/AAC.47.8.2714-2715.2003";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:216;a:14:{s:9:"citazione";s:200:"Nicastri E., S.L. (2003). Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy. JOURNAL OF MEDICAL VIROLOGY, 69(1), 1-6.";s:4:"data";s:4:"2003";s:2:"id";s:19:"PUBBLICAZIONE_22013";s:6:"handle";s:10:"2108/49440";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:132:"Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy";s:9:"metadata6";s:131:"Nicastri E., Sarmati L., D'Ettorre G., Palmisano L., Parisi S.G., Uccella I., Rianda A., Concia E., Vullo V., Vella S., Andreoni M.";s:9:"metadata7";s:17:"10.1002/jmv.10269";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:217;a:14:{s:9:"citazione";s:217:"Nicastri, E., Sarmati, L., & Andreoni, M. (2003). Reply to 'Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides', by Barreiro et al. [2]. AIDS, 17(3), 447-448.";s:4:"data";s:4:"2003";s:2:"id";s:17:"PUBBLICAZIONE_841";s:6:"handle";s:10:"2108/49476";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:144:"Reply to 'Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides', by Barreiro et al. [2]";s:9:"metadata6";s:36:"Nicastri, E; Sarmati, L; Andreoni, M";s:9:"metadata7";s:32:"10.1097/00002030-200302140-00022";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:218;a:14:{s:9:"citazione";s:237:"Nicastri, E., Sarmati, L., Andreoni, M., Joly, V., Descamps, D., Flandre, P., et al. (2003). Stavudine protective function and emergence of lamivudine resistance [4] (multiple letters). ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 47(3), 1176.";s:4:"data";s:4:"2003";s:2:"id";s:17:"PUBBLICAZIONE_846";s:6:"handle";s:10:"2108/49475";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:91:"Stavudine protective function and emergence of lamivudine resistance [4] (multiple letters)";s:9:"metadata6";s:79:"Nicastri, E; Sarmati, L; Andreoni, M; Joly, V; Descamps, D; Flandre, P; Yeni, P";s:9:"metadata7";s:26:"10.1128/AAC.47.3.1176.2003";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:219;a:14:{s:9:"citazione";s:346:"Nicastri, E., Sarmati, L., D'Ettorre, G., Parisi, S., Palmisano, L., Galluzzo, C., et al. (2003). High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis. JOURNAL OF CLINICAL MICROBIOLOGY, 41(7), 3007-3012.";s:4:"data";s:4:"2003";s:2:"id";s:18:"PUBBLICAZIONE_1504";s:6:"handle";s:10:"2108/49470";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:195:"High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis";s:9:"metadata6";s:165:"Nicastri, E; Sarmati, L; D'Ettorre, G; Parisi, S.G; Palmisano, L; Galluzzo, C; Montano, M; Uccella, I; Amici, R; Gatti, F; Vullo, V; Concia, E; Vella, S; Andreoni, M";s:9:"metadata7";s:31:"10.1128/JCM.41.7.3007-3012.2003";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:220;a:14:{s:9:"citazione";s:236:"Sarmati L., A.M. (2003). Infection with human herpesvirus-8 and its correlation with hepatitis B virus and hepatitis C virus markers among rural populations in Cambodia. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 68(4), 501-502.";s:4:"data";s:4:"2003";s:2:"id";s:17:"PUBBLICAZIONE_818";s:6:"handle";s:10:"2108/49477";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:143:"Infection with human herpesvirus-8 and its correlation with hepatitis B virus and hepatitis C virus markers among rural populations in Cambodia";s:9:"metadata6";s:80:"Sarmati L., Andreoni M., Suligoi B., Bugarini R., Uccella I., Pozio E., Rezza G.";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:221;a:14:{s:9:"citazione";s:277:"Sarmati L., N.E. (2003). Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing. JOURNAL OF CLINICAL MICROBIOLOGY, 41(4), 1760-1762.";s:4:"data";s:4:"2003";s:2:"id";s:18:"PUBBLICAZIONE_8051";s:6:"handle";s:10:"2108/49464";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:199:"Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing";s:9:"metadata6";s:133:"Sarmati L., Nicastri E., Uccella I., D'Ettorre G., Parisi S.G., Palmisano L., Galluzzo C., Concia E., Vullo V., Vella S., Andreoni M.";s:9:"metadata7";s:31:"10.1128/JCM.41.4.1760-1762.2003";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:222;a:14:{s:9:"citazione";s:304:"Sarmati, L., Andreoni, M., Suligoi, B., Bugarini, R., Uccella, I., Pozio, E., et al. (2003). Infection with human herpesvirus-8 and its correlation with hepatitis B virus and hepatitis C virus markers among rural populations in Cambodia. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 68(4), 501-502.";s:4:"data";s:4:"2003";s:2:"id";s:18:"PUBBLICAZIONE_8083";s:6:"handle";s:10:"2108/49463";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:143:"Infection with human herpesvirus-8 and its correlation with hepatitis B virus and hepatitis C virus markers among rural populations in Cambodia";s:9:"metadata6";s:80:"Sarmati, L; Andreoni, M; Suligoi, B; Bugarini, R; Uccella, I; Pozio, E; Rezza, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:223;a:14:{s:9:"citazione";s:262:"Sarmati, L., Ticconi, C., Santangelo, R., Montano, M., Rezza, G., Andreoni, M., et al. (2003). Does the risk of abortion increase in women with high human herpesvirus-8 antibody titers? [1] (multiple letters). THE JOURNAL OF INFECTIOUS DISEASES, 188(1), 173-175.";s:4:"data";s:4:"2003";s:2:"id";s:19:"PUBBLICAZIONE_16468";s:6:"handle";s:10:"2108/49452";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:113:"Does the risk of abortion increase in women with high human herpesvirus-8 antibody titers? [1] (multiple letters)";s:9:"metadata6";s:120:"Sarmati, L; Ticconi, C; Santangelo, R; Montano, M; Rezza, G; Andreoni, M; Brayfield, Bp; West, Jt; Mitchell, Cd; Wood, C";s:9:"metadata7";s:14:"10.1086/375830";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:224;a:14:{s:9:"citazione";s:167:"Serraino D., C.R. (2003). Infection with human herpesvirus type 8 and Kaposi's sarcoma in a central Italian area formerly endemic for malaria. INFECTION, 31(1), 47-50.";s:4:"data";s:4:"2003";s:2:"id";s:18:"PUBBLICAZIONE_2427";s:6:"handle";s:10:"2108/49468";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:115:"Infection with human herpesvirus type 8 and Kaposi's sarcoma in a central Italian area formerly endemic for malaria";s:9:"metadata6";s:95:"Serraino D., Corona R.M., Giuliani M., Farchi F., Sarmati L., Uccella I., Andreoni M., Rezza G.";s:9:"metadata7";s:25:"10.1007/s15010-002-3107-9";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:225;a:14:{s:9:"citazione";s:253:"Parisi, S.G., Mazzi, R., Sarmati, L., Carolo, G., Uccella, I., Rianda, A., et al. (2002). Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapy. AIDS, 16(7), 1089-1091.";s:4:"data";s:7:"2002-04";s:2:"id";s:20:"PUBBLICAZIONE_213372";s:6:"handle";s:11:"2108/106769";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:139:"Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapy.";s:9:"metadata6";s:103:"Parisi, SG; Mazzi, R; Sarmati, L; Carolo, G; Uccella, I; Rianda, A; Nicastri, E; Concia, E; Andreoni, M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:226;a:14:{s:9:"citazione";s:192:"Andreoni, M., Sarmati, L., Nicastri, E., El Sawaf, G., El Zalabani, M., Uccella, I., et al. (2002). Primary human herpesvirus 8 infection in immunocompetent children. JAMA, 287(10), 1295-1300.";s:4:"data";s:7:"2002-03";s:2:"id";s:20:"PUBBLICAZIONE_213369";s:6:"handle";s:11:"2108/106919";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:66:"Primary human herpesvirus 8 infection in immunocompetent children.";s:9:"metadata6";s:112:"Andreoni, M; Sarmati, L; Nicastri, E; El Sawaf, G; El Zalabani, M; Uccella, I; Bugarini, R; Parisi, SG; Rezza, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:227;a:14:{s:9:"citazione";s:250:"Broccolo, F., Locatelli, G., Sarmati, L., Piergiovanni, S., Veglia, F., Andreoni, M., et al. (2002). Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids. JOURNAL OF CLINICAL MICROBIOLOGY, 40(12), 4652-4658.";s:4:"data";s:4:"2002";s:2:"id";s:17:"PUBBLICAZIONE_662";s:6:"handle";s:10:"2108/49478";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:95:"Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids";s:9:"metadata6";s:123:"Broccolo, F; Locatelli, G; Sarmati, L; Piergiovanni, S; Veglia, F; Andreoni, M; Butto, S; Ensoli, B; Lusso, P; Malnati, M.S";s:9:"metadata7";s:32:"10.1128/JCM.40.12.4652-4658.2002";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:228;a:14:{s:9:"citazione";s:255:"D'Ettorre, G., Forcina, G., Andreotti, M., Sarmati, L., Palmisano, L., Galluzzo, C.M., et al. (2002). Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine production. AIDS, 16(14), 1877-1885.";s:4:"data";s:4:"2002";s:2:"id";s:17:"PUBBLICAZIONE_443";s:6:"handle";s:10:"2108/49479";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:127:"Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine production";s:9:"metadata6";s:141:"D'Ettorre, G; Forcina, G; Andreotti, M; Sarmati, L; Palmisano, L; Galluzzo, CM; Nicastri, E; Mastroianni, CM; Vullo, V; Vella, S; Andreoni, M";s:9:"metadata7";s:32:"10.1097/00002030-200209270-00004";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:229;a:14:{s:9:"citazione";s:290:"Fernandez, L., Serraino, D., Rezza, G., Lence, J., Ortiz, R., Cruz, T., et al. (2002). Infection with human herpesvirus type 8 and human T-cell leukaemia virus type 1 among individuals participating in a case-control study in Havana City, Cuba. BRITISH JOURNAL OF CANCER, 87(11), 1253-1256.";s:4:"data";s:4:"2002";s:2:"id";s:15:"PUBBLICAZIONE_4";s:6:"handle";s:10:"2108/49483";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:156:"Infection with human herpesvirus type 8 and human T-cell leukaemia virus type 1 among individuals participating in a case-control study in Havana City, Cuba";s:9:"metadata6";s:121:"Fernandez, L; Serraino, D; Rezza, G; Lence, J; Ortiz, R.M; Cruz, T; Vaccarella, S; Sarmati, L; Andreoni, M; Franceschi, S";s:9:"metadata7";s:22:"10.1038/sj.bjc.6600613";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:230;a:14:{s:9:"citazione";s:279:"Malnati, M., Broccolo, F., Nozza, S., Sarmati, L., Ghezzi, S., Locatelli, G., et al. (2002). Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy. BLOOD, 100(5), 1575-1578.";s:4:"data";s:4:"2002";s:2:"id";s:18:"PUBBLICAZIONE_2209";s:6:"handle";s:10:"2108/49469";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:159:"Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy";s:9:"metadata6";s:178:"Malnati, M; Broccolo, F; Nozza, S; Sarmati, L; Ghezzi, S; Locatelli, G; Delfanti, F; Capiluppi, B; Careddu, A; Andreoni, M; Monini, P; Poli, G; Lazzarin, A; Lusso, P; Tambussi, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:231;a:14:{s:9:"citazione";s:234:"Parisi, S.G., Sarmati, L., Pappagallo, M., Mazzi, R., Carolo, G., Farchi, F., et al. (2002). Prevalence trend and correlates of HHV-8 infection in HIV-infected patients. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 29(3), 295-299.";s:4:"data";s:4:"2002";s:2:"id";s:18:"PUBBLICAZIONE_7712";s:6:"handle";s:10:"2108/49465";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:75:"Prevalence trend and correlates of HHV-8 infection in HIV-infected patients";s:9:"metadata6";s:116:"Parisi, SG; Sarmati, L; Pappagallo, M; Mazzi, R; Carolo, G; Farchi, F; Nicastri, E; Concia, E; Rezza, G; Andreoni, M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:232;a:14:{s:9:"citazione";s:313:"Sarmati, L., Nicastri, E., Parisi, S.g., D'Ettorre, G., Mancino, G., Narciso, P., et al. (2002). Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cells. JOURNAL OF CLINICAL MICROBIOLOGY, 40(2), 335-340.";s:4:"data";s:4:"2002";s:2:"id";s:18:"PUBBLICAZIONE_1019";s:6:"handle";s:10:"2108/49472";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:165:"Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cells";s:9:"metadata6";s:96:"Sarmati, L; Nicastri, E; Parisi, Sg; D'Ettorre, G; Mancino, G; Narciso, P; Vullo, V; Andreoni, M";s:9:"metadata7";s:29:"10.1128/JCM.40.2.335-340.2002";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:233;a:14:{s:9:"citazione";s:256:"Andreoni, M., Goletti, D., Pezzotti, P., Pozzetto, A., Monini, P., Sarmati, L., et al. (2001). Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. JOURNAL OF INFECTION, 43(3), 195-199.";s:4:"data";s:7:"2001-10";s:2:"id";s:20:"PUBBLICAZIONE_134249";s:6:"handle";s:10:"2108/66846";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:34:"Settore MED/12 - Gastroenterologia";s:9:"metadata4";N;s:9:"metadata5";s:122:"Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients";s:9:"metadata6";s:173:"Andreoni, M; Goletti, D; Pezzotti, P; Pozzetto, A; Monini, P; Sarmati, L; Farchi, F; Tisone, G; Piazza, A; Pisani, F; Angelico, M; Leone, P; Citterio, F; Ensoli, B; Rezza, G";s:9:"metadata7";s:22:"10.1053/jinf.2001.0899";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:234;a:14:{s:9:"citazione";s:254:"Schatz, O., Monini, P., Neipel, F., Schulz, T.F., Andreoni, M., Erb, P., et al. (2001). Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. JOURNAL OF MEDICAL VIROLOGY, 65(1), 123-132.";s:4:"data";s:7:"2001-09";s:2:"id";s:20:"PUBBLICAZIONE_213085";s:6:"handle";s:11:"2108/106931";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:121:"Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays.";s:9:"metadata6";s:261:"Schatz, O; Monini, P, Bugarini, R; Neipel, F; Schulz, TF; Andreoni, M; Erb, P; Eggers, M; Haas, J; Buttò, S; Lukwiya, M; Bogner, JR; Yaguboglu, S; Sheldon, J; Sarmati, L; Goebel, FD; Hintermaier, R; Enders, G; Regamey N, Wernli M, Stürzl M, Rezza G, Ensoli, B";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:235;a:14:{s:9:"citazione";s:281:"Nicastri, E., Ercoli, L., Sarmati, L., d'Ettorre, G., Iudicone, P., Massetti, P., et al. (2001). Human immunodeficiency virus-1 specific and natural cellular immunity in HIV seronegative subjects with multiple sexual exposures to virus. JOURNAL OF MEDICAL VIROLOGY, 64(3), 232-237.";s:4:"data";s:7:"2001-07";s:2:"id";s:20:"PUBBLICAZIONE_213082";s:6:"handle";s:11:"2108/106925";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:139:"Human immunodeficiency virus-1 specific and natural cellular immunity in HIV seronegative subjects with multiple sexual exposures to virus.";s:9:"metadata6";s:97:"Nicastri, E; Ercoli, L; Sarmati, L; d'Ettorre, G; Iudicone, P; Massetti, P; Vullo, V; Andreoni, M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:236;a:14:{s:9:"citazione";s:249:"Andreoni, M., Goletti, D., Pezzotti, P., Pozzetto, A., Monini, P., Sarmati, L., et al. (2001). Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. JOURNAL OF INFECTION, 195-199.";s:4:"data";s:4:"2001";s:2:"id";s:19:"PUBBLICAZIONE_55031";s:6:"handle";s:10:"2108/23252";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/18 - Chirurgia Generale";s:9:"metadata4";N;s:9:"metadata5";s:123:"Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients.";s:9:"metadata6";s:170:"Andreoni, M; Goletti, D; Pezzotti, P; Pozzetto, A; Monini, P; Sarmati, L; Farchi, F; Tisone, G; Piazza, A; Pisani, F; Angelico, M; Leone P; Citterio F; Ensoli B; Rezza, G";s:9:"metadata7";s:22:"10.1053/jinf.2001.0899";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:237;a:14:{s:9:"citazione";s:234:"Mazzi, R., Parisi, S.G., Sarmati, L., Uccella, I., Nicastri, E., Carolo, G., et al. (2001). Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS [1]. AIDS, 15(15), 2061-2062.";s:4:"data";s:4:"2001";s:2:"id";s:17:"PUBBLICAZIONE_163";s:6:"handle";s:10:"2108/49481";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:116:"Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS [1]";s:9:"metadata6";s:102:"Mazzi, R; Parisi, SG; Sarmati, L; Uccella, I; Nicastri, E; Carolo, G; Gatti, F; Concia, E; Andreoni, M";s:9:"metadata7";s:32:"10.1097/00002030-200110190-00026";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:238;a:14:{s:9:"citazione";s:195:"Rezza, G., Danaya, R., Wagner, T., Sarmati, L., Owen, I., Monini, P., et al. (2001). Human herpesvirus-8 and other viral infections, Papua New Guinea. EMERGING INFECTIOUS DISEASES, 7(5), 893-895.";s:4:"data";s:4:"2001";s:2:"id";s:16:"PUBBLICAZIONE_11";s:6:"handle";s:10:"2108/49482";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:64:"Human herpesvirus-8 and other viral infections, Papua New Guinea";s:9:"metadata6";s:114:"Rezza, G; Danaya, R.T; Wagner, T.M; Sarmati, L; Owen, I.L; Monini, P; Andreoni, M; Suligoi, B; Ensoli, B; Pozio, E";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:239;a:14:{s:9:"citazione";s:359:"Sarmati, L., D'Ettorre, G., Nicastri, E., Ercoli, L., Uccella, I., Massetti, P., et al. (2001). Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 8(4), 822-824.";s:4:"data";s:4:"2001";s:2:"id";s:19:"PUBBLICAZIONE_16467";s:6:"handle";s:10:"2108/49453";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:200:"Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment";s:9:"metadata6";s:108:"Sarmati, L; D'Ettorre, G; Nicastri, E; Ercoli, L; Uccella, I; Massetti, P; Parisi, Sg; Vullo, V; Andreoni, M";s:9:"metadata7";s:29:"10.1128/CDLI.8.4.822-824.2001";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:240;a:14:{s:9:"citazione";s:266:"Sarmati, L., Parisi, S.g., Nicastri, E., D'Ettorre, G., Andreoni, C., Dori, L., et al. (2001). Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations. JOURNAL OF MEDICAL VIROLOGY, 65(4), 631-636.";s:4:"data";s:4:"2001";s:2:"id";s:17:"PUBBLICAZIONE_949";s:6:"handle";s:10:"2108/49474";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:125:"Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations";s:9:"metadata6";s:152:"Sarmati, L; Parisi, Sg; Nicastri, E; D'Ettorre, G; Andreoni, C; Dori, L; Gatti, F; Montano, M; Buonomini, Ar; Boldrin, C; Palu, G; Vullo, V; Andreoni, M";s:9:"metadata7";s:16:"10.1002/jmv.2083";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:241;a:14:{s:9:"citazione";s:222:"Sarrecchia, C., Niutta, P., Testore, G.P., Sordillo, P., Proietti, F., & Andreoni, M. (2001). Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon. RECENTI PROGRESSI IN MEDICINA, 92(5), 336-339.";s:4:"data";s:4:"2001";s:2:"id";s:20:"PUBBLICAZIONE_208354";s:6:"handle";s:10:"2108/99318";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:33:"Settore MED/09 - Medicina Interna";s:9:"metadata4";N;s:9:"metadata5";s:80:"Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon";s:9:"metadata6";s:76:"Sarrecchia, C; Niutta, P; Testore, GP; Sordillo, P; Proietti, F; Andreoni, M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:242;a:14:{s:9:"citazione";s:262:"Serraino, D., Toma, L., Andreoni, M., Buttò, S., Tchangmena, O., Sarmati, L., et al. (2001). A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 17(9), 871-876.";s:4:"data";s:4:"2001";s:2:"id";s:20:"PUBBLICAZIONE_213367";s:6:"handle";s:11:"2108/100890";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:118:"A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area.";s:9:"metadata6";s:118:"Serraino, D; Toma, L; Andreoni, M; Buttò, S; Tchangmena, O; Sarmati, L; Monini, P; Franceschi, S; Ensoli, B; Rezza, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:243;a:14:{s:9:"citazione";s:278:"Testore, G.P., Falco, F., Sarrecchia, C., Sordillo, P., Bontempo, G., & Andreoni, M. (2001). Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 41(1-2), 23-27.";s:4:"data";s:4:"2001";s:2:"id";s:20:"PUBBLICAZIONE_208353";s:6:"handle";s:10:"2108/99160";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:121:"Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome.";s:9:"metadata6";s:75:"Testore, GP; Falco, F; Sarrecchia, C; Sordillo, P; Bontempo, G; Andreoni, M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:244;a:14:{s:9:"citazione";s:265:"Rezza, G., Dorrucci, M., Serraino, D., Andreoni, M., Giuliani, M., Zerboni, R., et al. (2000). Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study. AIDS, 14(11), 1647-1653.";s:4:"data";s:7:"2000-07";s:2:"id";s:20:"PUBBLICAZIONE_213080";s:6:"handle";s:11:"2108/106917";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:145:"Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study.";s:9:"metadata6";s:145:"Rezza, G; Dorrucci, M; Serraino, D; Andreoni, M; Giuliani, M; Zerboni, R; Sarmati, L; Colangeli, V; Salassa, B; Monini, P; Ensoli, B; Pezzotti, P";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:245;a:14:{s:9:"citazione";s:226:"Rezza, G., Tchangmena, O.B., Andreoni, M., Bugarini, R., Toma, L., Bakary, D.K., et al. (2000). Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. SEXUALLY TRANSMITTED DISEASES, 27(3), 159-164.";s:4:"data";s:7:"2000-03";s:2:"id";s:20:"PUBBLICAZIONE_213078";s:6:"handle";s:11:"2108/107107";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:82:"Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon";s:9:"metadata6";s:132:"Rezza, G; Tchangmena, OB; Andreoni, M; Bugarini, R; Toma, L; Bakary, DK; Glikoutou, M; Sarmati, L; Monini, P; Pezzotti, P; Ensoli, B";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:246;a:14:{s:9:"citazione";s:298:"Andreoni, M., Parisi, S.G., Sarmati, L., Nicastri, E., Ercoli, L., Mancino, G., et al. (2000). ellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy. AIDS, 14(1), 23-29.";s:4:"data";s:7:"2000-01";s:2:"id";s:20:"PUBBLICAZIONE_213076";s:6:"handle";s:11:"2108/106923";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:183:"ellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy.";s:9:"metadata6";s:144:"Andreoni, M; Parisi, SG; Sarmati, L; Nicastri, E; Ercoli, L; Mancino, G; Sotgiu, G; Mannazzu, M; Trevenzoli, M; Tridente, G; Concia, E; Aceti, A";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:247;a:14:{s:9:"citazione";s:251:"Nicastri, E., Sarmati, L., Andreoni, M., Biggar, R.J., Black, F., & Whitby, D. (2000). Human herpesvirus 8 in Brazilian Amerindians: Does vertical transmission play a role? [1] (multiple letters). THE JOURNAL OF INFECTIOUS DISEASES, 182(5), 1574-1575.";s:4:"data";s:4:"2000";s:2:"id";s:18:"PUBBLICAZIONE_6826";s:6:"handle";s:10:"2108/49466";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:108:"Human herpesvirus 8 in Brazilian Amerindians: Does vertical transmission play a role? [1] (multiple letters)";s:9:"metadata6";s:69:"Nicastri, E; Sarmati, L; Andreoni, M; Biggar, RJ; Black, F; Whitby, D";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:248;a:14:{s:9:"citazione";s:272:"Testore, G.P., Uccella, I., Sarrecchia, C., Mattei, A., Impagliazzo, A., & Andreoni, M. (2000). Long-term intramuscular teicoplanin treatment of chronic osteomyelitis due to oxacillin-resistant Staphylococcus aureus in outpatients. JOURNAL OF CHEMOTHERAPY, 12(5), 412-415.";s:4:"data";s:4:"2000";s:2:"id";s:20:"PUBBLICAZIONE_208356";s:6:"handle";s:10:"2108/99317";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:134:"Long-term intramuscular teicoplanin treatment of chronic osteomyelitis due to oxacillin-resistant Staphylococcus aureus in outpatients";s:9:"metadata6";s:91:"Testore, GP; Uccella, I; Sarrecchia, C; Mattei, A; Impagliazzo, A, Sordillo, P; Andreoni, M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:249;a:14:{s:9:"citazione";s:295:"Ascoli, V., Sirianni, M.c., Mezzaroma, I., Mastroianni, C.m., Vullo, V., Andreoni, M., et al. (1999). Human herpesvirus-8 in lymphomatous and nonlymphomatous body cavity effusions developing in Kaposi's sarcoma and multicentric Castleman's disease. ANNALS OF DIAGNOSTIC PATHOLOGY, 3(6), 357-363.";s:4:"data";s:7:"1999-12";s:2:"id";s:20:"PUBBLICAZIONE_289395";s:6:"handle";s:11:"2108/161776";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/15 - Malattie del Sangue";s:9:"metadata4";N;s:9:"metadata5";s:145:"Human herpesvirus-8 in lymphomatous and nonlymphomatous body cavity effusions developing in Kaposi's sarcoma and multicentric Castleman's disease";s:9:"metadata6";s:136:"Ascoli, V; Sirianni, Mc; Mezzaroma, I; Mastroianni, Cm; Vullo, V; Andreoni, M; Narciso, P; Scalzo, Cc; Nardi, F; Pistilli, A; Lo Coco, F";s:9:"metadata7";s:20:"10.1053/ADPA00300357";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:250;a:14:{s:9:"citazione";s:280:"Rezza, G., Andreoni, M., Dorrucci, M., Pezzotti, P., Monini, P., Zerboni, R., et al. (1999). Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 91(17), 1468-1474.";s:4:"data";s:7:"1999-09";s:2:"id";s:20:"PUBBLICAZIONE_213074";s:6:"handle";s:11:"2108/107128";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:126:"Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases.";s:9:"metadata6";s:181:"Rezza, G; Andreoni, M; Dorrucci, M; Pezzotti, P; Monini, P; Zerboni, R; Salassa, B; Colangeli, V; Sarmati, L; Nicastri, E; Barbanera, M; Pristerà, R; Aiuti, F; Ortona, L; Ensoli, B";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:251;a:14:{s:9:"citazione";s:266:"Andreoni, M., El-Sawaf, G., Rezza, G., Ensoli, B., Nicastri, E., Ventura, L., et al. (1999). High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 91(5), 465-469.";s:4:"data";s:7:"1999-03";s:2:"id";s:20:"PUBBLICAZIONE_213366";s:6:"handle";s:11:"2108/106932";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:115:"High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission.";s:9:"metadata6";s:104:"Andreoni, M; El-Sawaf, G; Rezza, G; Ensoli, B; Nicastri, E; Ventura, L; Ercoli, L; Sarmati, L; Rocchi, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:252;a:14:{s:9:"citazione";s:157:"Nicastri E., S.L. (1999). Reduction of IFN-gamma and IL-2 production by peripheral lymphocytes of HIV-exposed seronegative subjects. AIDS, 13(11), 1333-1336.";s:4:"data";s:4:"1999";s:2:"id";s:19:"PUBBLICAZIONE_18037";s:6:"handle";s:10:"2108/49451";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:105:"Reduction of IFN-gamma and IL-2 production by peripheral lymphocytes of HIV-exposed seronegative subjects";s:9:"metadata6";s:116:"Nicastri E., Sarmati L., Ercoli L., Mancino G., D'Ambrosio E., D'Ettorre G., Mastroianni C.M., Vullo V., Andreoni M.";s:9:"metadata7";s:32:"10.1097/00002030-199907300-00009";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:253;a:14:{s:9:"citazione";s:261:"Andreoni, M., Sarmati, L., Nicastri, E., Ventura, L., Ercoli, L., Parisi, S.G., et al. (1998). Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy. JOURNAL OF MEDICAL VIROLOGY, 56(4), 332-336.";s:4:"data";s:7:"1998-12";s:2:"id";s:20:"PUBBLICAZIONE_213071";s:6:"handle";s:11:"2108/106918";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:121:"Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy.";s:9:"metadata6";s:107:"Andreoni, M; Sarmati, L; Nicastri, E; Ventura, L; Ercoli, L; Parisi, SG; Giannini, G; Galluzzo, C; Vella, S";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:254;a:14:{s:9:"citazione";s:262:"Nicastri, E., Ercoli, L., Sarmati, L., Ventura, L., Parisi, S.G., Ciapetti, C., et al. (1998). Five human immunodeficiency virus type 1 phenotypic variants with different MT-2 cell tropisms correlate with prognostic markers of disease. JOURNAL OF HUMAN VIROLOGY.";s:4:"data";s:7:"1998-01";s:2:"id";s:20:"PUBBLICAZIONE_213073";s:6:"handle";s:11:"2108/106921";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:139:"Five human immunodeficiency virus type 1 phenotypic variants with different MT-2 cell tropisms correlate with prognostic markers of disease";s:9:"metadata6";s:97:"Nicastri, E; Ercoli, L; Sarmati, L; Ventura, L; Parisi, SG; Ciapetti, C; Montano, M; Andreoni, M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:255;a:14:{s:9:"citazione";s:243:"Ercoli, L., Sarmati, L., Nicastri, E., Giannini, G., Galluzzo, C., Vella, S., et al. (1997). HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity. AIDS, 11(10), 1211-1217.";s:4:"data";s:7:"1997-08";s:2:"id";s:20:"PUBBLICAZIONE_208851";s:6:"handle";s:10:"2108/99235";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:124:"HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity";s:9:"metadata6";s:83:"Ercoli, L; Sarmati, L; Nicastri, E; Giannini, G; Galluzzo, C; Vella, S; Andreoni, M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:256;a:14:{s:9:"citazione";s:267:"Andreoni, M., Sarmati, L., Ercoli, L., Nicastri, E., Giannini, G., Galluzzo, C., et al. (1997). Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy. AIDS RESEARCH AND HUMAN RETROVIRUSES, 13(7), 555-561.";s:4:"data";s:7:"1997-05";s:2:"id";s:20:"PUBBLICAZIONE_208852";s:6:"handle";s:10:"2108/99234";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:117:"Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy.";s:9:"metadata6";s:96:"Andreoni, M; Sarmati, L; Ercoli, L; Nicastri, E; Giannini, G; Galluzzo, C; Pirillo, MF; Vella, S";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:257;a:14:{s:9:"citazione";s:202:"Sarmati L., N.E. (1997). Increase in neutralizing antibody titer against sequential autologous HIV-1 isolates after 16 weeks saquinavir (invirase) treatment. JOURNAL OF MEDICAL VIROLOGY, 53(4), 313-318.";s:4:"data";s:4:"1997";s:2:"id";s:19:"PUBBLICAZIONE_18092";s:6:"handle";s:10:"2108/49450";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:131:"Increase in neutralizing antibody titer against sequential autologous HIV-1 isolates after 16 weeks saquinavir (invirase) treatment";s:9:"metadata6";s:96:"Sarmati L., Nicastri E., El-Sawaf G., Ventura L., Salanitro A., Ercoli L., Vella S., Andreoni M.";s:9:"metadata7";s:60:"10.1002/(SICI)1096-9071(199712)53:4<313::AID-JMV1>3.0.CO;2-A";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:258;a:14:{s:9:"citazione";s:342:"Vella, S., Galluzzo, C., Giannini, G., Pirillo, M.F., Duncan, I., Jacobsen, H., et al. (1996). Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity. ANTIVIRAL RESEARCH, 29(1), 91-93.";s:4:"data";s:7:"1996-01";s:2:"id";s:20:"PUBBLICAZIONE_208849";s:6:"handle";s:10:"2108/99233";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:213:"Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity.";s:9:"metadata6";s:107:"Vella, S; Galluzzo, C; Giannini, G; Pirillo, MF; Duncan, I; Jacobsen, H; Andreoni, M; Sarmati, L; Ercoli, L";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:259;a:14:{s:9:"citazione";s:234:"Ercoli, L., Sarmati, L., Parisi, S., Mancino, G., DE SANTIS, G., Bonanno, E., et al. (1996). Human immunodeficiency virus infection of human bone marrow stromal myoid cells. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 28(4), 335-340.";s:4:"data";s:4:"1996";s:2:"id";s:20:"PUBBLICAZIONE_204088";s:6:"handle";s:11:"2108/194373";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:79:"Human immunodeficiency virus infection of human bone marrow stromal myoid cells";s:9:"metadata6";s:107:"Ercoli, L; Sarmati, L; Parisi, S; Mancino, G; DE SANTIS, G; Bonanno, E; Spagnoli, L; Rocchi, G; Andreoni, M";s:9:"metadata7";s:25:"10.3109/00365549609037915";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:260;a:14:{s:9:"citazione";s:234:"Ercoli, L., Sarmati, L., Parisi, S., Mancino, G., De Santis, G., Bonanno, E., et al. (1996). Human immunodeficiency virus infection of human bone marrow stromal myoid cells. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 28(4), 335-340.";s:4:"data";s:4:"1996";s:2:"id";s:20:"PUBBLICAZIONE_136165";s:6:"handle";s:10:"2108/69296";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:36:"Settore MED/08 - Anatomia Patologica";s:9:"metadata4";N;s:9:"metadata5";s:79:"Human immunodeficiency virus infection of human bone marrow stromal myoid cells";s:9:"metadata6";s:107:"Ercoli, L; Sarmati, L; Parisi, S; Mancino, G; De Santis, G; Bonanno, E; Spagnoli, L; Rocchi, G; Andreoni, M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:261;a:14:{s:9:"citazione";s:242:"Ercoli, L., Sarmati, L., El Sawaf, G., Cochi, S., Lanti, T., Iudicone, P., et al. (1995). Plasma Viremia Titration and RNA Quantitation in ICD-p24 Negative HIV Type-1-Infected Patients. AIDS RESEARCH AND HUMAN RETROVIRUSES, 11(10), 1203-1207.";s:4:"data";s:7:"1995-10";s:2:"id";s:20:"PUBBLICAZIONE_208848";s:6:"handle";s:10:"2108/99232";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:94:"Plasma Viremia Titration and RNA Quantitation in ICD-p24 Negative HIV Type-1-Infected Patients";s:9:"metadata6";s:143:"Ercoli, L; Sarmati, L; El Sawaf, G; Cochi,S; Lanti, T;Iudicone, P; Guglielmetti, M; Giannini, M; Galluzzo, C; Tomino, C; Andreoni, M; Vella, S";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:262;a:14:{s:9:"citazione";s:264:"Sarmati, L., Ercoli, L., Parisi, S.g., Rocchi, G., Giannini, G., Galluzzo, C., et al. (1994). High rate of HIV isolation from plasma of asymptomatic patients through polyethylene glycol (PEG) treatment. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 7(1), 10-14.";s:4:"data";s:4:"1994";s:2:"id";s:18:"PUBBLICAZIONE_5853";s:6:"handle";s:10:"2108/49467";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:107:"High rate of HIV isolation from plasma of asymptomatic patients through polyethylene glycol (PEG) treatment";s:9:"metadata6";s:93:"Sarmati, L; Ercoli, L; Parisi, Sg; Rocchi, G; Giannini, G; Galluzzo, C; Vella, S; Andreoni, M";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:263;a:14:{s:9:"citazione";s:221:"Andreoni, M., Sarmati, L., Parisi, S.G., Ercoli, L., & Rocchi, G. (1992). Efficient and reproducible new semimicromethod for the detection and titration of HIV in human plasma. JOURNAL OF MEDICAL VIROLOGY, 38(3), 207-213.";s:4:"data";s:7:"1992-11";s:2:"id";s:20:"PUBBLICAZIONE_208840";s:6:"handle";s:10:"2108/99231";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:101:"Efficient and reproducible new semimicromethod for the detection and titration of HIV in human plasma";s:9:"metadata6";s:57:"Andreoni, M; Sarmati, L; Parisi, SG; Ercoli, L; Rocchi, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:264;a:14:{s:9:"citazione";s:288:"Sarmati, L., Parisi, S.G., Armignacco, O., Sarrecchia, C., Antonucci, G., Ercoli, L., et al. (1992). HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI]. Paper presented at International Conference on AIDS, Amsterdam.";s:4:"data";s:4:"1992";s:2:"id";s:19:"PUBBLICAZIONE_18559";s:6:"handle";s:10:"2108/49449";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:35:"Settore MED/17 - Malattie Infettive";s:9:"metadata4";N;s:9:"metadata5";s:122:"HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI]";s:9:"metadata6";s:101:"Sarmati, L; Parisi, SG; Armignacco, O; Sarrecchia, C; Antonucci, G; Ercoli, L; Andreoni, M; Rocchi, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:265;a:14:{s:9:"citazione";s:254:"Andreoni, M., El-Bassiouni, E.A., Giannini, F., Rocchi, G., & Vatalaro, F. (1989). Definition and design of an integrated satellite system for telemedicine and distance learning. Paper presented at 37° convegno int. delle comunicazioni, Genova - Italia.";s:4:"data";s:4:"1989";s:2:"id";s:19:"PUBBLICAZIONE_67182";s:6:"handle";s:10:"2108/34333";s:9:"metadata1";s:21:"Intervento a convegno";s:9:"metadata2";N;s:9:"metadata3";s:38:"Settore ING-INF/03 - Telecomunicazioni";s:9:"metadata4";N;s:9:"metadata5";s:94:"Definition and design of an integrated satellite system for telemedicine and distance learning";s:9:"metadata6";s:66:"Andreoni, M; El-Bassiouni, EA; Giannini, F; Rocchi, G; Vatalaro, F";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:266;a:14:{s:9:"citazione";s:228:"Sarmati, L., Andreoni, M., Arcese, W., Pica, F., Bianchi, A., Mauro, F., et al. (1987). L'infezione da Citomegalovirus in 16 pazienti sottoposti a trapianto di midollo. GIORNALE DI MALATTIE INFETTIVE E PARASSITARIE, 39, 935-936.";s:4:"data";s:4:"1987";s:2:"id";s:20:"PUBBLICAZIONE_142944";s:6:"handle";s:10:"2108/69409";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:80:"L'infezione da Citomegalovirus in 16 pazienti sottoposti a trapianto di midollo.";s:9:"metadata6";s:85:"Sarmati, L; Andreoni, M; Arcese, W; Pica, F; Bianchi, A; Mauro, F; Papa, G; Rocchi, G";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:267;a:14:{s:9:"citazione";s:188:"Andreoni M, R.L. (1985). Indagini sull'infezione da virus Herpes simplex in casi di vaginite aspecifica in gravidanza. vol. 37, p. 1009-1010. GIORNALE DI MALATTIE INFETTIVE E PARASSITARIE.";s:4:"data";s:4:"1985";s:2:"id";s:20:"PUBBLICAZIONE_142965";s:6:"handle";s:10:"2108/69412";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:115:"Indagini sull'infezione da virus Herpes simplex in casi di vaginite aspecifica in gravidanza. vol. 37, p. 1009-1010";s:9:"metadata6";s:74:"Andreoni M, Reverberi L, Pica F, Cecinato F, Vercelli B, Volpi A, Magno MS";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}}" } ["meta_keywords"]=> array(1) { [0]=> string(1) "," } ["reserved"]=> array(1) { [0]=> string(1) "0" } ["auth_ip"]=> array(1) { [0]=> string(1) "0" } } ["_fieldBoosts":protected]=> array(6) { ["content_id"]=> bool(false) ["content_title"]=> bool(false) ["description"]=> bool(false) ["meta_keywords"]=> bool(false) ["reserved"]=> bool(false) ["auth_ip"]=> bool(false) } } }